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Abstract 
Background and purpose:  
In vivo dosimetry is one of the quality assurance tools used in radiotherapy to 
monitor the dose delivered to the patient. The digital image format makes 
electronic portal imaging devices (EPIDs) good candidates for in vivo dosimetry. 
Currently there is no commercial transit dosimetry module, which could 
facilitate routine in vivo dosimetry with the EPID. Some centres are developing 
their in-house packages, and they are under assessment before introduction into 
routine clinical usage. The main purpose of this work was to develop the EPID as 
an in vivo dosimetry device. 
 
Materials and methods:  
Knowledge of a detector’s dose-response behaviour is a prerequisite for any 
clinical dosimetric application, hence in the first phase of the study, the 
dosimetric characteristics of eleven Varian a-Si500 EPIDs that are in clinical use 
in our centre were investigated. The devices have been in use for varying 
periods and interfaced with two different acquisition control software packages, 
IAS2 / IDU-II or IAS3 / IDU-20. Properties investigated include: linearity, 
reproducibility, signal uniformity, field size and dose-rate dependence, memory 
effects and image profiles as a function of dose. In the second phase, an EPID 
was calibrated using the quadratic method to yield values for the entrance and 
exit doses at the phantom or patient. EPID images for a set of solid water 
phantoms of varying thicknesses were acquired and the data fitted onto a 
quadratic equation, which relates the reduction in photon beam intensity to the 
attenuation coefficient and material thickness at a reference condition. The 
quadratic model was used to convert the measured grey scale value into water 
equivalent path length (EPL) at each pixel for any material imaged by the 
detector. For any other non-reference conditions, scatter, field size and MU 
variation effects on the image were corrected. The 2D EPL is linked to the 
percentage exit-dose for different thicknesses and field sizes, thereby 
converting the plane pixel values at each point into a 2D dose map at the exit 
surface of the imaged material. The off axis ratio is corrected using envelope 
and boundary profiles generated from the treatment planning system (TPS). The 
method was extended to include conformal and enhanced dynamic wedge (EDW) 
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fields. A method was devised for the automatic calculation of areas (to establish 
the appropriate scatter correction) from the EPID image that facilitated the 
calculation of EPL for any field, and hence exit dose. For EDW fields, the fitting 
coefficients were modified by utilizing the Linac manufacturer’s golden 
segmented treatment tables (STT) methodology. Cross plane profiles and 2D 
dose distributions of EPID predicted doses were compared with those calculated 
with the Eclipse 8.6 treatment planning system (TPS) and those measured 
directly with a MapCHECK 2 device. 
Results:  
The image acquisition system influenced the dosimetric characteristics with the 
newer version (IAS3 with IDU-20) giving better data reproducibility and linearity 
fit than the older version (IAS2 with IDU-II). The irradiated field areas can be 
accurately determined from EPID images to within ± 1% uncertainty. The EPID 
predicted dose maps were compared with calculated doses from TPS at the exit. 
The gamma index at 3% dose difference (DD) and 3mm distance to agreement 
(DTA) resulted in an average of 97% acceptance for the square fields of 5, 10, 15 
and 20 cm thickness solid water homogeneous phantoms. More than 90% of all 
points passed the gamma index acceptance criteria of 3% DD and 3mm DTA, for 
both conformal and EDW study cases. Comparison of the 2D EPID dose maps to 
those from TPS and MapCHECK shows that, more than 90% of all points passed 
the gamma index acceptance criteria of 3% dose difference and 3mm distance to 
agreement, for both conformal and EDW study cases. 
Conclusions:  
The quadratic calibration can effectively predict EPL and hence exit dose. Good 
agreement between the EPID predicted and TPS calculated dose distributions 
were obtained for open fields, conformal and EDW test cases. There were 
noteworthy deviations between EPID, TPS and MapCHECK doses on field edges. 
But it should be emphasised that, for practical in vivo dosimetry, these areas of 
reduced accuracy at the field edges are much less important.  It is concluded 
that the EPID Quadratic Calibration Method (QCM) is an accurate and convenient 
method for online in vivo dosimetry and may therefore replace existing 
techniques. 
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1 CHAPTER ONE: INTRODUCTION AND AIM OF THIS 
RESEARCH 
1.1 Radiotherapy 
Radiation has been used in medicine for diagnostic and therapeutic purposes 
since the discovery of x-rays over one hundred years ago. Radiotherapy is the 
use of high energy x-rays and other ionising radiation such as gamma rays, 
electrons, protons, etc to treat diseases.  The radiotherapy process is complex 
and involves a series of procedural steps beginning with patient diagnosis, 
disease staging and lastly the treatment of a specified target volume with 
predetermined radiation energies and beam parameters. Currently 80% of cancer 
patients will require radiotherapy as part of their treatment (Janaki et al, 2010), 
complementing other cancer treatment modalities like surgery, chemotherapy, 
hormonotherapy or immunotherapy.   
Radiotherapy is subdivided into two major branches: internal 
(Brachytherapy) and external (Teletherapy). In internal radiotherapy the sources 
are placed in contact with the patient. Mainly sealed sources of radioactive 
nuclides such as Ir-192, Cs-137, Co-60, Au-198, I-125, etc with different 
characteristics are used in treatment. On the other hand is external beam 
radiotherapy, where the radiation source is at a distance from the patient. The 
most widely used external type of treatment is by photon beam. External photon 
beams fall into two categories depending on their origin, means of production 
and energy. The first categories are the gamma rays, which originate from 
radioactive nuclei such as Cobalt-60 radiocative sources units. The second 
categories are the X rays which originate in a target bombarded with energetic 
electrons. The X rays are produced either in an X ray tube (orthovoltage X rays) 
or in a linear accelerator (linac) (megavoltage X rays). Photon and electron 
beams produced by linacs are the most commonly used beams in cancer 
treatments. A very small fraction of treatments are carried out by particles such 
as protons, neutrons and other heavier ions, but many of these are still under 
investigation. This study was conducted with external photon beams, using a 
Linear accelerator. 
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1.2 Portal dosimetry and Equivalent Path Length 
The principal focus of this study is on portal dosimetry, which is defined as 
the extraction of quantitative dosimetric information from a portal image (image 
taken behind the irradiated object). Portal dosimetry can be done mainly with a 
film and electronic portal imaging devices (EPID); limited information can be 
obtained from using TLDs, diodes, etc. Portal dosimetry is subdivided into transit 
(where photon beams pass through a phantom or patient) and non-transit 
dosimetry (where there is no attenuating material between the beam source and 
the imaging device). EPID portal dosimetry is achieved by the acquisition of 
grayscale images and conversion to 2D dose maps in the plane of the imager. 
 
The presence in a patient’s body of many different tissues each with its 
own density and chemical composition constitutes a big challenge in 
radiotherapy, since it would require simulating the ions traversals through all 
these materials. One possibility of approaching this problem is to apply the 
concept of water equivalent path length (EPL), defined as the radiological depth 
between a source and a any other point of interest or calculation point, as 
determined by the linear attenuation of each material in the path. In other 
words, if we consider a single radiation ray traversing several tissues of different 
thicknesses and densities, the EPL concept scales all these tissues to the depth 
of water which has the same attenuating effects. In this study we calibrated 
EPID images to determine the EPL, hence the term EPL is used to denote the 
water thicknesses at each EPID pixel location of the imaged phantom, measured 
via the transmission of mega voltage photon beams.  
 
1.3 Major structural components of a medical Linear 
accelerator 
Figure 1.1 shows a photograph of a Varian medical linear accelerator (Varian 
Medical Systems, Palo Alto, California, USA), showing the main structural 
components. 
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Figure 1- 1. Varian linear accelerator (Model ix) 
 
1.3.1 The gantry and treatment couch 
The beam is generated within the gantry, which rotates around the patient. The 
patient lies on a moveable treatment couch that can move in many directions 
including vertical (up / down), lateral (right / left) and longitudinally (in / out). 
Radiation can be delivered to the tumour from any angle by rotating the gantry 
and moving the treatment couch. Alignment and precision of the linear 
accelerator gantry and the treatment table are very important parameters in the 
quality of patient treatment. In operating a linear accelerator, the gantry and 
collimator rotate around the isocentre (a point in space where radiation beams 
intersect when the gantry is rotated), and laser (used to make sure the patient is 
in the proper position) alignment are important parameters for commissioning 
and quality assurance. The geometric gantry accuracy of 1.0 mm radius at the 
isocentre is required to deliver a precise dose distribution in conformal and 
advanced treatment techniques such as intensity modulated radiation therapy 
(IMRT) image guided radiation therapy (IGRT) and stereotactic treatments. 
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1.3.2 The treatment head 
To make use of and control the produced radiation, all accelerators are designed 
with a treatment head which provides sufficient shielding against leakage 
radiation, consisting of a thick shell of high-density shielding material such as 
lead or tungsten. The treatment head contains many components and the major 
ones are: X-ray target, primary fixed collimator, scattering foils, flattening 
filter, ion chamber dosimetry system (two completely independent systems 
located directly under the x-ray flattening filter which monitor delivered dose, 
dose rate and beam symmetry), secondary adjustable jaws and the multi leaf 
collimator (MLC) system that provides mechanically variable collimation. 
 
1.3.3 Electronic portal imaging device 
A critical requirement in radiation therapy is accurate day-to-day treatment 
setup. The primary objective for the development of the electronic portal 
imaging devices (EPID) was to provide high quality portal images. A Portal image 
is obtained by positioning any 2D radiation detector such as film in the radiation 
beam, behind a patient while on treatment.  The primary purpose is to verify 
patient position under actual conditions of treatment, which is an essential 
component of a patients’ treatment. The EPID is mounted at the base of the 
treatment machine and controlled via a robotically controlled arm. The 
retractable arm allows quick and easy set up of the image detector during 
clinical operation and hence saves time. The EPID retractable arm has the 
capability of moving the radio-sensitive part of the detector to any desired 
vertical, horizontal or lateral position within its geometrical operating positions.  
 
 
1.3.4 On-board Imager 
The On-Board Imager (OBI) device is used for verification of correct patient 
position in relation to the isocentre and verification of the treatment fields in 
relation to assigned landmarks in radiotherapy treatments. The OBI is an 
automated system recently added to modern linacs, specifically to ease IGRT 
treatments by managing patient and target movement- both before and during 
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treatments. The OBI is a kilovoltage X ray imaging system that improves tumour 
targeting using high resolution, low dose digital imaging in the treatment room. 
The use of kV imaging means lower patient dose and provides better image 
quality than megavoltage imaging performed with an EPID. Similar to the EPID, 
the OBI is mounted on the treatment machine via robotically controlled arms 
which operate along three axes of motion so that they can be positioned for the 
best possible view of the tumour. The OBI provides the tools to manage both 
interfraction motion (changes in position caused by day-to-day set up conditions) 
and intrafraction motion (changes in position during a treatment session because 
of normal respiratory, organ motion and patient movement). The system allows 
a number of imaging choices including: 2D radiographic, fluoroscopic or 3D Cone 
beam CT imaging modalities. 
 
1.3.5 Support systems 
A medical accelerator has several ancillary systems that include: the power 
supply system, cooling water system, dielectric gas system, interlock and control 
systems.  
• The power supply system: The external power supply delivers the power 
required to operate the entire unit.  
• The cooling water system: Cooling is necessary in order to maintain a 
precise temperature control for stability of operation. The main parts 
which need cooling include: microwave generator, accelerating 
waveguide structure, radiofrequency isolators, pulse modulator, high 
power transformers, beam focusing and steering coils and X ray target. 
For convenience, the same cooling system is used for all components to 
be cooled, requiring water to be supplied at a fixed flow rate and 
temperature.  
• The dielectric gas system: The transition section between the Klystron (on 
dual energy accelerators) and transmission waveguide needs to be gas 
filled and is operated at high pressure to prevent sparking. It is typically 
operated at twice atmospheric pressure and filled with Sulphur 
Hexafluoride (SF6) gas. The circulating water provides surface cooling for 
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the dielectric load. Both gas filled sections of the microwave system are 
separated from the evacuated sections by the waveguide windows. The 
high pressure system is usually fitted with a gauge and pressure operated 
switch which provides an interlock, inhibiting the operation of the 
modulator if the pressure falls bellow a pre-set level. 
1.4 Radiation beam production 
Accelerators used in radiotherapy accelerate bunches of electrons either by 
travelling or stationary electromagnetic (EM) waves to high energies through a 
disc loaded tube at frequencies in the microwave (≈ 3000 MHz, wavelength ≈10 
cm) region, in a vacuum. Radiotherapy accelerators accelerate electrons either 
by travelling or standing waves, and the main difference between the two is the 
design of the accelerator structure. Travelling wave structure requires a 
terminating load to absorb the residual power at the end of structure preventing 
backward reflected waves. The standing wave provides maximum reflection of 
the waves at both ends of the structure such that the combination of forward 
and reverse travelling waves will give rise to standing waves. Figure 1-2 shows 
the block diagram of the main components commonly used in a medical linear 
accelerator, adapted from Khan (2003). The accelerator structure is quite 
complex, but mainly consists of an evacuated copper tube with its interior 
divided by copper discs of varying aperture and spacing. Pulsed microwaves 
produced in the Magnetron or Klystron are injected into the accelerator 
structure via a wave guide system and at the same instant electrons produced 
from the electron gun are also pulse injected into the accelerator structure. As 
the electrons are injected into the accelerator structure with an initial energy of 
≈ 50 KeV, the electrons interact with the EM field of the microwaves and the 
electrons gain energy from the sinusoidal electric field. After the electrons have 
been accelerated the full length of the wave guide, the electron energy will 
depend mainly on the wave guide design, power applied to it and the current in 
the wave guide.  
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Figure 1- 2. Block diagram, illustrating the major components of the accelerator needed for 
the generation of the radiation beam (Adapted from Khan, 2003). 
 
The high-energy electrons emerge from the exit window of the accelerator 
structure in a pencil beam ≈ 3 mm in diameter. In the electron mode, this beam 
is made to strike a scattering foil in order to spread the beam and to get uniform 
electron fluence across the treatment field. In the photon mode, after electrons 
have been accelerated to relativistic velocities, they strike a target and forward 
peaked photons with a broad energy spectrum are emitted due to 
bremsstrahlung production. As a result of the collisions, high-energy x-rays are 
produced from the target. In this case the collimated beam then passes through 
the flattening filter whose main function is to modify the forward peaked X-ray 
beam to a uniform beam and to filter the low energy X-rays. These high energy 
x-rays are directed to the patient’s tumour and shaped as they exit the machine 
to conform to the shape of the patient’s tumour. The beam may be shaped 
either by moving jaws that are placed in the head of the machine, by a multi-
leaf collimator (MLC) that is incorporated into the head of the machine or a 
combination of both. 
 
 
 8 
1.5 Physical properties of radiotherapy beams 
1.5.1 Electron beam properties 
A number of different types of particles e.g electrons, protons, neutrons and 
heavy ions are in use in radiotherapy and of these electrons and protons have 
gained wide spread use. The most clinically useful energy range for electrons is 
4-22 MeV (Khan, 2003) and at these energies the electron beam can be used for 
the treatment of superficial tumours less than 5 cm deep. Because electrons are 
charged, they rapidly ionise the matter through which they are passing and 
therefore they are referred to as directly ionising radiation. In the process they 
lose energy, which falls off rapidly with depth in matter, hence their inability to 
deliver high dosages to deeper tissues. Typical applications for electron 
radiation include the treatment of skin cancers, chest wall irradiation for breast 
cancers, para-spinal lesions, some head and neck cancers and boosting dose to 
nodes. Although there are many similarities between the behaviour of electron 
and photon beams, there are also many differences and chief among the 
differences are summarised below (ICRU report 42, 1987):  
1) One of the main features of the electron beam that makes it attractive for 
radiotherapy is the steep fall-off of the depth-dose curve beyond the dose 
maximum.  
2) The broadening of the dose distribution with depth resulting in a bulged shape 
in the penumbra region. 
3) The complex behaviour of electrons in and around tissue inhomogeneities due 
to multiple scattering. 
4) The shape of the dose distribution particularly at depths greater than the 
electron beam range which is due to the bremsstrahlung produced mainly in the 
radiation head of the Linac and also irradiated material / patient. 
 
1.5.2 Photon beam properties 
Photons are often referred to as X-rays (generated as a result of atomic process) 
or γ-rays which is a result of decay of radioactive sources (nuclear process). X-
radiation is mainly produced when fast moving electrons strike a high density 
target material and depending on the energy of incident electrons, either low or 
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high (or a combination of both) energy X-rays may be produced. Clinical X-ray 
beams typically range in energy between 10 kVp and 50 MV (Podgorsak, 2005). X-
rays in the energy range between 10 – 50 kVp are used for diagnostic purposes. 
For therapeutic purposes the energy range is subdivided into superficial (50 -200 
kVp), orthovoltage (200 to 500 kVp) and mega-voltage (0.5 to 50 MV). The most 
commonly used photon beams in radiotherapy range between 4 to 20 MV, 
produced from linear accelerators.  Because photons have no charge, they are 
often referred to as indirectly ionising radiation and this physical property plays 
a fundamental role in their interaction mechanism. When photons interact with 
matter, ionisation is produced as a secondary effect, and this reaches a peak 
value at a certain depth from the surface, resulting in relatively less dose to the 
surface. This phenomenon leads to a skin sparing effect observed when patients 
are irradiated. An important consideration in the use of mega voltage photon 
beams for the treatment of cancer is the amount of surface dose delivered to 
the patient (Petti et al, 1983). One of the main characteristics of a high energy 
photon beam is its ability to penetrate deep into tissue while depositing energy 
in the form of radiation dose, and because of this, photons are mainly used for 
the treatment of deep seated tumours. Principal applications for photon 
radiation include the treatment of cancers of the prostate, cervix, oesophagus, 
lung, etc. 
 
1.5.3 Interaction processes 
The most important phenomena during interactions of radiotherapy photon 
beams are: 
- Attenuation of photons by scattering and absorption 
- Energy transfer to charged particles, i.e electrons and positrons 
- Transport of charged particles 
- Deposition of energy 
The three most important photon interaction types relevant at energies used in 
radiotherapy (Metcalfe et al, 1997, Cherry et al 1998, Khan 2003) are 
photoelectric, Compton and pair production processes. Other interaction 
processes are the coherent (Classical or Rayleigh) scattering and gamma-n 
interactions, although their cross sections are small at radiotherapy energies. 
Figure 1-3 summarises the main interaction processes. The probability of each is 
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determined by a cross-section which depends on the photon energy and on the 
density and atomic number of the medium. 
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Figure 1- 3. Primary photon interaction processes with their secondary emissions 
 
 
1.5.3.1 Photoelectric absorption 
The photoelectric interaction is more probable at low photon energies and 
interactions occur with inner shell electrons e.g the K or L shells. All the energy 
of the incident photon (hν) is transferred to a bound electron, which is ejected 
from the atom with kinetic energy Ee = hν-Eb, where Eb is the binding energy of 
the electron in the atom. A vacancy left in the shell after the ejection of the 
photoelectron is filled by electrons from outer orbits, and in the process 
characteristic x-rays are emitted. Auger electrons, which are mono-energetic, 
are emitted as a result. 
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1.5.3.2 Compton scattering 
Compton scattering is the dominant photon interaction process at beam energies 
used in Megavoltage radiotherapy, replacing the photoelectric effect as the 
chief means of removing photons from the initial beam. It is the predominant 
interaction process in soft tissue at energies in the range of 200 kV to 2 MV. In 
these energy ranges, the energy of the incident photon is much greater than the 
binding energy of the atomic electrons. The interaction occurs with the 
outermost shell electrons that have negligible binding energies, resulting in the 
electron and scattered photon being ejected from the atom. By energy 
conservation, the incident photon energy (hν) is equal to the sum of the 
scattered photon energy and the kinetic energy of the ejected electron. The 
main outcome of the Compton scattering process is the ionisation of the atom. 
 
1.5.3.3 Pair production   
Pair production is most predominant at very high energies, with a threshold 
photon energy of 1.022 MeV (equivalent to 2moC
2, where mo is the electron rest 
mass and C is the speed of light) required to supply the rest energy of the two 
particles. At high energies, the incident photon escapes interaction with the 
electron cloud and enters the strong field surrounding an atomic nucleus. The 
photon disappears totally resulting in the formation of two oppositely charged 
ion particles, a positron and electron. The photon’s energy in excess of the 
threshold is imparted to the ion pair as kinetic energy. That is, the total kinetic 
energy shared by the ion pairs is (hν - 2moC
2). Annihilation radiation occurs when 
the positron comes to rest and combines with an electron. 
 
1.5.4 Attenuation of photons 
Figure 1.4 shows an experimental arrangement for the study of photons 
attenuated through an absorbing material. A collimated mono-energetic photon 
beam is incident on an absorber of thickness ∆t and a radiation detector is 
placed in the beam direction to measure the number of photons that pass 
through.  
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Figure 1- 4. Attenuation of photon beam through an absorber 
 
It is assumed that if a photon interacts with an absorber atom, it is either 
absorbed or scattered according to the photoelectric, Compton and pair 
production processes. The intensity of the beam is reduced as the absorbing 
material thickness ∆t is increased. Neglecting scatter, the reduction in photon 
intensity (∆I) is proportional to incident photon intensity (I) and to the thickness 
of the absorber. Assuming a collimated beam where there are no scattered 
photons detected and also in the limit ∆t → 0, then ∆t → dt, thus 
IdtdItII µα −=⇒∆∆ .                                                                          (1.1)  
Where the constant of proportionality µ is the linear attenuation coefficient and 
the minus sign indicates that the intensity of photons decreases as the absorber 
thickness increases.  The solution of the equation is given by 
t
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Where It is the intensity transmitted through thickness t and Io is the incident. 
The equation indicates that the attenuation of a mono-energetic beam follows 
an exponential law and a plot of ln(It) versus t gives a straight line with a 
negative slope equal to µ. The total attenuation coefficient is the sum of the 
attenuation coefficients due to photoelectric, Compton, pair production and 
coherent processes.  
 
1.5.5 Photon dosimetry 
Dosimetry is a process of measuring radiation dosages. Conventional radiation 
dosimetry involves measuring doses resulting from ionising radiation and 
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modelling the particle interactions within tissue. Photons are indirectly ionising, 
that is they bring about their ionisation by a two-stage process. In the first 
stage, they interact with matter to produce electrons (and positrons) and these 
charged particles then produce ionisation along their tracks. The energy 
transferred from the photon beam to the irradiated material depends on the 
photon energy, interaction coefficients, atomic number of the material and 
electron density. The dose to a point in a medium is composed of the primary 
and scattered components. The primary dose component is composed of energy 
deposited by photons emitted from the source. The scattered dose component is 
the result of the scattered radiations from the collimator and irradiated 
phantom or material.  
 
1.5.5.1 Depth influence  
Several methods are available for calculating the absorbed dose to a point in a 
patient / phantom (Podgorsak, 2005 and Khan 2003). These methods utilise 
either the percentage depth doses (PDD) or tissue phantom ratios (TPR) or tissue 
maximum ratios (TMR).  
The PDD distributions inside a phantom are usually normalised to Dmax=100% at 
the depth of maximum dose (dmax), hence 
max
max
100100),,,(
d
d
d
d
D
D
D
D
EfAdPDD
•
•
==       (1.3)  
where  
• ),,,( EfAdPDD  is the percentage depth dose at depth d, due to field area 
A, source to surface distance (SSD) f and photon beam energy E.  
• dD  and dD
•
 are the dose and doserates respectively at a point at depth d  
• maxdD  and maxdD
•
 are the dose and doserates respectively at a point at 
depth dmax on the central axis of the phantom.  
However the dependence of PDD on SSD, makes the ),,,( EfAdPDD  method 
cumbersome for isocentric techniques. This limitation is overcome by using the 
TPR or TMR concepts that are nearly independent of SSD or SAD.  
The TMR and TPR concepts are defined as  
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 where  
• ),,( EAdTMR M  and ),,( EAdTPR P are the tissue maximum ratio and 
tissue phantom ratio respectively at depth d , AP and AM are field 
areas defined at the isocentre for TPR and at a reference depth for 
TMR respectively and photon beam energy E. 
• dD  and dD
•
 are the dose and dose rates respectively in a phantom 
at an arbitrary point at depth d on the beam central axis. 
• drefD  and drefD
•
 are the dose and dose rates respectively in a 
phantom on the beam central axis, at a reference depth dref = 5cm 
or 10 cm (or any convenient depth) for the TPR and dref = dmax for 
the TMR. 
• The phantom position is varied such that the arbitrary 
measurement point and the reference point are the same distance 
from the source. 
 
1.5.5.2 Effect of field size  
For a photon beam with small field sizes, the central axis depth dose is delivered 
mainly by the primary beam component. For larger field sizes, photons are 
scattered to every location on and below the surface, including those along the 
central axis. The relative contribution of scattered radiation to the absorbed 
dose increases with depth because photon beams tend to be scattered in the 
forward direction. The radiation output for an accelerator then increases with 
increasing field sizes. Usually the outputs are measured for different field sizes 
ranging from the smallest to largest possible at a fixed depth for each field size. 
The obtained readings are normalised to that of the 10x10 cm2 field area, and 
the resulting ratios are referred to as output factors OF(A,E), which are a 
function of field area A and photon beam energy E.  
For isocentric setup, the dose ),( AdD  at a depth d for a field area A is 
then calculated according to the equation (Williams et al 2004)  
100
),(),()(),( AdTPRxAdxDAMUxOFAdD refref=           (1.5) 
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Where:   
• MU is the number of monitor units given 
• OF(A) is the output factor of field A relative to the reference field size 
( refA = 10x10cm
2) 
• ),( AdTPR  is the tissue phantom ratio at depth d and field size A 
• ),( refref AdD  is the dose per MU (for linac, approximately 1cGy/MU) 
 
1.6 Objective of radiotherapy  
The main objective of radiotherapy is to deliver radiation that will maximize 
dose to the tumour and minimize dose to normal tissue and/or critical organs, 
thereby increasing the probability of cure and lowering normal tissue morbidity. 
Thus considerable effort is devoted to disease localisation, treatment planning, 
verification of patient setup and finally dose delivery to ensure that the most 
accurate treatment possible for the patient is provided. Due to the increased 
complexity of treatment planning and delivery techniques, verification of the 
dose before and during the actual patient treatment is necessary since the 
relationship between the absorbed dose and both tumour control probability 
(TCP) and normal tissue complication probabilities (NTCP) is steep (Podgorsak 
2005, Metcalfe et al 1997).  Figure 1-5 illustrates the relation between TCP and 
NTCP.  
 
 16 
D2D1
Therapeutic Ratio = D2/D1
 
Figure 1- 5. Dose-response curves for tumour control probability (curve A) and normal 
tissue complication probability (curve B) (adapted from Podgorsak 2005). 
 
The objective of radiotherapy is achieved by increasing the TCP while keeping 
NTCP to the minimum, a phenomenon known as the therapeutic ratio as defined 
in figure 1-5 above. There is a considerable amount of clinical evidence which 
indicates that a high degree of accuracy in dose delivery is essential for 
successful outcome of radiotherapy treatment (Wambersie et al 2001). A 
generally accepted criterion for dose accuracy which is developed on the basis 
of clinical and dosimetric experience is that the administered tumour dose 
should be within 5% of that specified by the oncologist (ICRU report 50 1993, 
ICRU report 62 1999). The striving for improved accuracy has led to tremendous 
developments in radiotherapy. 
 
1.7 Radiotherapy treatment planning 
Radiotherapy treatment planning is a process whereby sources of ionising 
radiation are suitably arranged and combined to give a desired dose distribution 
in a particular region of the body. The goal of treatment planning is to produce a 
high and uniformly distributed dose throughout the target volume while keeping 
the dose to the surrounding normal tissues / organs at risk as low as possible. It 
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is usually necessary to combine a number of external beams of radiation 
entering the body from different directions to obtain the desired distribution of 
absorbed dose in the target volume and to minimise unwanted exposures 
elsewhere. The combination of beams necessitates two important parameters in 
treatment planning and these are beam weighting and dose normalisation. Two 
sets of data are needed for the initialisation and accomplishment of treatment 
planning (ICRU report 24, 1987) and these are: 
1. Beam data: These characterise the radiation and implies measurement 
at the therapy machine. The number and type of measurements 
depend on the model used for beam representation and the algorithm 
used to combine the information with patient data. 
2. Patient data: These describe the patient’s anatomy (geometry) in a 
form that can be combined with the beam data. These data include 
information on the external surface of the patient, the target volume, 
organ at risk and relevant tissue inhomogeneities.  
The enormous amount of beam combination, dose distribution and patient 
information data necessitate the use of computers for planning. When a patient 
undergoes the necessary procedures involved in producing a treatment plan, 
including imaging e.g CT scan, MRI, etc, a computer plan is generated which is 
used as a tool for the accurate beam direction on the linac. Instructions from 
the plan have to be carried out in order to reproduce the correct arrangement of 
treatment fields. The plan specifies the gantry position, collimator positions and 
orientation, field sizes, shielding, wedge information and source to skin distance 
pertinent to an individual patient.  The plan also provides a contour of the 
patient’s anatomy giving a view of tumour and surrounding normal tissues / 
critical organs. 
 
1.8 Treatment verification 
Radiotherapy treatment is complicated and involves a series of processes that 
result in a dose distribution to a patient. It is a complex process involving many 
steps before the actual treatment begins. Figure 1-6 summarises the chain of 
processes involved before the patient is treated with radiotherapy (van Dyk 
2005). A number of uncertainties are introduced at every step in the process of 
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planning and delivery of treatment, which makes treatment verification a crucial 
step in ensuring accurate treatment delivery. 
 
 
Figure 1- 6. Steps in the radiotherapy treatment process, linked by a chain 
 
 
The process starts with the diagnosis and the decision to treat the patient with 
radiation therapy. This is followed by delineation of the target volume and 
organs at risk, usually from CT or MR scans. Next is dose calculation that 
includes beam energy selection, shaping and optimisation. Radiation fields are 
combined in an optimal manner to create a treatment plan for a particular 
patient to be given in one or an extended set of fractions. Each step in this 
treatment chain has one or more sources of error and it is therefore important 
that each single step is executed with the greatest accuracy possible. The 
uncertainty in each step will influence the accuracy of subsequent steps and, 
therefore impact on the overall treatment result. Uncertainties in the treatment 
process may include: 
o Uncertainties in the position and extent of the target volume 
o Inaccuracies in dose calculation algorithms 
o Inaccuracies in treatment machine calibration, mechanical alignment and 
machine settings 
o Inaccuracies in patient setup and/or inter-fractional patient movement 
o Variability of patient’s internal anatomy 
The advancement and development of new procedures in radiotherapy demands 
a stringent verification procedure due to their complexity. The high dose 
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gradients in these complex treatments make single point-dose measurements 
inadequate in verifying the dose distribution. Radiotherapy treatment 
verification is the process that enables the tumour volume to be treated as 
planned. A comprehensive treatment verification programme is necessary that 
includes positional verification, treatment parameter verification and dosimetric 
verification to ensure that the right radiation dose is given to the correct place. 
 
1.8.1 Positional (Geometric) verification 
The aim of geometric verification is to ensure that the geometric accuracy of 
radiotherapy is within the limits set by the uncertainty margin allowed in the 
treatment plan. This is achieved by comparing information from the delivery 
against that planned. Verification is only one component of the treatment 
process. Accurate and reproducible planning procedures, including the 
acquisition of good quality reference images, are essential to successful 
verification. Geometric verification is achieved by comparing 2D or 3D images 
(data) of the treatment delivered with that planned. In many instances a 
reference image is obtained, which shows the planned geometry of the 
treatment field placement relative to internal or anatomical bones or markers. 
The reference image can be digitally reconstructed radiographs, simulator 
images or the entire volumetric planning data. Any of these may be used as the 
standard against which treatment images are assessed. Before the start of 
radiotherapy, a pre-treatment verification (process that compares the reference 
images with the planned treatment) is done. 
 
1.8.2 Treatment parameter verification 
There are several control mechanisms to evaluate the accuracy of the single 
steps in the treatment procedure. These checks are based on QA of the 
treatment equipment, including the Linac and treatment planning system, and 
on the data transfer among the various types of equipment, such as transfer of 
data from a CT-scanner to the TPS and from the TPS to the linear accelerator. 
However, human procedures are subject to error also and determine the 
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accuracy of the actual patient treatment. In practice, despite these control 
mechanisms random or systematic errors still may occur (Lavalle et al 2006). The 
dosimetric impact of these errors is unique for each case and depends on the 
proportion of fields in error and volume mistreated (Ramaseshan et al 2004). An 
additional check during the actual treatment delivery provides information 
about the actual dose delivery and gives the ability to correct the dose before 
the next treatment fraction, when dose errors occur. 
 
1.8.3 Dosimetric verification:  In vivo dosimetry 
Dosimetric verification is as crucial as the field placement geometric 
verification, considering the complicated treatment protocols employed in 
modern radiotherapy. Verifying dose is the most obvious method of assessing the 
accuracy of a patient’s treatment. Patient dose verification, in vivo dosimetry, 
serves as an important part of a QA programme in radiotherapy and has been 
recommended for quality improvement of patient care in radiation therapy by 
several organizations such as the European Society of Therapeutic Radiology and 
Oncology (Ferreira et al, 2000) and the Royal College of Radiologists (RCR) 
report No BFCO(08)1 “towards Safer Radiotherapy” (2008) . In vivo dosimetry is 
a tool to measure the radiation dose delivered to patients during radiotherapy. 
The aim of in vivo dosimetry is to compare dose measured at the time of 
treatment with the dose values specified by the radiation oncologist and the 
dose values calculated by the TPS, to ensure that the accuracy of the prescribed 
dose to the target volume is within acceptable limits. In addition to the use of in 
vivo dosimetry for assessing the dose delivered to an individual patient for the 
detection of various types of errors in the dose delivery process, it can also 
serve as a tool to verify new treatment techniques in the clinic, after the initial 
validation of the procedure using phantoms, or as an indicator to assess the dose 
in organs at risk. It is recommended that in vivo dosimetry should be carried out 
on all patients and that the treatment dose delivery should be accurate to 
within 5% (Huyskens, et al 2001, ICRU report 62 1999). For each individual 
patient the deviations between the delivered dose distribution and the 
distribution according to the treatment plan should be within the accepted 
tolerance limits. Radiation detectors that have been used for dose verification 
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include thermoluminescent dosimeters, diodes, films, and most recently 
electronic portal imaging devices (EPID).  
 
 
1.8.3.1 Entrance and exit dosimetry 
The most direct form of in vivo dosimetry is to physically place detectors inside 
the patient (Podgorsak, 2005), however this is only possible for treatments 
where there are cavities inside the body such as the mouth, vagina and rectum. 
The most common method is to measure the entrance or exit doses directly on 
the surface of the patient. Entrance dose measurements are performed in many 
centres during radiotherapy due to their simpler setup on the surface of the 
patient (Leunens et al 1990, Fiorino et al 2000). They are useful for identifying 
setup errors such as incorrect patient source to surface distance. Entrance 
dosimetry is commonly performed with single point dose devices such as diodes 
or Thermoluminescent detectors (TLDs) which unfortunately do not cover the 
entire radiation field, and possible errors may not be detected, more especially 
in IMRT treatments where there are numerous steep dose gradients occurring in 
the combined beam segments.  In addition to the errors above that can be 
detected by entrance dose the exit dose, defined as the dose on the patient at 
the exit side of the beam, can be used to identify changes in tissue thicknesses 
and detect inhomogeneities via changes in dose transmitted through the patient 
(Broggi et al 2001).  
 
Figure 1-7 illustrates the exit and entrance calibration planes used in the in vivo 
dosimetry calculations (Heukelom et al 1991) and also recommended by ESTRO 
(Huyskens et al 2001). The entrance point is defined at the dose plane a distance 
dmax from the entrance surface of the phantom. The exit dose is defined at the 
dose plane positioned at a distance dmax, from the exit surface of the phantom. 
It should be noted that the exit dose and entrance dose do not refer to the exit 
surface dose and entrance surface dose. Figure 1-8 shows a typical depth dose 
curve illustrating the main differences between entrance and exit doses and 
their respective surface doses. The lack of appropriate back scatter results in 
reduction of surface dose.  
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Figure 1- 7. Illustration of the (a) entrance and (b) exit dose calculation planes 
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Figure 1- 8. Typical depth dose curve in water phantom 
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1.8.4 Modalities of treatment verification 
1.8.4.1 Film 
Film dosimetry can only be used for pre-treatment dose verification and 
typically employs high resolution radiographic film combined with film density 
digitisation to get a 2D dose distribution (Ezzell  et al, 2003). The technique 
involves placing a film inside a solid water (dosimetrically water-equivalent 
plastic) flat phantom at the isocentre perpendicular to the beam axis. One film 
is used for each clinical field that is being verified. Film depth can vary from the 
depth of maximum dose (d
max
) to any depth of interest in the treatment plan. 
Pinholes are placed in the film marking the location of the cross-hair or points of 
registration. To calibrate the film used for the clinical fields, a set of calibration 
films, taken from the same batch of film, are exposed with known radiation field 
sizes, depth and doses to generate a calibration curve or exposure of one film 
with step and shoot MLC controlled field beam. The calibration curve is then 
used to convert the optical densities of the test film to absolute dose. 
Advantages of using film are that 2D dose distribution is possible and that the 
required equipment is commonly available in most radiotherapy departments. 
However, film dosimetry suffers from several drawbacks (Warkentin et al 2003):  
1) It is time consuming since it requires processing and scanning of the film, and 
needs a sensitometric curve to convert optical densities into absorbed doses. 
2) The dose response may be affected by the production batch and processing 
conditions, which are difficult to control 
3) Film verification of multiple fields is labour intensive 
4) Film requires digitisation for quantitative comparison 
5) Requires darkroom and processing facilities. 
6) Storage and archiving of film are inconvenient and labour intensive  
 
1.8.4.2 Thermoluminescent dosimeters 
Thermoluminescence dosimeters (TLD) can be used to measure the dose at the 
entrance and/or the exit side of the patient. The fact that no cables are 
required during the measurement allows the use of TLDs inside tissue-equivalent 
phantoms to verify radiation doses delivered in new treatment techniques. These 
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features make TLDs a good in vivo dosimetry tool allowing dose assessments 
directly on patients during therapeutic procedures. A drawback of this approach 
is that dosimetric information is only obtained at a single or a few points. The 
major disadvantages of TLD are that there is no instant readout and that the 
signal is erased during readout and hence it is easy to lose dosimetric 
information.  
 
1.8.4.3 Diodes 
Diodes are semiconductor detectors which, when connected to a suitable 
electrometer, offer the unique combination of high sensitivity, immediate 
readout, simplicity of operation (no external bias voltage), small size and 
robustness against radiation damage. Silicon diodes can be made from either n-
type or p-type silicon and in the boundary between two regions, one of p-type 
and another of n -type silicon, there is a depletion of free charge carriers. 
Irradiation induces charge flow and due to defects in the crystal lattice some 
electrons are trapped and will consequently not contribute to the diode signal. 
The charge can be amplified and measured with an electrometer. Diode signal 
depends on many factors (Huyskens et al 2001) including: photon beam energy, 
dose-rate, temperature, field size, source to surface distance, beam angulations 
and the presence of wedges or blocks. For this reason, diodes require many 
correction factors. Diodes are conventionally used for treatment verification. 
They are the most commonly used detector type for patient dose verification 
(van Elmpt et al 2008; Fiorino et al 2000). However, since they are usually 
placed on the patient’s skin surface, they are used for point dose measurement 
and dose verification is usually limited to a number of superficial points. 
 
1.8.4.4 MOSFET 
Recently there has been an increased interest in the use of the metal oxide-
silicon semiconductor field effect transistor (MOSFET) for in vivo dosimetry 
purposes (Ferreira et al 2000, Bloemen-van Gurp et al 2007). The system uses 
miniature non-intrusive MOSFET semiconductor radiation dosimeters (size less 
than 4 mm2). Other characteristics of MOSFET devices are the direct and simple 
dose readout, the portability of the system and the recording of the 
accumulated dose of each detector. The output can be converted from mV to 
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cGy by entering a calibration factor in the reader for each single dosimeter. 
MOSFETs exhibit in addition a good linearity of their response (Ferreira et al 
2000, Bloemen-van Gurp et al 2007). These studies determined important 
physical characteristics of the detectors to demonstrate the usefulness of 
MOSFETs as clinical dosimeters; and measurements were performed at different 
sites of the patient’s body, with both photon and electron beams of various 
energies. 
 
1.8.4.5 Ionisation Chambers 
Ionisation chamber matrix detectors have been produced for measuring energy 
fluence or absorbed dose in two dimensions (Amerio et al 2004, Spezi et al 
2005). These detectors consist of a large number of ionisation chambers placed 
in a regularly spaced array or at specific points in a phantom. Matrix detectors 
can be attached to the gantry of the linear accelerator or placed on the 
treatment couch. A quick verification of the beam is performed by comparing 
the output of these devices with a dose distribution predicted by the TPS. A 
drawback of these devices is that they have relatively few measuring points and 
therefore a low spatial resolution. This potentially limits their applicability to 
the verification of highly intensity-modulated fields. 
 
1.8.4.6 Electronic Portal Imaging Devices 
Currently electronic portal imaging devices (EPIDs) are mainly used for patient 
setup verification during treatment, but several other geometric properties like 
beam blocking shapes and leaf positions can also be determined. Recent 
literature indicates an increase in treatment verification with portal imaging 
(Topolnjak et al, 2010) and it is an effective means of reducing setup errors 
(Murthy et al 2008, Krengil et al, 2009). Furthermore, one of the most recent 
usages of EPIDs is portal dosimetry, which allows the possibility of dosimetric 
treatment verification. Pre-treatment monitor unit verification is possible with 
high accuracy and also geometric parameters can be verified using the same 
EPID image. The acquired images are available for on-line review before 
commencement of treatment. By combining geometric and dosimetric 
information, the data transfer between treatment planning system (TPS) and 
linear accelerator can be verified. The EPID dosimetric capability is based on the 
 26 
presumption that the mean pixel value of the imager is dependent upon the 
photon fluence incident upon the corresponding area of the detector. This in 
turn is related to the dose at the exit surface of a patient or phantom. Thus, 
radiation dose measured at the detector is related to the attenuation through 
the patient and input dose. If the detector is far enough away from the patient 
to reduce scatter to a minimum, then the EPID image should produce an 
accurate estimate of the radiological thickness of the patient (Kairn et al, 2007), 
which can be related to dose (Kavuma et al, 2010). 
 
 
1.8.5 Advantages of electronic portal imaging devices over other 
modalities 
The EPIDs have several advantages over the other detectors used for dose 
verification, and the major ones are: 
o The device is in most centres already attached to the accelerator 
o Fast image acquisition 
o No film processing and need of cassettes 
o The image is in digital format with high resolution 
o Point and 2D dose measurements 
o Possibility of 3D dose verification, reconstructed by back projection of the 
2D dose into a 3D image data from CT scan or cone beam CT 
o Possibility of performing in-vivo dosimetry on linac-based treatments 
without the need for additional equipment  
o Immediate image analysis is possible and review can be done at any 
workstation 
 
The past 2-3 decades have yielded new clinical capabilities and substantial 
improvements in patient care. The greater complexity of today's radiotherapy 
practice creates considerable challenges for users. There is a general need to 
use a wide range of equipment features and clinical applications to improve the 
quality (e.g. reducing the radiation dose to patients’ non-targeted areas) and 
effectiveness of the treatment. EPID has evolved because it provides real-time, 
fast image archiving, retrieval and automated image analysis. This has prompted 
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many research groups to study their use for radiotherapy dosimetry. However 
the current techniques are limited to pre-treatment verification, where the 
radiation fluence is only verified in the absence of a patient (non-transit). The 
actual day-to-day treatment verification of dose received by the patient is 
imperative to keep up with the pace of the increasing complexity of 
radiotherapy treatments. In vivo dosimetry using diode, TLD and/or MOSFET is 
commonly employed to verify the dose delivered during external beam 
radiotherapy (Nijsten et al 2007, Piermattei et al 2007). These measurement 
techniques, however, require considerable time and effort to implement 
routinely in busy radiotherapy departments and the amount of information 
gathered is limited to a single or a few selected points.  
 
1.9 Portal Dosimetry Literature Review  
1.9.1 History of EPID usage for dosimetry 
One of the first uses of EPIDs for dose measurement was developed at the 
Netherlands Cancer institute and involved the scanning liquid-filled ionisation 
chamber (SLIC) EPID (Van Herk, 1991). Later in mid 1990’s, this technological 
development led to PortalVision, a Varian (Palo Alto, CA, USA) commercial 
portal dosimetry software system. One of the main limitations of the SLIC was 
the relatively long read-out time (van Elmpt, 2008), such that the device could 
not measure dose directly, but was suitable for measuring dose rate. The 
measured dose rate was converted to absolute dose by recording a continuous 
readout of the monitor chamber signal of the linac during image acquisition and 
the number of MUs delivered for the measured dose image. Chang et al (2000) 
investigated dose verification using the liquid-filled ion chamber EPID by 
comparing profiles and dose measurement at the isocentre.  The study reported 
an accuracy of 3% in central axis, better than the 5% requirement recommended 
by the Task Group 40 Report (Kutcher et al 1999) of the American Association of 
Physicist in Medicine (AAPM) for independent verification of the dose at the 
isocentre. Although this was sufficiently accurate for clinical QA, the slow 
response detector memory effect and beam hold-off effects (the withholding of 
linac beam pulses when MLC leaves are not in the correct positions), made the 
liquid-filled ionising chamber EPID usage impractical for clinical use (Chang et 
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al, 2002). Mohammadi et al (2007) used a scanning liquid-filled ionization 
chamber electronic portal imaging device (SLIC-EPID) and extended dose range 
(EDR2) films to evaluate transmitted dose profiles for homogeneous and 
inhomogeneous phantoms. Calibrated ionisation chamber measurements were 
used to convert the pixel values acquired from the electronic portal images to 
dose. For homogenous and inhomogeneous phantoms, more than 90% agreement 
was achieved using gamma criteria of 2% and 3 mm and 3% and 2.5 mm 
respectively. 
In the mid 1990’s, camera-based EPIDs were invented and developed into 
commercial products by various vendors, among which was iViewTM, marketed by 
Elekta Oncology Systems, Crawley, UK (Heijmen et al, 1995). The main 
advantages of these systems were that a large portion of the field could be 
imaged quickly due to the fast read-out of the camera and they had a high 
spatial resolution. The measured grey scale value was approximately linear with 
dose and did not depend on the absorber thickness placed in the beam (Pasma et 
al, 1998). The camera based EPID however, had a large field size dependence 
caused by scattered visible photons inside the optical system. Once the camera-
based EPID was calibrated, mainly by removing the influence of the optical 
scatter effects, the device was suitable for performing portal dosimetry with 
deviations around 1–2% (van Elmpt, 2008). Pasma et al (1999) reported on the 
use of charged-coupled device (CCD) camera based system for pre-treatment 
dosimetric verification of IMRT beams produced with a dynamic MLC. EPID 
images were acquired for all beams and these images were then converted into 
2D dose distributions and compared with the calculated dose distributions using 
a commercial TPS. The dose profile measured with the EPID was also compared 
with ionisation chamber measurements. The agreement between the EPID and 
ion chamber was within 2%.  
The amorphous-silicon EPIDs (a-Si EPID) or flat-panel imagers were first 
described by Antonuk et al (1998) and currently are the most common type of 
EPID available. The panel consists of an X-ray converter, light detector, and an 
electronic acquisition system for receiving and processing the resulting digital 
image. The dose–response behaviour of the three commercially available a-Si 
EPIDs has been described; the Elekta iView GT system, the Siemens OptiVue and 
the Varian Portal Vision a-Si 500/1000 (McDermott et al 2004, McDermott et al 
2006).  
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Munro et al (1998a, 1998b) investigated the dosimetric characteristic of a 
small (96x96 mm2) a-Si indirect flat panel detector; they measured the linearity, 
spatial resolution, glare, noise and signal to noise characteristics. The results 
indicated that the response of the sensor was linear and did not suffer from the 
glare phenomenon associated with camera-based EPIDs.  This study concluded 
that a-Si detectors are more suitable for dosimetric verification. El-Mohri et al 
(1999) studied linearity response, dose rate dependence, sensitivity, long and 
short term reproducibility of a-Si flat panel. This study investigated EPIDs in both 
the indirect and direct configuration modes. The direct detection mode was 
superior over the indirect mode in terms of linear response and good long term 
stability in pixel response. 
 
1.9.2 Dosimetric characteristics of a-Si electronic portal imaging 
devices  
The dosimetric characteristics of EPIDs have been studied by several 
investigators. McCurdy et al (2001) investigated dosimetric properties of a-Si 
detector such as linearity with dose (±0.5%), reproducibility (±2%) and response 
variations in gantry rotation and source to detector distance. Greer et al (2003) 
investigated the dosimetric properties of an a-Si EPID using continuous frame-
averaging acquisition mode for 6 MV radiation beam. The properties investigated 
included effect of build-up, dose response, field size response, response to rapid 
MLC leaf speed, beam dose rate effect, memory effect and reproducibility. The 
dependence of response on EPID calibration and dead time in image frame 
acquisition occurring every after 64 frames was measured. The results of this 
study indicated that the response of the EPID with dose and dose rate was 
linear, and response to MLC motion (leaf speed of 2.5 cm/s) was also found to be 
linear. A field size deviation of ≈ 5% relative to dmax ion chamber measurement 
was found. Memory effect was negligible at ≈ 0.2% and reproducibility was good 
at ≈ 0.8%. This investigation also reported on the relative dosimetry of an a-Si 
EPID, where they measured the accuracy of the EPID in recording open and static 
wedge fields. EPID profiles through the central axis for the open field and in the 
wedged direction for the wedge field were compared to ion-chamber 
measurement and the agreement was within 3%.  
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 Van Esch et al (2004) performed EPID detector saturation, linearity, 
reproducibility, ghosting, field size dependence and portal depth dose 
measurements. The results from this investigation indicated that detector 
saturation may result in dosimetric errors in the range 0.35 to 1.4%, though it 
can be worse than this depending on type of detector. The EPID response for 
depth dose (dose measurements as a function of absorbing material, normalised 
to their maximum value) was within 1% compared to an ion chamber in terms 
inverse square law behaviour. Short term and long term detector reproducibility 
was found to be within 2% for static as well as dynamic field delivery. Ghosting 
was below 1% for 6 MV and 18 MV. The field size dependence for EPID and ion-
chamber measurements were similar for 6 MV and showed discrepancies of up to 
9% for the 18 MV beam. The dose maximum plateau region is wider for the a-Si 
EPID with widths of ≈ 1.5 cm and ≈ 3 cm for 6 and 18 MV respectively.  
Winkler and George (2006) carried out an inter-comparison of eleven 
Elekta iViewGTTM EPIDs from different institutions and reported on dose, dose-
rate, and field-size responses among others. Chen et al (2006) and Nijsten et al 
(2007) reported the dosimetric properties for the Siemens EPID, mainly focusing 
on calibration methods for transit dosimetry. McDermott et al (2006) compared 
the ghosting effects for three (Varian, Elekta and Siemens) a-Si EPIDs and 
reported on their signal-to-MU ratios. Several articles have reported on the 
dosimetric characteristics of the Varian EPID (Greer et al 2003, Chang and Ling 
2003). 
One specific area where EPIDs have been successfully used for dosimetric 
purposes is in the pre-treatment verification of IMRT fields, by assessing the 
accuracy of the intended fluence as used in the treatment planning system (TPS) 
for dose calculation and the actually delivered fluence (Greer et al 2003, Van 
Esch et al 2004).  These studies investigated the application of a-Si for pre-
treatment dose verification by comparing clinical EPID IMRT images with fluence 
maps predicted by TPS. Van Esch et al (2004) developed and evaluated a portal 
dose prediction algorithm based upon the pencil beam dose calculation as 
implemented in the CadPlan TPS. Measured and predicted portal dose images 
were compared by means of line profiles and gamma index criteria. Over 90% of 
points in the IMRT fields passed the gamma criteria at 3% dose difference and 3 
mm distance to agreement. Chang et al (2003) evaluated the use of a-Si 500 
EPIDs for the verification of IMRT beam delivery using synchronous frame 
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averaging acquisition, which was evaluated on 25 prostate IMRT fields. The 
acquired EPID images for IMRT fields were converted to dose using a dose profile 
calibration curve. The measured dose profiles compared with the planned were 
in good agreement with a mean error of 1.9% and standard deviation of 0.5%. 
The central axis dose agreement was better than 2.0 %. 
A major problem associated with a-Si EPIDs for transit dosimetry is the 
presence of a phosphor layer, which can introduce large deviations from water-
equivalent behaviour due to energy-dependent response and visible light 
scattering, though the effect caused by the latter may be negligible. During the 
present work, Sabet et al (2010) modified an a-Si EPID to a direct detection 
configuration by removing the phosphor layer, and the accuracy of using it for 
transit dosimetry measurements was investigated for 6 and 18 MV treatment 
beams by comparison to ion-chamber in water measurements. This study 
concluded that the direct EPID could perform as an ion-chamber detector for 
transit dosimetry applications in all geometries. The major current limitation of 
the direct EPID is the poor image quality compared with the clinical 
configuration. This study suggested that the practicability of interchanging 
between imaging and dosimetry setups should be investigated.  
 
1.9.3 Dose Verifications 
Several authors have reported on different ways of using the EPID for dose 
verification. Leunens et al (1990) and Terron et al (1994) combined entrance and 
exit point dose measurements to determine a mid-plane dose inside the 
patients. This approach has been shown to be valuable for immediately 
identifying errors related to the inaccuracy of the TPS, especially for 2D dose 
calculation algorithms, setup errors, human errors and fluctuations in Linac 
output. The limitation of the approach has been the simplicity of the algorithms 
used to determine the midplane dose, which are only effective under certain 
geometric and symmetric (phantom) conditions (Leunens et al 1990). Algorithms 
for determining the midplane dose at a single point were later extended to 2D 
(Dam et al 1992, Ebert et al 1994), by correlating the 2D transmitted dose 
measured with film at a certain distance behind the phantom (patient) with a 2D 
dose at the exit surface of the patient. This was then used to predict 2D 
midplane dose distributions. These authors reported the agreement between 
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exit doses derived from transmitted film and diodes measurements to be within 
5-8%. Discrepancies were attributed to scatter approximations for large phantom 
to detector distances and curvature in phantom geometry at the exit beam side. 
Under such conditions, the correlations in off-axis ratios at the midplane and 
transmitted dose plane deteriorated due to the decrease in contribution of 
scattered dose relative to the primary dose contribution. This was shown to 
overestimate the dose near the edges of the field calculated at the midplane 
relative to measurements or TPS calculations at the midplane (Dam et al 1992, 
Fiorino 2000).  
For dosimetric use, portal images must be corrected for field size 
dependence, energy dependency and ghosting effects (Herman et al 2001). This 
idea was used by several investigators, e.g. comparison of the measured and 
predicted portal dose for each treatment field (Pasma et al 1998 and Van Esch et 
al 2004), verification of leaf positions for intensity modulated fields (Greer et al 
2003 and Parent et al 2006),  reconstructing the dose to the patient using the 
exit image acquired during treatment (Piermattei et al 2007 and Wendling et al 
2006) and converting the image to a fluence distribution that is used as input to 
a dose algorithm to reconstruct a 3D dose to the patient (Renner et al 2005, 
Steciw et al 2005, Van Elmpt et al 2006 and Van Zijtveld  et al 2007). 
 
 
1.9.4 In vivo dosimetry with electronic portal imaging devices 
The advancement of radiotherapy technology resulted in the transition from 2D 
film measurements described in section 1.8.4.1 to EPID acquired images as 
described in section 1.8.4.6. Kirby et al (1994) were one of the first authors to 
use an EPID for determining exit doses of phantoms and patients, using 
integrated images from a fluoroscopic EPID with 6 and 20 MV photon beams. 
They determined an empirical relationship between exit doses measured with 
diodes and transmitted doses measured with the EPID based on homogeneous 
phantom measurements for a variety of thicknesses and patient-to-EPID air gap 
distances. The empirical data were tested on a variety of irradiation geometries 
using an anthropomorphic phantom as well as on patients undergoing 
radiotherapy and the agreement was within ± 7%. The limitation of the method 
was its failure to accurately predict the exit dose under asymmetric scatter 
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conditions and also the ± 7% is out of tolerance compared to the ± 5% 
recommended by ICRU report 62. 
The earlier 2D midplane dose calculation methods above were only 
accurate for small air gap distances ≈ 10 cm between the exit surface of the 
patient and the transmitted dose plane and did not take into account the 
decrease in scatter contributions for larger sized air gaps. Furthermore if EPIDs 
are to be used for exit and midplane dosimetry, such models need to be 
adjusted for the extended distances from the beam focus and patient for which 
EPIDs are installed. As a consequence, Boellaard et al (1997) developed a 2D 
back-projection-convolution model for converting transmitted doses to exit 
doses more accurately at larger phantom to detector air gaps of ≈ 50 cm. The 
idea was based on the separation of the total exit dose into the primary and 
scatter components. The scatter dose at the exit surface was calculated by 
convolving the primary exit dose with an exponential spread function, from 
which they derived the scatter to primary ratio transmissions. The agreement 
between exit doses calculated with the convolution model compared with exit 
dose measured with an ion chamber for an 8 MV photon beam under 
homogeneous and inhomogeneous phantoms was within 2.5% (Boellaard 1997).  
Wendling et al (2006) extended the original convolution model of 
Boellaard et al (1997) for a-Si EPIDs. Additional kernels were applied to account 
for the unique response of the a-Si EPID, corrections for lateral scatter effects 
occurring within the EPID itself and improving accuracy in beam penumbra. More 
recent work focused on extension of 2D convolution models into a 3D dose 
reconstruction applied in different targets and organs at risk (Louwe et al 2007). 
Modifications such as the inclusion of patient contour information were included 
and were found to significantly improve the results. 
Fidanzio et al (2010) used a generalized set of correlation functions 
F(TPR,w,L) and empirical factors f(TPR,d,L); where TPR is the Tissue Phantom 
Ratio, w is the phantom thickness, L is the square field side, and d is the 
distance between the phantom mid-plane and the isocenter to reconstruct the 
isocenter dose for 6, 10 and 15 MV photon beams. The in vivo dosimetry method 
was developed from previous work done by the same group (Piermattei et al 
2006 and Piermattei et al 2007). The function F(TPR,w,L) is defined as the ratios 
between the transit signals per MU, obtained by an a-Si EPID positioned below a 
solid water phantom, and the dose per MU values measured along the beam 
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central axis at phantom mid-plane coincident with the SAD. In the experimental 
set-up they determined the mid-plane doses per MU, and the transit signals per 
MU for different phantom and field sizes measured at the Source to EPID 
Distance. They used these data to determine the empirical factors f(TPR,d,L) 
that take into account the variations of the scattered photon contributions on 
the EPID due to the different phantom position with respect to the SAD. They 
reported tolerance levels that ranged between ±5% and ±6% depending on the 
tumour body location. 
Whilst EPIDs are in routine use in radiotherapy departments to verify the 
desired treatment geometry in relation to anatomical structures, their role as in 
vivo dosimeters is less common (van Elmpt et al, 2008). In the past decade, 
research and development has been undertaken which relates to their double 
utilisation as an in vivo dosimeter and field verification tool (Fiorino et al 2000, 
Broggi et al 2001, Piermattei at al 2007, McDerrmott et al 2007, van Zijtveld et 
al 2009). Within the last two decades, EPIDs based on amorphous silicon panels 
mounted on an accelerator gantry have been introduced for patient setup 
verification (Fielding et al 2002, Herman et al 2001) while more recently, dose 
verification became more possible (Chen et al 2006, Wendling et al 2006, Parent 
et al 2007). EPIDs offer the possibility of performing in-vivo dosimetry on linac-
based treatments without the need for additional equipment. EPID in-vivo 
dosimetry is thus defined as the determination of a dose distribution inside the 
patient based on EPID images acquired during treatment, and is only possible 
with the transit method (Wending et al 2006, van Elmpt et al 2008).  In vivo 
verification of the delivered dose is achieved by comparing the portal image 
acquired during treatment to a predicted transmission. Such comparison can 
reveal problems in dosimetric performance of the linear accelerator, errors in 
the treatment plan or beam modifying devices such as wedges and 
compensators, and changes in patient anatomy. 
 
1.9.5 Portal dosimetry commercial Packages 
1.9.5.1 Varian's portal dosimetry system 
The current portal dosimetry package available, version 8.2.0, is a non-transit 
package; hence it is used for pre-treatment verification of IMRT plans only. The 
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averaged grayscale image is converted into a portal dose image in the Dosimetric 
Workspace by summing all images taken over the beam-on time. Commissioning 
of the portal dosimetry system starts with configuring the Varis / Vision system. 
The portal dose image prediction (PDIP) software algorithm first has to be 
configured in Beam Configuration before it can be used in Eclipse 8.6. Among 
other things, an image of a test pattern has to be measured with the imager, 
and output factor tables of the imager have to be measured. This is analogous to 
the beam data measurements (water-phantom) needed for configuration of 3D 
dose-calculation algorithms. The processes inside the amorphous silicon imager 
are rather complicated and not comparable to ionisation-chamber water 
dosimetry. Hence the terms "dose" and the corresponding unit "Gy" are avoided 
by Varian in the context of Portal Dosimetry. Instead they use Calibrated Units 
(CU), where 1 CU corresponds to 1 Gy at a reference depth.  
 
1.9.5.2 Dosimetry Check  
Math Resolution LCC (USA) developed an EPID dose verification package 
“Dosimetry Check”, which was initially dedicated to non-transit pre-treatment 
dose verification, but now is extended to transit verification. In the UK, the 
“Dosimetry Check” software was first tested at the Edinburgh Cancer Center, 
Western General Hospital and evaluation of its suitability in different conditions 
was presented at the Scottish Radiotherapy Physics meeting (Nichol et al, 2010). 
The analysis of the results of the presentation concluded that, “Dosimetry 
Check” can be used as either a pre-treatment verification or as a transit 
dosimetry tool with reasonable accuracy and that further studies are required in 
order to establish acceptable tolerances for different clinical sites. By the end of 
2010, at the end of the present project, the Dosimetry Check software was 
commercially available. This system works with input from the Varian, Elekta, 
and Siemens EPID in integration mode. 
 
1.9.5.3 EPIQA 
EPIQA is also a non-transit commercial software that can convert a dosimetric 
image acquired by an EPID into a dose map, and to compare the dose map with a 
reference dose distribution. EPIQA was developed specifically for use with Varian 
a-Si500 mounted on a Varian 6EX linear accelerator. The software can be utilised 
 36 
for verification of static as well dynamically modulated fields. The portal 
dosimetry image conversion to dose is based on the GLAaS algorithm (Nicolini 
and Fogliata 2006). It is a pre-treatment verification tool, hence incapable of in 
vivo verification. The main goal is to identify potential errors either in the 
calculation or in the delivery process.  
 
1.9.5.4 EPIDose 
EPIDose (Sun Nuclear, Melbourne, FL) is a tool designed for the use of EPIDs in 
IMRT QA that uses raw MV EPID images (no additional build-up and independent 
of gantry angle, but with dark and flood field corrections applied) to estimate 
absolute dose planes normal to the beam axis in a homogeneous media (i.e. 
similar to conventional IMRT QA methods) (Nelms et al 2010, Varatharaj et al 
2010). EPIDose is a non-transit package used for pre-treatment verification of 
fluence by comparing the TPS and EPIDose dose distributions. EPIDose converts 
an EPID image to dose maps for analysis in the MapCHECK software (also a Sun 
Nuclear product), by performing a dose-to-dose comparison independent of TPS. 
Nelms et al (2010) evaluated its suitability by using the Varian EPIDs images (a-
Si500 and a-Si1000) and Siemens EPIDs images (OptiVue500 and OptiVue1000).  
 
1.9.5.5 Elekta iViewGT and Siemens Optivue 
There is evidence in the literature suggesting that the Elekta iViewGT (Winkler 
et al 2007 and Cilla et al 2011) and Siemens Optivue (Fidanzio et al 2010) EPIDs 
were calibrated for transit and non-transit dosimetry. The purposes of these 
studies were to develop, implement and validate methods for portal dosimetry 
with amorphous silicon EPID for a wide energy range. Analytic functions were 
applied in order to correct for nonlinearities in detector response with dose 
rate, irradiation time and total dose. EPID scattering processes were corrected 
for by means of empirically determined convolution kernels. Unlike the known 
Varian PDIP, we did not find corresponding commercial portal dosimetry 
packages from Elekta and Siemens. 
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1.9.6 Current drawbacks for the wide use of electronic portal 
imaging devices as a dosimeter 
Despite the positive characteristics of EPIDs over other modalities, there is 
limited usage of these devices for dosimetry and there is currently only one 
commercial transit dosimetry module (section 1.9.5 above): This became 
available only near the conclusion of this work. An appropriate calibration 
method for the conversion of the EPID image to dose is one of the main setbacks 
for using the devices dosimetricaly. Electronic portal imaging devices have been 
calibrated either by conversion of grey scale pixel value to dose value using an 
ion chamber or by using Monte Carlo simulation methods (prediction of the grey 
scale pixel value). The drawback is that these calibration models are not robust 
enough to cover all treatment techniques and irradiation configurations (van 
Elmpt et al 2008: see section 2.3.3.1). Some centres have developed in-house 
packages, which require assessment before induction into routine clinical usage. 
It is desirable to use a single piece of equipment for geometrical and 
dosimetrical verification to keep operational costs, treatment times and 
maintenance work to a minimum. The general aim for this study was therefore 
to develop techniques for integrated transit in vivo dosimetry verification using 
an EPID.  
 
1.10 Aims of this study 
As can be seen from section 1.9.4, there was no clinically usable system for 
transit dosimetry (either commercial or non-commercial) at the commencement 
of this project. The main aim of the study was to develop techniques for the 
transit dosimetric treatment verification using an a-Si EPID. The four sub-aims 
were: 
 To investigate the dosimetric characteristics of Varian a-Si500 EPIDs by 
assessing a large number of clinically used devices, for consistency of 
performance and portal dosimetry implications. 
 To develop a method to predict portal dose in different radiotherapy 
(clinical) settings based on equivalent path length, measured with an EPID 
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 To develop a method for dose verification by deriving the plane phantom 
/ patient dose at the exit from the portal dose measured with the EPID 
which is compared with intended dose from TPS and MapCHECK device. 
 To evaluate the developed techniques by comparing the predicted and 
measured patient doses in homogeneous / anthropomorphic phantoms. 
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2 CHAPTER TWO: MEGA-VOLTAGE ELECTRONIC 
PORTAL IMAGING DEVICES: DEVELOPMENT 
2.1 Introduction to electronic portal imaging devices 
For nearly 30 years, electronic portal imaging devices (EPIDs) have been under 
development by accelerator manufactures and individual investigators. In 
addition to the imaging system developments, there has been an extensive 
advancement in the means of extracting quantitative information from the 
images (Herman et al 2001, Antonuk 2002). These include extracting the 
treatment field edge to establish a known reference image and registration 
techniques to compare reference images with the newly acquired portal images. 
Despite the considerable development of imaging technology and image analysis 
techniques, the clinical role of this technology is still evolving. Initially touted as 
replacements for portal films, these systems have been used to reduce 
systematic errors in patient positioning for on-line (i.e., immediate) patient 
repositioning, to identify the location of radiopaque markers to account for 
organ motion, for megavoltage cone-beam CT and also for kilovoltage cone-
beam CT. In addition to their use for imaging, these imaging systems are also 
being used for pre-treatment verification of IMRT fields and for transit 
dosimetry. Clinical acceptance of the imaging systems is increasing but much 
remains to be done. Improved methods of identifying errors in patient 
positioning and automated methods to correct these errors (e.g., moving the 
couch or changing the MLC pattern) will be required. Radiation therapy is 
becoming an image-guided therapy and portal imaging will become ever more 
important in the delivery process (van Elmpt et al, 2008).  
 
2.2 Types of electronic portal imaging devices 
2.2.1 Direct and Indirect radiation detection electronic portal 
imaging devices 
Electronic portal imaging devices are designed to operate between 1 and 20 MV 
(Boyer et al 1992). Images from the EPID are the result of a high energy x-ray 
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beam passing through and interacting with the EPID sensitive layer. They detect 
low energy electrons resulting from Compton scattering of high energy photons. 
The differences in the attenuation of the photons due to varying densities and 
thicknesses in the object give rise to different grey scale or pixel values which 
form an image. The pixel value is proportional to the number of electrons or ions 
formed as a result of interactions of the attenuated x-rays beam with the 
sensitive medium of the EPID. With the technological advancement in 
electronics, the image quality of EPIDs of various types has improved 
significantly. Imaging devices can be classified into directly and indirectly 
detectors (Mayles et al, 2007), as illustrated in figure 2-1. Direct detection 
(figure 2-1 b) incorporates a buildup material (photodetector) to produce 
electrical charges on detection of an x-ray whereby the incoming photons are 
converted directly into secondary electrons for detection. Indirect detection 
(figure 2-1 a) incorporates a phosphor to produce visible wavelength photons on 
detection of an x-ray. The Indirect detector converts incident radiation into 
secondary electrons which are converted into visible light for detection. The 
process is indirect because the image information is transferred from the x-rays 
to visible light photons and then finally to electrical charge.  
 
light
electrons electrons
Detector
Phosphor
Buildup material
(a)
(b)
Incoming Photons Incoming Photons
 
Figure 2- 1. Types of radiation detectors. Figure (a) is the Indirect detector while figure (b) 
show the direct detector mechanism. 
 
Both detectors have a build-up layer, typically a piece of thin copper, to convert 
high energy photons to secondary electrons. This layer also serves to minimise 
the contamination electrons from the head of the linear accelerator treatment 
unit. In the indirect case, an additional phosphor layer is required to convert the 
secondary electrons to visible photons (figure 2-1a). Detectors are used to 
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detect the optical photons. For the direct detector EPID, detectors are placed 
directly beneath the build-up layers (figure 2-1b). Upon collecting the secondary 
particles in both the direct and indirect cases, a signal is generated and 
transferred for analysis via a set of peripheral electronics located around the 
device. For any imaging system, the most important physical quantity that must 
be determined is the signal-to-noise ratio (SNR). The detective quantum 
efficiency (DQE), which is defined as the square of output SNR divided by the 
input SNR, is the metric used to gauge the efficiency of imaging devices. DQE 
gives the SNR transfer characteristics of an imaging system as a function of 
spatial frequency. DQE gives a measure of how efficient the imaging system is, 
at transferring SNR (i.e. information) contained in the radiation beam on a 0 to 1 
scale (Boyer et al 1992). Low optical conversion efficiency from one layer to the 
next may result in decreased DQE of the imaging system. Commercially available 
systems consist of scanning liquid ion chamber EPIDs, camera-based EPIDs and 
the active matrix flat panel imaging detectors (Munro et al 1998b, Antonuk  
2002). 
 
2.2.2 Matrix (Scanning liquid) Ion Chamber detectors 
The matrix ion chamber device consists of two sets of electrodes that are 
oriented perpendicularly to each other separated by a 0.8-mm gap, which is 
filled with a fluid (2,2,4-trimethylpentane) that is ionized when the device is 
irradiated. Each set of electrodes consists of 256 wires spaced 1.27 mm apart to 
provide an active area of 32.5x32.5 cm2. One set of electrodes is connected to 
256 electrometers and the other set of electrodes is connected to a high-voltage 
supply that can apply a 300-V potential to each electrode individually. As 
illustrated in figure 2-2, the matrix ion chamber array is read out by applying a 
high voltage to each of the high-voltage electrodes in succession (for 
approximately 20 milliseconds) and measuring the signal generated in each of 
the 256 signal electrodes. The readings are read out via the electrometers which 
are multiplexed and sent to output via an amplifier.  
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Figure 2- 2. Schematic of a SLIC EPID. 
 
 
Several authors have investigated the use of SLIC EPID for dosimetry 
purposes Chang et al (2000), Mohammadi et al (2007). Advantages of these types 
of EPIDs are their compact sizes and their geometric reliability (images acquired 
with the system have no geometric distortions). The major limitation of a 
scanning radiation detector is quantum utilisation, since only one high-voltage 
electrode (out of 256) is active at any one time and the relatively long read-out 
time (van Elmpt, 2008). 
 
 
2.2.3 Camera-Based detectors 
Camera-based systems consist of a metal plate and a phosphor (gadolinium 
oxysulfide (Gd2O2S)) screen viewed by a camera using a 45° mirror. A 
metal/phosphor screen is used for converting x-rays to visible light which is 
directed to the camera via a mirror. When irradiated, high-energy electrons 
generated in the metal plate and the phosphor screen are converted into light in 
the phosphor screen and this light creates the video signal generated by the 
camera (figure 2-3). The video signal from the camera can be digitised and the 
digitised image can be viewed on a monitor located in the control area of the 
accelerator.  
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Figure 2- 3. Schematic of a video-based EPID  
 
The main disadvantages of Video EPIDs are the poor light collection efficiency of 
the optical chain, which reduces the image quality, and optical glaring error 
which makes the use of these devices for dose verification difficult (Patridge et 
al 1999, Munro et al 1998). Since light is highly scattered within the phosphor 
screen, it is emitted from the rear of the screen in all directions with equal 
probability. Only those light photons that are emitted within a small cone 
subtended by the lens of the camera can generate a signal in the camera; 
typically only 0.1-0.01% of the light emitted by the phosphor screen reaches the 
camera. Two main reasons causing poor light collection efficiency (Herman et al 
2001):  
 If an x-ray photon interacts in the x-ray detector but none of the light 
generated by this interaction reaches the camera, then no measurable 
signal is produced 
 If only a small signal is produced in the camera, then noise generated by 
the pre-amplifier and other electronics of the camera may be large 
compared to the signal.  
As a result, the development of commercial camera-based EPIDs has focused on 
increasing light collection efficiency. 
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2.2.4 Flat panel detectors 
Both the liquid-filled and camera-based types of EPIDs generally produced 
images of inferior contrast and spatial resolution to those obtained using film 
(Antonuk 2002). For this reason amorphous silicon (a-Si) flat panel EPID 
technology has replaced the liquid-filled and camera-based EPIDs due to their 
superior image quality. Flat panel detectors are currently divided into two 
types, Silicon or photodiode systems and Selenium or photoconductor systems. In 
either case, the image quality from the flat panel devices is superior to that of 
the liquid ion chamber or the video EPIDs. The most common type of EPID 
available today is the amorphous-silicon EPID (a-Si EPID) or flat-panel imager, 
first described by Antonuk et al (1998). The panel consists of an X-ray converter, 
light detector, and an electronic acquisition system for receiving and processing 
the resulting digital image. The underlying technology behind flat-panel a-Si 
EPIDs is large area integrated circuits called active-matrix arrays. Active-matrix 
technology allows the deposition of semiconductors, like amorphous silicon, 
across large-area substrates such that the physical and electrical properties of 
the resulting structures can be adapted for many different applications.  
 
 
2.2.4.1 Basic image formation theory for the indirect a-Si electronic portal 
imaging devices 
The amorphous silicon EPID consists of a copper plate, a gadolinium phosphor 
screen and an active-matrix array light sensor coupled to readout electronics. 
These devices have pixel resolution of less than 1mm. As illustrated in figure 2-
4, each pixel in the flat-panel light sensor consists of a photodiode, which 
detects the light emitted by the phosphor screen, and a thin film transistor 
(TFT), which acts like a switch to control the readout of the signal. The data are 
read out through the data line and the timing is controlled by the control Field 
Effect Transistor (FET). The bias line is used to control the bias to the 
photodiode and the charge-up line is used to control the opening and closing of 
the control FET. The intensity of the light emitted from a particular location of 
the phosphor is a measure of the intensity of the x-ray beam incident on the 
surface of the detector at that point. During irradiation, each photodiode 
collects visible photons generated by the high energy x-rays; light that is 
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generated in the phosphor screen discharges the photodiode, which has a 5 V 
bias voltage applied. The TFT is non-conducting during this period. During 
readout, the TFT is made conducting and this allows current to flow between 
the photodiode and an external amplifier. The photodiode is recharged to its 
original bias voltage and the external amplifier records the necessary charge. 
This charge is proportional to the light reaching the photodiode during the 
irradiation. This charge is stored in the pixel until the active-matrix array is read 
out. By activating the TFT's one line at a time and by having all of the TFT's in 
one column connected to a common external amplifier, the signals generated in 
the flat-panel light sensor can be read out one line at a time with a modest 
number of electronic components. Readout frame rates of up to 30/s are 
achievable. This sequence continues while the x-ray exposure is occurring, 
allowing real-time images to be acquired.  
 
(a)
(b)
Gate line
 
Figure 2- 4. Figure (a) is a schematic illustration of an a-Si photo diode coupled to thin film 
transistor (TFT). Figure (b) is a schematic arrangement of photodiodes and controls used in 
the flat panel imager (Reproduced from Varian document library). 
 
 
The principle of operation of the a-Si-detector is shown schematically in Figure 
2-5. The photodiodes have a very poor DQE for high-energy photons. To increase 
the DQE, there is an approximately 0.5 mm thick layer of gadolinium scintillator 
(Gd
2
O
2
S), and a 1mm thick copper build-up plate between the photo diodes and 
the radiation source (Varian Portal vision 2000 and McCurdy et al 2001). The 
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copper plate converts the high-energy photons into electrons, which produce 
optical light in the phosphor. These photons (Figure 2-5 b) are detected in the 
photodiode and stored as charge until the TFT is triggered to conduct the charge 
collected into the ADC in the readout electronics.  
 
 
Copper Plate
Flat Panel a-Si 
Plate (2D array)
Phosphor Screen
X-ray 
Detector
Glass Substrate
(a) (b)  
Figure 2- 5. Figure (a) shows the main layers making up the detector (b) Functional cross-
section of EPID 
 
The system efficiency is considered to be x-ray quantum limited. The size of the 
pixel, in addition to light spread in the phosphor screen and electron spread in 
the copper plate are the main factors affecting spatial resolution (Antonuk 2008, 
Munro 1998b). Glare, which is defined as light scatter, is insignificant for 
imaging suggesting that a flat panel EPID is capable of producing high image 
quality (Antonuk 2002). About 50% of the light emitted from the scintillator is 
used to produce the useful image which is orders of magnitude higher than the 
camera based and scanning liquid ion chamber EPIDs. For dosimetry purposes, a 
1-2% deficiency in signal is significant enough to cause inaccuracy in dose 
verifications (Warkentin et al 2003).  
 
 
2.3 General uses of electronic portal imaging devices 
The current primary applications of EPIDs include treatment machine QA, 
patients’ treatment-setup verification, assessment of target and organ motion, 
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patient dosimetry and compensator design and verification (Herman et al 2001, 
van Elmpt et al 2008). 
 
2.3.1 Treatment setup verification 
The goal of radiation therapy is to accurately deliver a prescribed radiation dose 
to the tumour and spare the surrounding healthy tissues. Treatment setup 
verification can be divided into verification of the geometric configuration of the 
treatment unit and verification of the patient and target position with respect to 
the treatment geometry. The geometric accuracy of patient positioning relative 
to the treatment beam is crucial and factors that could affect this accuracy 
include: incorrect patient alignment relative to the treatment beam, mis-
alignment of the light field versus radiation field and the shift of skin markers 
and patient movement. Portal imaging is used to verify the accuracy of the 
patient positioning prior to treatment. Proper evaluation of treatment setup 
involves relating the information in a portal image to that extracted from a 
reference image (simulation film or DRR). Information compared may be the 
field border, the anatomic landmark or the 3D models of the patient from CT 
data.  
 
Flat panel amorphous silicon (a-Si) detectors are now standard in the 
construction of electronic portal imaging devices (EPIDs) used for positional and 
dosimetric verification in external radiotherapy practice (McGarry et al 2007, 
Greer 2007, Berger et al 2006). With excellent image quality, patient setup 
verification and organ motion detection is readily achievable (Vetterli et al 
2004). In addition, the convenience of EPID technology has led to growing 
interest in its role as a replacement for the laborious and time consuming 
methods of using x-ray film in dosimetric and quality assurance measurement 
(Menon and Sloboda 2004, Nijsten et al 2007).  
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2.3.2 Electronic portal imaging devices as a physics tool for 
routine linear accelerator QA 
The digital format of the EPID image offers added advantages of using a-Si EPIDs 
for routine physics QA instead of the traditional ionization chambers, solid water 
stacks, and film. EPIDs can be calibrated to check photon beam field flatness 
and relative doses during routine machine QA. EPID results are used as “relative 
standards” to which later EPID results should be compared. EPID signal values 
are meaningless by themselves unless they are calibrated against another 
detector. EPID relative standards should be obtained after the treatment unit 
has been properly tuned, adjusted, and calibrated by using a conventional 
scanning water phantom and ionisation chambers. The major QA tests that can 
be done with EPIDs include: 
o Verification of light field and radiation field coincidence or verification of 
light field and radiation field coincidence with field size dimensions 
o Constancy check of radiation field flatness and symmetry 
o Constancy check to compare day-to-day linac output   
o Collimator isocentric accuracy check 
o Cross-hair tray isocentric accuracy check 
o Gantry Isocentric accuracy check 
o Enhanced dynamic wedge (EDW) constancy check by comparing profiles in 
the direction of jaw motion 
o Dynamic MLC QA, for example the popular Varian picket fence and 
complex tests  
o Constancy check of electron beam energies, by comparing beam in-plane 
profiles (Beck et al, 2009). 
 
The above QA procedures suggest that the EPID performance is a reliable 
medical physics tool. The main QA tests needed to be carried out on the EPID 
itself include: 
o Positioning in the imaging plane 
o Positioning perpendicular to the imaging plane  
o Mechanical integrity and collision interlocks  
o Spatial distortion and Noise 
o On screen measurement tools of distances, angles and pixel resolution  
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o Contrast and Modulation transfer function 
o Regular recalibration to ensure constant signal stability 
 
2.3.3 Dosimetric application 
Amorphous-silicon flat panel detectors are used to acquire digital portal images 
with excellent image quality. The efficiency in the use of detected signal and 
the improved spatial resolution makes the a-Si EPID better suited for dose 
verification compared to SLIC and camera based EPIDs (Warkentin et al 2003). 
Their ease of use also makes them attractive for dosimetry applications, but the 
images must be corrected for non-water equivalence of a-Si material, non-linear 
behaviour of the electronics, inhomogeneous pixel sensitivities, scattering in the 
detector and the panel's complex energy response.  
The EPID image resulting from the whole radiation delivery may be calibrated to 
obtain a quantity that may be compared with a prediction based on the 
prescribed dose. This may be the total fluence reaching the detector or the dose 
delivered, in which case this image is calibrated using a dosimetric model and 
the resulting dose image is compared with a theoretical dose image based on 
prescription. Van Elmpt et al (2008) gave a comprehensive literature review of 
electronic portal imaging for radiotherapy dosimetry citing the advantages of 
EPIDs as: fast image acquisition; high resolution; digital format; potential for in 
vivo measurements; point dose measurement; and 3D dose verification. This has 
prompted many research groups to study their use for radiotherapy dosimetry. 
 
2.3.3.1 Electronic portal imaging devices calibration for dosimetry 
The use of any EPID for dosimetric verification requires implementation of a 
suitable calibration procedure to establish a relation between the pixel intensity 
and either fluence or dose distribution. Various authors have used different 
approaches to calibrate the EPID detectors for dosimetry purposes including 
analytical methods involving comparison of detector grey scale value with 
ionisation chamber response and Monte Carlo simulations. The first approach 
utilises empirical (measurement based) models by comparing grey scale pixel 
values to measured dose using a calibrated ionisation chamber inserted into a 
water phantom (Chen et al 2006, Chang et al 2000). The second approach uses 
 50 
Monte Carlo simulations to predict the relation between the grey scale pixel 
values and dose (Siebers et al 2004, Chin et al 2003). However, a detailed model 
of the EPID is necessary for accurate simulations. Like many other Monte Carlo 
simulations, the calculation times are long and all the technical details regarding 
the construction and materials of the various layers are not always available. 
Hence the first method is simpler and faster than a Monte Carlo simulation and 
therefore more suited for implementation in clinical routine. The limitation is 
that empirical models need to be validated outside the reference conditions 
(van Elmpt et al 2008); in particular their robustness under various clinically 
encountered radiotherapy situations should be studied. 
 
 
2.3.3.2 Transit and Non-transit dosimetry 
Dosimetry verification techniques using EPIDs may be categorised according to 
whether the beams have passed through an attenuating medium e.g phantom or 
patient (transit); or not (non-transit) (Vial et al 2008, Elmpt et al 2008, 
Piermattei et al 2007). In both cases the dose can be reconstructed either inside 
or outside a phantom or patient. 
 
EPID
Radiation source
(b) Transit(a) Non-transit
Patient or phantom
* *
 
Figure 2- 6. Transit and non-transit 
 
The non-transit (Figure 2-6(a)) approach is where the dose or fluence is acquired 
without any attenuating material (patient or phantom) in the beam. The method 
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involves the determination of the dose in the detector or patient (phantom) or 
determination of the incident energy fluence, based on measurements without 
an attenuating medium between the source and the detector. An image is 
acquired for each field without a patient (phantom) in the beam and compared 
with a predicted EPID response at the level of the imager. Alternatively the EPID 
image signal is reconstructed into dose inside the patients (phantom) as detailed 
above. The non-transit approach is mainly used as a pre-treatment dose 
verification method and hence is a valuable tool for performing quality control 
of treatment parameters related to dosimetric and geometric characteristics of 
the linac, independent of the patient. 
 
Transit dosimetry (Figure 2-6(b)) or back projection is where the EPID is 
calibrated to predict dose based on the radiation transmitted through the 
patient or phantom. The technique involves the determination of the dose at the 
position of the detector or patient (phantom) or determination of the incident 
energy fluence, based on radiation transmitted through the patient or phantom. 
This approach is mainly used as a treatment dose verification method and offers 
the possibility of in-vivo dosimetry. An image is acquired for each field with the 
detector located behind the patient (phantom) and compared with predicted 
EPID response at the level of the imager or behind the patient/phantom. 
Alternatively the EPID image primary signal is back-projected and computed into 
dose inside the patient (phantom) CT scan by converting the image to energy 
fluence, using this as an input for the dose calculation algorithm and comparing 
to a plan calculated from the patient/phantom CT scan. The transit method has 
the potential of verifying both the treatment planning system (TPS) calculation 
of dose to the phantom or patient, and the delivery of dose by the Linac. 
 
Nijsten et al (2007b) proposed a two-step global calibration model for a-Si EPIDs 
for transit dosimetry based on measurements and mathematical convolution 
methods. First, dosimetric EPID characteristics like long-term stability, build-up, 
ghosting effects, and field size dependence were investigated to implement a 
dosimetric calibration for open fields. Second, the model was extended for 
transit dosimetry application by including an energy spectrum correction model 
that corrects differences in EPID response between measurements with and 
without an object in the beam, field size dependence kernels, beam profile 
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correction derived for two photon energies and the conversion factor to absolute 
dose in water from EPID greyscale values.  
 
2.4 Overview of the Varian electronic portal imaging 
device detector system  
The EPID flat-panel used by Varian is an indirect detection system and comprises 
three main components, namely: Image detection unit, Image acquisition system 
and computer control software. 
 
2.4.1 Image detection unit 
The first component is the image detection unit (IDU). It has the shape and size 
of a standard film cassette and  is positioned in the imaging plane using a 
robotic- controlled R-arm or exact-arm. It is connected by cables to the therapy 
control area from where image acquisition, processing and display are 
controlled. Within the detector, a phosphor scintillator converts incoming x-rays 
to visible photons which are sensed by an array of photodiodes implanted on the 
amorphous silicon panel. The photodiodes convert the incoming light to charge 
and the integrated charge is transferred to the read-out electronics to be 
counted as a pixel signal, proportional to incoming radiation intensity. The 
detector electronics allow the transfer of charges from the pixels to the read-
out electronics by activating row after row of the pixel matrix while all the 
columns (data lines) are read-out thus forming an image. Radiation shielding of 
the electronics is required to avoid damage due to their close proximity to the 
detector (ie they are too near to the primary beam). Figure 2-7 shows a block 
diagram of a plan view of the IDU. Varian has two versions of IDUs, the older one 
is the IDU-II and the more recent is the IDU-20. 
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Figure 2- 7. Block diagram of the image detection unit (IDU) (Reproduced from Varian 
document library). 
 
 
2.4.2 Image acquisition system 
The image acquisition system (IAS) contains drivers and acquisition electronics 
for the image detection unit. The IAS interfaces to the IDU, the linac and the 
imager controller (the R-Arm or the exact-Arm). It is essentially a digital signal 
processor that provides frame averaging capabilities and image buffering. It 
controls and reads the image detector and performs image corrections. Varian 
has two versions of IAS, the older one is the IAS2 and the more recent is the 
IAS3. 
 
2.4.3 Acquisition computer control software  
The third component is the computer control software that maintains the 
interfaces and controls the communication between the IDU and the acquisition 
unit. Image correction data and acquisition parameters are stored on the hard 
disk of this computer. The EPID image is the average of acquired frames in the 
integration mode.  
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PortalVisionTM is a Varian software system supporting the acquisition of 
electronic portal images before, during and after treatment and provides tools 
for quantitative portal image registration and review. Table 2-1 summarises the 
physical characteristics and specifications of the Varian imager.  
Table 2- 1. Specifications of the Varian imager (Varian PortalVisionTM aS500, 2001)  
4-25 MV
100-600 MU/min
3 frames / second
2  images / second
Energy range
Doserate range
Image acquisition rate
Image storage rate
n-i-p photodiode
384x512 (a-Si 500) and 768x1024 (a-Si 1000)
784 µm (a-Si 500) and 392 µm (a-Si 1000)
40x30 cm2
Pixel
Pixel format
Pixel pitch
Array dimensions
0.6 mm copper
Gadolinium Oxy-sulphide
Amorphous-Silicon
Detection Components
Metal plate
Phosphor screen
Photon detector
 
 
2.4.4 Electronic readout of a-Si detectors 
There are 3 modes for electronic readout schemes used for image acquisition 
with the a-Si EPID (Varian portal vision 2001). All three modes work towards a 
common goal of acquiring images with optimal Signal to Noise Ratio (SNR).  
 
2.4.4.1 Single (integrated) mode 
During single mode acquisition, the configured numbers of frames are readout 
prior to the start of irradiation. This cycle is called the refresh cycle; it clears 
the accumulated dark current and residual data. No readout occurs during the 
delivery of the radiation and the signal is integrated over the entire exposure 
period. The trailing edge of the Radiation-on signal generates one trigger pulse 
initiating one frame readout and also the accumulated data of the pixels during 
 55 
the exposure interval. This readout scheme reduces the effects of readout noise 
and eliminates the pulsing effects of the linac on the final image. Since the 
signal is integrated during the exposure time and the readout is performed after 
the exposure, this improves the signal to noise ratio (SNR). The single mode 
acquisition is routinely used clinically and allows the acquisition of clinical 
images with exposures as low as 2 MU (Kirby et al 2006, de Boer et al 2000). 
 
2.4.4.2 Continuous mode - high dose imaging 
Continuous mode is primarily used for monitoring the patient during intensity 
modulated radiotherapy (IMRT) treatment. This acquisition mode includes movie 
images and the verification image (average of movie images). Implementation of 
this mode can be done with either the use of free running mode or external 
trigger mode. The external trigger continuous mode synchronises the frame 
readout with linac pulses thus eliminating the pulsing artefacts. This not only 
improves the image quality of movie images but also increases the accuracy of 
dosimetric verifications for applications such as IMRT. The external continuous 
mode can be further divided into two synchronisation modes; line 
synchronisation and frame synchronisation. In line synchronisation, each line can 
be triggered and readout individually. In frame synchronisation mode, the start 
of frame is synchronised with linac pulses. The sensors are forced to be 
discharged prior to the start of radiation-on to eliminate the dark current 
accumulation. The linac beam pulses are synchronised to the external trigger 
pulses which in turn are synchronised with the start of each frame scan. An 
offset correction image is used to correct the dark current of each pixel. During 
the gain correction, the median value of the pixel data of the whole sensor is 
evaluated and each individual pixel value is mapped to the median value. The 
final image is the average of the frame scan during radiation exposure.  
 
2.4.4.3 Cone beam mode (only available on linacs with OBI system) 
Cone beam acquisition mode is used to perform volume (multi-slice) kilovoltage 
CT (kVCT) or CBCT in the cone beam geometry to visualize 3D (three 
dimensional) anatomy during patient positioning. In this mode, image acquisition 
is synchronized with the linac enabling the imager to remove the pulsing 
artefacts from the image while also improving the SNR. 
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2.4.5 Imager calibration 
The system requires a set of calibration images for each combination of 
acquisition mode, energy and dose rate parameters of the treatment machine 
used. An imager calibration set comprises two images, a dark-field image and a 
flood-field image. Each set is stored in the IAS database. Both images consist of 
up to 10 individual images taken in succession. PortalVisionTM uses the averaged 
result of all images for correction. 
 
2.4.5.1 Dark field image 
In the dark-field image (DF), individual pixel-by-pixel values are measured by 
periodically acquiring an image without radiation. The DF correction is 
synchronised with linac pulses. An average of several images measured in quick 
succession is taken for minimum noise. Its contents reflect array imperfections 
and electrometer offsets. Figure 2-8 (a) displays a typical dark-field image 
exhibiting bright and dark vertical stripes. 
 
(a)   Dark-Field (b)   Flood-Field
 
Figure 2- 8. Dark-field and Flood-field images 
 
2.4.5.2 Flood field image 
The flood-field (FF) image is also measured several times in quick succession and 
averaged for minimum noise. Its contents represent the field homogeneity, 
individual cell sensitivities and electrometer gains. The sensitivity of each pixel 
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is determined periodically by acquiring an image with radiation for a wide open 
field without an object. During the acquisition of the FF image, any 
interferences in the radiation field or the dose rate at which the EPID is being 
calibrated, will lead to a wrong FF correction file. The flood field image, 
illustrated in figure 2-8 (b) exhibits vertical bands of varying brightness.  
 
These images are used to correct the beam-on raw object image according to 
the equation 
meanFF*j),FF_image(i
j),DF_image(ij)i,Raw_Image(j)Image(i,Corrected_ 




 −
=               (2- 1) 
 
Where the offset correction is equal to the stored dark field image subtracted 
from the acquired raw image. The gain correction is defined as the offset 
corrected image divided by the stored normalised flood-field image. FFmean is the 
mean value of the flood field image. The i and j notations in the equation above 
represent the ith - jth pixel values in the X and Y directions of the image. 
 
2.4.5.3 Main components of the Varian's portal dosimetry system 
The Varian portal dosimetry system has three main requirements, namely: 
1) The portal Imager (a-Si 500 or a-Si 1000): Portal dosimetry software in 
addition to the image acquisition system (IAS) is also required for the EPID 
to acquire dose maps. A special license is needed to activate the 
Dosimetry Workspace. 
2) Portal dose prediction: Eclipse 8.6 treatment planning system algorithms 
are required to enable prediction of dose maps. These predicted dose 
images (PDI) are compared to the measured dose maps for dosimetric 
verification of treatment plans.  
3) Portal dosimetry review workspace to evaluate the agreement between 
predicted and measured images. An evaluation module is required for the 
comparison of PDI and measured dose maps. The review workspace in 
Vision caters for this purpose. The software has tools for comparison and 
evaluation of dosimetric images e.g. gamma analysis, dose differences, 
etc. However, this is not a mandatory requirement as such analysis can be 
carried out using other analytical software.  
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3 CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Dosimetric performance of a-Si500 EPIDs 
The department is equipped with eleven linear accelerators which are: 4 
Clinac 600 C/EX, 4 Clinac 2100 C/CD/EX and 3 Clinac iX series with 6MV, 10MV 
and 16MV, all equipped with EPIDs as detailed in table 3-1. Six of the detectors 
(A, B, C, E, F and H) use hardware/software IDU-II/IAS2 while the other five 
detectors (D, G, I, J and K) use IDU-20/IAS3 (Varian Medical Systems, Palo Alto, 
California, USA). At the time of this study all the detectors were being used for 
clinical imaging only apart from detector I, which in addition had been 
configured / calibrated for dosimetric purposes. For simplicity we refer to 
hardware/software IDU-II/IAS2 as system-I and IDU-20/IAS3 as system-II (Table 3-
1). Both system-I and system-II used in this study are a-Si500, though Varian has 
introduced a system-II fitted with an a-Si1000. The main difference between the 
a-Si500 and a-Si1000 is that the latter has a better pixel resolution compared to 
the former, as indicated in table 2-1. 
 
Table 3- 1. The different accelerator models with EPIDs, the EPID image acquisition system 
and their corresponding clinical use period in months.  
10iXIIIDU-20 / IAS3K
17iXIIIDU-20 / IAS3J
17iXIIIDU-20 / IAS3I
326 EXIIDU-II / IAS2H
3221 EXIIIDU-20 / IAS3G
3221 EXIIDU-II / IAS2F
756 EXIIDU-II / IAS2E
3421 EXIIIDU-20 / IAS3D
822100 C/DIIDU-II / IAS2C
86600 C/DIIDU-II / IAS2B
86600 C/DIIDU-II / IAS2A
Months in useAccelerator ModelSystemHardware / SoftwareEPID
 
 
 
 
 
  
 59 
The manufacturer’s technical specification suggests system-II has lower noise 
readout electronics, higher readout rates and faster data acquisitions compared 
to system-I.  The EPID detectors in the two systems have active dimensions of 
0.4m x 0.3m and a resolution of 512x384 pixels yielding an effective pixel size of 
784µm. For system-I, readout of the EPID amorphous silicon array is synchronised 
with the beam pulses and a fixed integration time of 320 ms was used for image 
acquisition. System-II uses the asynchronous mode where the readout is 
controlled by an internal clock. This setup, specifically designed for IMRT fields’ 
acquisition, is Varian’s default mode for the system-II EPIDs, activated by setting 
the sync mode parameter to zero. For both systems portal images were acquired 
using AM maintenance (Varian portal imaging control software used to acquire 
EPID images) version 7.1. 
Table 3-1 also shows the length of time each EPID had been in clinical use 
within our centre at the time this study was conducted. System-I detectors had 
been used for periods ranging from 32 to 86 (mean 66) months while system-II 
detectors had been used for a period ranging from 10 to 34 (mean 22) months. 
All measurements were performed in the evenings after the detectors had been 
in clinical use to ensure warm up. In this study a nominal photon energy beam of 
6 MV was used in all measurements.  
 
3.1.1  Image acquisition 
For system-I, parameter settings in AM maintenance were kept constant for the 
400 MU/min dose-rate, e.g number of rows acquired before next row 
synchronisation (Rows Per PVSYNC) = 9, synchronization delay = 350µs, IDU/ACPU 
Gain = 1, PV synchronisation frequency = 2400 Hz. For system-II, Varian uses a 
standard set of acquisition settings from their own optimisation experiments for 
each dose-rate. These parameters include the number of trigger pulses the 
system waits before acquisition begins, frame cycle time, number of rows to be 
acquired and subsequent number of frames between accelerator pulses. 
To ensure uniform pixel response, EPIDs were calibrated for dark field 
(DF) to eliminate background and electronic noise. A flood field (FF) calibration 
was also used to correct for variations in sensitivity of individual pixels. While 
this eliminates variations in pixel sensitivity, it also has the effect of removing 
the characteristic horn-shape of the photon beam profile downstream of the 
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flattening filter. The number of frame averages for the DF and FF calibration 
fields for system-I were 60 and 30, while for system-II it was 30 and 30 
respectively. Detectors were calibrated at the maximum effective field sizes of 
28.6 x 21.4 cm2 and 30.5 x 22.5 cm2 for system-I and system-II respectively. Both 
detector systems have same area  of 30x40 cm2 at the isocenter, but due to 
mechanical positioning limitations vertically, all the system-I detectors could not 
attain the same effective field size at the imaging plane. All field sizes were 
defined at the source-to-isocenter distance of 100 cm, unless otherwise stated. 
The vertically downwards position of the accelerator-gantry was ensured with 
the help of a spirit level. The IDUs were positioned at lateral = 0, longitudinal = 
0 and vertical = 40cm below the isocenter. For each EPID, the physical position 
of the detector was maintained on the central axis of the linear accelerator. The 
distance from the accelerator targets to the EPID surfaces was maintained at 
138±0.5 cm aiming the distance to the sensitive layer to be at 140.0 for 
calibration and subsequent measurements. Van Esch et al (2004) and Greer et al 
(2003) reported negligible ghosting effects on Varian EPIDs. A minimum period of 
1 minute was employed (Winkler et al, 2005) to minimise these memory effects 
even further since EPIDs of varying life periods were being investigated.  
Images were acquired in the integrated mode, whereby the accumulated frames 
are displayed as a single image after irradiation is complete. At each setting, the 
measurement was repeated 3–4 times to derive the EPID integrated response (IR) 
which was calculated as the average of acquired number of frames (ANF).  
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                                                           (3. 1) 
Where n is the total number of measurements done and MPV is the mean pixel 
value. 
 
3.1.2  Detector reproducibility and responses to a reference beam  
Each detector was irradiated with a reference beam, defined as a 50 MU 
exposure, at a fixed field size of 10 x 10 cm2, 400 MU/min doserate and at a 
fixed SDD of 138±0.5 cm. The average pixel value in the 13 x13 central pixel 
region was obtained for ten consecutive irradiations for each detector. The 
mean (of the average pixel values) for the ten consecutive readings was used to 
compare the detector’s response to a reference beam and the percentage pixel 
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deviation from the mean value was calculated for each detector from [(MPV-
Mean)/Mean] x 100%, where MPV is the mean pixel value for each detector 
(obtained as the average of ten consecutive measurements) and Mean is the 
average values for the detectors for each system. The responses for system-1 
and system-II acquisition systems were analysed separately. Also the ten 
consecutive readings for each detector were used to calculate the short-term 
reproducibility. The long-term reproducibility was done by comparing the mean 
pixel value over a six month period.  
 
3.1.3  Dose-response behaviour / Linearity 
To assess the linearity of their dose response, each EPID was positioned at a 
fixed SDD of 138±0.5 cm and exposed at a constant dose rate of 400MU/min. 
Three integrated images of a 10x10 cm2 open field were acquired. The linear 
accelerator monitor units used were 1, 2, 5, 10, 20, 50, 100, 200 500, and 1000. 
EPID response was assessed in a 13 x 13 pixel (approximately 1.0 cm2 area) 
region of interest in the centre of the image. For all detectors, the signal-to- 
monitor units ratios (SMUR) in the range of 1–1000 MU were calculated by 
dividing the average EPID response by MU delivered. To ensure stability of the 
accelerators, MU variation measurements were monitored using an ion chamber 
(Wellhoffer Dosimetrie, Schwarzenbruck Germany) in a mini-water phantom at a 
depth of 1.5cm, prior to measurements with EPIDs. The phantom was placed on 
the couch in the centre of the beam and the source to water surface distance 
was maintained at the same level as for each EPID detector.  Ionisation chamber 
measurements after temperature and pressure correction were compared with 
corresponding measurement with the EPIDs. 
The effect of cumulative response was investigated by comparing an EPID’s 
response to a single 20 MU exposure to a series of lower-dose exposures with 
equivalent MU. The total response given by ( )∑ ANFxMPV  and the 
percentage deficit from the single 20 MU exposure were calculated. 
 
 
 62 
3.1.4 Pixel uniformity-response across the entire detector panel 
The EPID uniformity across each entire detector was investigated by comparing 
their response at specific positions relative to the central positions. The 
radiation beam uniformity for each accelerator was monitored as part of general 
quality assurance. The mean response in a 13x13 pixel region surrounding each 
of the positions P0, P1, …, P8 was obtained for each detector in a 20 x 20 cm
2 (28 
x28 cm2 at the detector level) field size and PL, PR, PG and PT in the penumbra 
region as illustrated in figure 3-1. The penumbra region is known to be sensitive 
to detector and collimator positioning, a critical parameter in dosimetric 
applications. During irradiation, scatter in the imaging detector and over-
response to lower energy photons, increases the pixel values in the periphery of 
the field. For each EPID, three images were acquired at the same monitor unit 
(50 MU) and doserate (400 MU/min). At the detector level, positional lengths 
are: cmPPPP 0.72010 ==  located at the EPID central axis along the left-right 
direction of the gantry. cmPPPP 5.104030 == , located at the EPID central axis 
along the Gun-Target direction of the gantry. cmPPPPPPPP 2.1480706050 ==== . 
Points P5, P6, P7 and P8 are 1.8 cm and 1.0 cm from the field edge in the left-
right and the Gun-Target directions respectively. The four values in the 
penumbra regions were averaged (Pavr) for each detector such that any 
deviation/shift in one side is counterbalanced by the results in another. MATLAB 
(The MathWorks, Inc) was used to obtain the average of the three images and 
normalise the response to that of the central position P0. 
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Figure 3- 1. Specific locations used to measure the uniformity with in a 20 x 20 cm2 radiation 
field size in the EPID detector. Each of the positional points has an area of 13 x 13 pixels. 
Mean response for all the points were compared to the central axis (P0) reading of each 
EPID detector. The response of the points (PL, PR PG and PT) in the penumbra region were 
averaged (Pavr) for each EPID.  
 
3.1.5 Electronic portal imaging device’s relative dosimetry 
A physical step-wedge with relative thicknesses of 0.25, 0.50, 0.75 and 1.00 was 
used to assess relative response. The steps create steep dosimetric gradients 
similar to those encountered in IMRT. The step-wedge was positioned at the 
surfaces of the EPID detectors at the same source to surface distance of 140.0 
cm. The centres of the EPID detectors and step-wedge were aligned using the 
isocentre lasers and checked with the central mechanical pointer of the 
accelerator. The field size was maintained at 1.0 x 7.5 cm2.  EPID images were 
obtained with 6 MV, 50 MU and 400 MU/Min in both Right-Left and Gun-Target 
directions relative to the accelerator. The signals were normalized to the open 
field reading and standard deviations at different steps calculated. 
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3.1.6 Field size dependence  
With the EPID detectors at fixed distance of 138±0.5 cm, fields of various sizes 
were obtained at a constant doserate of 400 MU/min. Open field images were 
obtained at a fixed dose of 50 MU to field sizes of 2x2, 5x5, 10x10, 15x15 and 
20x20 cm2. For each field size, response was measured in a 13 x 13 pixel region 
of interest (approximately 1.0 cm2 area) in the centre of the image. Each field 
size response was calculated as indicated in equation 3.1. Field size responses of 
the different EPID were compared to ionisation chamber measurements acquired 
in water with a fixed source=surface distance maintained to the corresponding 
level for each EPID detector. Both the EPID and ionization chamber data for 
different field sizes were normalised to that of a 10 x 10 cm2 and fitted to a 
second order polynomial equation,  
( ) ( )2210 FSAFSAAEF ++=   (3. 2) 
  
Where EF is the EPID field size dependence factor (defined on the central axis 
and assumed to be a constant for all pixels for a given field size), FS is the field 
size and A0, A1 and A2 are polynomial coefficients.  
 
3.1.7 Doserate influence 
The EPIDs were calibrated at accelerator dose-rates of 100, 200, 300, 400, 500 
and 600 MU/min utilising identical settings (field size/distances) and on the 
same day to minimise the day-to-day variations in pixel sensitivity, beam 
symmetry and accelerator outputs. For each dose-rate, the response of the 
EPIDs to 20MU and 100MU exposures at a 10x10cm2 field size was evaluated.  The 
EPID responses were obtained as described in the previous sections and readings 
normalised to those obtained at 400 MU/min. It is common practice to fit the 
doserate ( D
•
) response to a power potential function of the form  
∆•
= DkS  (3. 3) 
(Fowler and Attix 1966, Pardo et al 2005, Muhammadi et al 2006, Winkler et al 
2006). Where S is the detector read-out signal or detector relative read-out 
signal, k is a parameter for detector sensitivity and ∆ is a parameter related to 
the non-linearity of the detector response. Equation 3.3 can be used with 
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absolute or relative (normalised) data. In particular ∆ is less than one when the 
EPID shows an over-response and greater than one if the EPID shows an under-
response. 
 
 
3.1.8 Directional dependence 
The EPIDs were exposed at varying gantry angles between 0o to 360o in 12 equal 
intervals, to assess the influence of mechanical stability on their response as a 
result of gantry rotation. Open beams of 10x10cm2 field size, fixed SDD of 
138±0.5 cm, 25 MU exposures and doserate of 400 MU/min were used for this 
analysis. At each gantry angle the EPID central response was evaluated as 
described in previous sections. Measurements were performed at collimator 
angles 0o and 90o. EPID response values for each collimator angle were 
normalised to that obtained at gantry angle 0o.   
 
3.1.9 Further image profile analysis and memory effects 
Images for open field sizes 2x2, 5x5, 10x10, 15x15 and 20x20 cm2 at different 
doses (MU) were obtained and analysed with MATLAB. Profiles through the 
central image axis both in the Gun-Target and Left-Right directions relative to 
the EPID were obtained and compared. For each EPID, a 5x5 cm2 field size was 
irradiated with 50 MU followed by a 20x20cm2 field size irradiated with 3 MU to 
evaluate memory effects. The time interval between the two exposures ranged 
from 12-15 seconds. Another 3 MU image for a 20x20cm2 field size was obtained 
approximately 5 minutes later. The EPID ghosting effect response was 
characterised as the difference in the central axes profiles between the two 
20x20cm2 field size images expressed as the percentage increase in response at 
the centre of 5x5 cm2.  
 
3.1.10 Electronic portal imaging devices ageing due to 
radiation 
Electronic portal imaging device’s ageing due to radiation could be another 
factor that might cause degraded results. Hee et al. (2002) reported that 
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radiation damage affects the leakage current of photodiodes and the effect 
showed a linear dependence on absorbed dose. This may decrease the whole 
system performance, although it also depends on the ageing effects of other 
components. This effect was investigated further by extracting data from the 
“treatment field history” file of the Varis system for about 2.7 million treatment 
records of all our machines since 2001, when the first EPID was commissioned. 
The data were extracted using mySQL database software. The aim was to find 
out if there is correlation between the EPID cumulative dose/age and its 
performance. From the database, the actual linear accelerator monitor units 
delivered per treatment field when EPID images were acquired were obtained, 
from which the cumulative dose to the imagers could be calculated. 
 
3.1.11 Electronic portal imaging devices, as a dosimeter 
Electronic portal imaging devices were purposely developed for on-line patient 
setup verifications. The acquired image information is however related to the 
dose delivered to the EPID, and they are currently used as dosimeters as well. A 
study was conducted to evaluate the EPID as a dosimeter, by comparing its 
response with that of an ionisation chamber. Both detectors were positioned at 
the same source to detector distance (SDD) and same field size of 10x10 cm2, as 
shown in figure 3-2. The ionisation chamber was positioned at depth of 
maximum dose (1.5 cm build up for 6 MV) with appropriate back scatter. Both 
detectors’ signals were obtained at linear accelerator monitor units of 1, 2, 5, 
10, 20, 50, 100, 200 500, and 1000; and at the same doserate of 400 MU/min. 
The EPID response was measured as the mean pixel value in a 13 x 13 pixel 
(approximately 1.0 cm2 area) region of interest in the centre of the image.  
The same setup was used to compare the EPID with the ion chamber in terms of 
photon beam-intensity reduction, by measuring the dose variation as a function 
of absorbing material. This was done by interposing solid water materials of 
increasing thicknesses between the source and the detectors. For each phantom 
thickness, both detectors were exposed to the same radiation conditions, (SDD = 
140 cm, FS = 10x10 cm2 and 100 MU). Similarly, the EPID response was measured 
as the mean pixel value in a 13 x 13 pixel region of interest in the centre of the 
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image. The data for each detector were normalised to that when there is no 
absorbing material (thickness = zero). 
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Figure 3- 2. The geometrical setups for: (a) EPID image acquisition and (b) Ionisation 
chamber measurements. In both (a) and (b) the detectors (EPID and ion chambers) were 
kept at fixed SDD. The ion chamber was set with a 10.0 cm solid water backscatter and 
build-up equivalent to the beam dmax (1.5 cm). 
 
 
3.2 Water equivalent path length calculation from EPID 
images 
The photon beam physical property of intensity reduction with increasing 
material thickness, as described in the last paragraph of section 3.1.11 above, 
was used to explore further the dosimetric capability of the EPID. The quadratic 
calibration method was used, a technique first proposed by Morton et al (1991) 
to convert any acquired EPID image into water equivalent path length (EPL).  
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3.2.1 Treatment unit and EPID detector  
All measurements for the EPID calibration for equivalent path length (EPL) were 
performed using photon beams from the Varian linear accelerators (Clinac 2100 
C/CD/EX and Clinac iX series) at 6MV and 16MV.  The images were acquired with 
the Varian a-Si500 EPIDs, hardware/software IDU-20/IAS3 (Varian Medical 
Systems, Palo Alto, California, USA). Details regarding this imager design and 
calibration, image acquisition, and dosimetric characteristics have been 
described extensively in sections 2.5 and 3.1.1, and in the literature (McDermott 
et al 2006, van Esch et al 2004, Greer et al 2003, and Kavuma et al 2008). The 
EPID imager was kept at a fixed distance of 140 cm from the source for all 
images. Detectors were calibrated at fixed field sizes of 30.5 x 22.5 cm2 (i.e this 
study was only done with system-II detectors) All field sizes were defined at the 
source-to-isocenter distance of 100 cm. Two approaches were used in portal 
image acquisitions: 
o Using the Varian AM maintenance control software version 7.1 in the 
integrated mode where frames are acquired and integrated continuously 
giving a single image (the average) at the end of exposure. The acquired 
images were exported as DICOM files for analysis. 
o In the second approach, test plans with desired field settings (i.e field size, 
monitor units, MLC shapes, etc) were created using the Varian RT chart 
software. The test patients were scheduled in the time planner, exported to 
the accelerator and treatments executed in the clinical mode, acquiring 
single integrated images at the end of each treatment. The acquired images 
were opened using the Varian portal dosimetry software and exported as 
ASCII files for analysis. 
The second approach was mainly used because the images are automatically 
saved, test patients can be reused and image acquisition process is faster on the 
machine. Image processing and mathematical modelling were carried out using 
MATLAB v2008b (The MathWorks, Inc).  
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3.2.2 Measurements and Image acquisition for calibration  
This study is based on the premise that the EPID image in the integrated mode is 
ideally dependent of the number of monitor units used to acquire the image. 
EPID images for a set of solid water phantoms of thicknesses 5, 10, 15, 20, 26 
and 32 cm were acquired with a 21.5x21.5 cm2 field size, for calibration. This is 
the reference field size and all irradiations were 100 monitor units (MU) at a 
doserate of 400 MU min-1. Each phantom was positioned on the beam central axis 
on the treatment couch and the distance from the source to the centre of the 
phantom adjusted such that the source axis distance (SAD) was equal to 100 cm 
as shown in figure 3-3. 
                        
SAD = 100 cm
EPID
Solid water
40 cm
Field Area (s)
Source
 
Figure 3- 3. The experimental setup for EPID image acquisition. The solid water phantom 
thickness (T) was symmetrically set about the isocentre and the EPID kept at a fixed source 
to detector distance (SDD=140 cm).  
 
The photon beam has spectral variations due to the flattening filter, scatter and 
beam hardening in the object irradiated and hence the pixel intensity at any 
point in the detector will not follow exponential attenuation (equation 1.2) with 
object thickness. Equation 1.2 is modified by adding another term quadratic in 
thickness, and the data are fitted onto the resulting equation (Fielding et al 
2002). The calculation of equivalent path length using the quadratic calibration 
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method was done following the same principle as above; and also described by 
Kairn et al (2008). In their work, they used Monte Carlo simulations to validate 
the use of EPID as gauge for patient or phantom radiological thickness, as an 
alternative to dosimetry.  
The relationship between intensity and phantom thickness for a pixel at location 
(i,j) in the detector is assumed to be a quadratic function of thickness, given by 
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Where the ∗ symbol represents element-by-element matrix multiplication, M(i,j) 
is a 2D matrix of signals (i =1 to 384 and j =1 to 512) due to placing a thickness 
T(i,j) in the radiation beam and Mo(i,j) is the matrix image signal obtained 
without any material in the beam for each pixel in the detector. T(i,j) at each 
pixel can be calculated from an expression related to the physical thickness of 
the material and setup / geometry of the unit and is given by   
 
                                                                (3. 5) 
  
 
Where x and y denote the distance of the ith-jth pixel from the central axis, SDD 
and To are the source to detector distance and physical thickness of the material 
on the central axis respectively. θ(i,j) is the angle between the vertical axis and  
pixel (i,j) on the EPID is given by  
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The quadratic coefficients A(i,j) and B(i,j) are related to the attenuation 
coefficients of the material. All matrix multiplications and divisions are done 
element-by-element. The measured 2D signal array for each of the thicknesses 
above was fitted to equation 3.4 resulting in a set of 384x512x6 equations, linear 
in A(i,j) and B(i,j) of the form  
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Where M1(i,j), M2(i,j), M3(i,j) are the matrices resulting from the element-by-
element squaring of T(i,j), T(i,j) and simplification of the logarithmic term of 
equation 3.4 respectively. These sets of equations were solved by means of the 
least square method to obtain matrices A(i,j) and B(i,j).  
Any other material imaged by the detector resulting into matrix signal M4(i,j) 
can be solved by inverting equation 3.4 and substituting the values of fitting 
parameters A(i,j) and B(i,j) such that, 
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Where Th(i,j) is a two-dimensional matrix of thicknesses in cm which is equal to 
water equivalent path length (EPL) for the reference conditions. However if a 
patient / phantom is imaged at any other irradiation situation, other than the 
reference condition, the signal M4(i,j)  has to be corrected for field size, 
phantom scatter and monitor unit changes to determine the (EPL). It was found 
that the solution given by evaluating the negative route of 3.8 was unrealistic, 
and thus discarded.  
 
3.2.3 Measurement of correction factors  
3.2.3.1 Field size and phantom thickness 
Scatter correction factors (CF) due to phantom scatter and field size effects 
were used to correct for EPL calculations as described by Fielding et al 2002. 
These factors were determined experimentally for a range of field sizes with 
solid water phantoms of thicknesses 5, 10, 15, 20, 26 and 32 cm. Each phantom 
was positioned on the beam central axis on the treatment couch and the 
distance from the source to the centre of the phantom adjusted such that the 
SAD was equal to 100 cm. Figure 3-4 shows the setup used. The transit signals 
through the phantoms were detected either directly with the EPID (figure 3-4 a) 
or using an ionisation chamber positioned on the central axis at the EPID position 
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(figure 3-4 b). For the EPID, the response was measured as the mean pixel value 
in a 1 cm region of interest in the centre of the image. For the alternative 
method, the ionisation chamber was inserted in a 30x30cm2 solid water phantom 
slab, with appropriate build-up (1.5 cm and 2.5 cm for 6 MV and 16 MV 
respectively) and 1 cm solid water phantom for back scatter to simulate the 
EPID. Using Monte Carlo simulations, Siebers et al (2004) established that 9.8 
mm of water slab was optimum to model the equivalent EPID (Varian) 
backscatter material. Similarly, the phantom model used by Warkentin et al 
(2003) was ≈ 2.7 cm equivalent thickness for Monte Carlo simulation of the EPID. 
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Figure 3- 4. The experimental setups for (a) EPID and (b) ionisation chamber measurement 
of scatter and field size correction factors. The solid water phantom thickness (T) was 
symmetrically set about the isocentre and the detectors kept at fixed source to detector 
distances (SDD = 140 cm). The ion chamber was set with a 1.0 cm solid water backup and 
build-up equivalent to the beam dmax (1.5 cm and 2.5 cm for 6 MV and 16 MV respectively).  
 
The total radiation signal (dose) reaching the EPID detector is the sum of the 
primary and scatter components (Swindell et al 1996). The scatter factor, SF(s,z) 
due to field size (s) and physical thickness (z) is the ratio of the total signal   
(TD) to the primary signal (PD) and is defined by 
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Where SPR(s,z) is the scatter to primary ratio. The CF is related to the SPR 
(Mayles et al 2007, Kairn et al 2008), by  
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Where ref is the reference field size (21.5x21.5 cm2) and since the primary dose 
is independent of field size, then PD(z)ref = PD(z)s. Thus for either EPID or 
ionisation chamber measurements, the correction factor CF(s,z) due to field size 
(s) and solid water phantom thickness (z) were obtained as the signal ratios for 
the reference field and the field size of interest (s). 
 
3.2.3.2 Monitor unit effects 
The product of EPID pixel value and acquired number of frames has a linear 
relationship with the MU (McDermott et al 2006, Greer et al 2003 and Kavuma et 
al 2008). However, the preliminary results demonstrated significant differences 
between EPL for EPID images acquired with lower monitor units and those with 
higher monitor units. The effect of varying MU and the influence it has on the 
calculated EPL was studied by irradiating solid water materials of thicknesses 10, 
20 and 32 cm for square field sizes of 5, 10 and 20 cm; at 20, 50, 100, 200, 300 
and 500 MU; and doserates of 400 MU/min and 100 MU/min. The signal (average 
EPID response in a 13 x 13 pixel (approximately 1.0 cm2 area) region of interest 
in the centre of the image) versus MU plots were generated for the three 
thicknesses. Another dosimetric parameter, the signal-to-monitor-units ratio 
(SMUR) was calculated by dividing the same EPID signal above by the delivered 
number of monitor units. The main purpose of the SMUR calculation is to take 
into consideration the non-linear response of EPID at lower MU. The data were 
normalised to those at 100 MU. From these results, correction factors dependent 
on the MU were determined and equation 3.8 above was modified to take into 
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consideration the varying effect of MU on EPL. Hence the overall correction due 
to phantom thickness, field area and monitor unit is given by  
mu
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This correction factor ),(
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jiCF muzs , becomes the coefficient of the M4(i,j)/M0(i,j) 
term in equation 3.8 (Mayles et al 2007, Kairn et al 2008). 
The calculation of the water EPL was accomplished using an iterative 
numerical method (Appendix A). An iterative algorithm was created to obtain a 
converged solution ),(1 jixn+  and the thickness Th(i,j) calculated in equation 3.8 
is the initial approximate solution ),( jixn  given by  
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Matrices A(i,j), B(i,j) and the ratios M1(i,j)/M0(i,j) are constants, but the 
correction is included in the loop which makes matrix c(i,j) a variable at each 
iteration. In other words after each iteration, a new correction is obtained 
depending on the previous solution. The solution ),(1 jixn+  is the water equivalent 
path length or water equivalent thickness or radiological thickness. The solutions 
were tested for convergence for selected field sizes and thicknesses, i.e the 
solution xn+1 approached a steady value as n → large (see table 4.6, section 
4.2.5.1). Convergence was obtained after two – three iterations; hence the 
algorithm was set to repeat itself five times. Bad pixels within the imager and at 
edges of the imager may cause imaginary roots or not a number (NAN) within the 
matrix.  NANs were replaced by zeroes wherever they were in the matrix and 
imaginary roots were converted into the real numbers using Matlab. The stability 
of the fitting parameters A(i,j) and B(i,j) was investigated with a monthly repeat 
of image acquisition over a four month period for both 6 MV and 16 MV. 
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3.2.4 Open fields 
3.2.4.1  Verification of equivalent path length from EPID images   
EPID images were acquired for a range of field sizes and known thicknesses of 
water and non-water equivalent materials to verify the accuracy of calculated 
equivalent path length as described in equation 3.12. To investigate the 
influence of varying densities, materials of low, medium and high densities 
representing lung, water and bone respectively were used.  
(a) Slabs of solid water, bone and lung materials were positioned in steps (figure 
3-5 (a)). The dimensions of each slab were 30x30 cm2 with thicknesses 
(relative electron densities) of 10cm (0.99) for solid water, 3 cm (1.3) for 
bone and 3 cm (0.34) for lung.  
(b) In the second setup, cylindrical materials (diameter 3cm and height 7 cm) of 
lung, solid water and cortical bone with relative electron densities of 0.4, 
0.99 and 1.66 respectively were sandwiched between two 5cm slabs of solid 
water. The cylinders were inserted into Styrofoam slab (relative electron 
density 0.05) as indicated in (figure 3-5 (b)). The relative electron densities 
quoted here are from the manufacture and were engraved on each phantom.  
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Figure 3- 5. Figures (a) and (b) are schematic cross sectional diagrams for 
different phantoms of varying electron densities. 
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The phantoms were positioned on the table in the center of the beam axis such 
that the SAD=100 cm to the phantom centres. EPID images of 20x20cm2 field 
sizes were acquired with 6 MV exposures with 100 MU for both cases in figure 3-
5. A theoretical formula by Broggi et al (2001) was used to compute the 
radiological thicknesses (EPL) for the cases in figure 3-5, whereby for any given 
material of physical thickness Tm and relative electronic density ρm, the EPL or 
radiological thickness is given by       
mm xTEPL ρ=   (3. 13) 
 
                                                  
3.2.4.2 Exit dose prediction for open fields from EPID images 
After the equivalent path length calculation from the EPID image had been 
carried out as described above, the method was extended to dose prediction. 
The exit dose is defined at the dose plane positioned at a distance dmax, from 
the exit surface of the phantom. In cases where the phantom / patient do not 
have a flat exit surface, the exit dose is similarly defined at irregular locations, 
with distances dmax from the exit surface. The dose at a depth for a particular 
field size can be calculated from the given number of monitor units, appropriate 
depth-dose data, output factor and off-axis correction  (Williams et al 2004, 
Podgorsak et al 2005). For the 2D EPID image, an exit dose map (Dext) was 
calculated by relating the calculated EPL to the percentage exit-thickness-dose 
(PETD), which is defined as the ratio of the exit dose at a depth of z-dmax to the 
dose at dmax (Appendix B), where z is the thickness of the phantom. Table 3-2 
explains the conversion process for selected points in a 2D EPID image matrix 
obtained at 12 cm2 FS. Each point in the EPID generated EPL matrix (3-2 a) is 
converted into a corresponding exit thickness dose (3-2 c) using the PETD(z,s) 
table ( 3-2b) by interpolation (look-up-table) between depths (d) and field sizes 
(FS).  
Table 3- 2. Conversion process of EPL to dose using PETD table 
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-----
-55.249.0-18
-54.050.2-17
-60.155.0-16
-65.060.1-15
----d
-1510-FS
----
-17.616.8-
-17.215.5-
----
----
-48.852.7-
-50.759.5-
----
(a) EPL 2D matrix for 12 FS
(b) PETD table
(c) ETD 2D matrix for 12 FS
 
 
The PETD were derived from tissue phantom ratios (TPR) according to the 
equation 
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Where SAD is the source to axis distance, TPReff is the TPR at an effective 
distance z-dmax and dmax is the maximum depth dose for 6 MV photon beams. 
Similar to TPR, the field size (s) in PETD is defined at the isocenter. The TPR 
data generated from measured depth dose curves were imported from Eclipse 
8.6 TPS (Varian Medical Systems, Palo Alto, California, USA). Equation 3.14 is 
theoretically justified in Appendix B and was experimentally verified by 
ionisation chamber measurements for selected field sizes and solid water 
phantom thicknesses, as illustrated in figure 3.6. This was done for square field 
sizes of 5, 10, 15 and 20 cm; at varying phantom thicknesses of 10, 15, 20 and 32 
cm. At each setup, z/2 was always kept at SAD  and the ionisation chamber was 
located at distance z- dmax (z is the phantom thickness). 
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Figure 3- 6. The experimental setup used for ionisation chamber measurement of PETD 
 
Flood field calibration of the EPID, required by the manufacturer’s control 
software, has the effect of flattening the beam profile, thus improving imaging 
performance. However it has a deleterious effect on transit dosimetry because 
the process removes any in air / off-center ratio in the EPID image caused by the 
flattening filter (Van Esch et al 2004, Greer et al 2007). The off-axis doses were 
corrected by applying the open field envelope and boundary profiles (Storchi et 
al 1995, Storchi et al 1999).  The envelope profile Ep(r,z) is defined as the ratio 
of the dose at a point off-centre relative to the dose on the field central axis at 
the same depth and describes the off-axis ratio of each calculation point for an 
infinite uncollimated field. The boundary profile Bp(x,z,s) is defined as the ratio 
of the dose at a point off-centre in a finite field relative to the dose at the same 
point in an infinite field and describes the effect of the edges of the collimator 
jaws for each field size. The data used in this study were imported from Eclipse 
8.6 TPS’s (Beam configuration work space) pencil beam algorithm that is 
generated from measured beam profiles. 
The exit dose map is then calculated according to the equation  
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Where:   
• MU is the given monitor unit 
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• OF is the output factor of field s relative to the 10x10cm2 
• B(s) is a factor which corrects for reduced back scatter proximal to the 
exit surface (corrects dose in our setup to reference condition);  
• Ep(r,d) is the envelope profile, a function of radial distance (r) from the 
field central axis and the depth (z) of point 
• Bp(x,z,s) is the boundary profiles a function of distance (x) from the field 
central axis, depth (z) of point and field size(s).  
 
3.2.4.3 Entrance dose prediction for open fields from EPID images 
The entrance dose is the most commonly measured in vivo dosimetry parameter, 
which is usually compared to the expected dose predicted by the treatment 
planning system. The entrance dose is defined at the plane, a distance dmax from 
the entrance surface of the phantom. The entrance dose distribution was 
determined using back projection techniques based on the inverse square law 
and attenuation. The entrance dose (Dent) was determined by projecting the exit 
dose maps back to the phantom entrance surface at depth of maximum dose 
(dmax) given by 
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Where Bp(x,dmax,s) and Ep(r,dmax) are the boundary and envelope profiles at the 
entrance respectively. PDDcorr is the percentage depth dose for each pixel’s EPL, 
corrected for changes in SSDs using the Mayneord factor 
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Where d is set to be EPL- dmax. 
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3.2.4.4 Verification of exit dose  
From the calculated EPL of the EPID images, exit doses were calculated as 
described in equation 3.15, and verified by comparison with corresponding doses 
calculated by the TPS. The exit doses were verified using the setup described in 
figure 3-5 (section 3.4.2.1) for verification of EPL. In addition, an 
anthropomorphic lower torso phantom shown in figure 3-7 (The Phantom 
Laboratory, Salem, New York, USA) was positioned on the treatment couch and 
anterior-posterior fields were delivered. The phantom consists of natural-
human-skeleton lumbar vertebrae, pelvis, upper third of femur and a hollow 
cavity (reproduces the sigmoid flexure and rectum) cast into Urethane (material 
with same effective atomic number as the body soft tissue).  
 
 
Figure 3- 7. Shows the lower torso phantom and the white central square in (a) 
shows the 20x20 cm2 irradiated area. 
 
The phantoms were positioned on the table in the centre of the beam axis such 
that the SAD=100 cm to the phantom centres. EPID images of 20x20cm2 and 
10x10cm2 field sizes were acquired with 6 MV and 200 MU exposures. 
 
                
3.2.5 Irregular fields 
Radiation fields that are not square or rectangular or circular are termed 
irregular fields. An irregular field also has an equivalent square field that will 
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yield the same value of a given dose function as does the irregular field 
(Podgorsak 2005). 
3.2.5.1 Equivalent path length from EPID images for irregular fields  
The dose functions of interest are the scatter correction factor, CFs,z(i,j) as 
described in equations 3.10 and 3.11 above, and the output factor (OF) due to 
an irregular area. Field area and resulting phantom scatter are essential for 
predicting the EPL from an EPID image. In case of irregular fields, one option of 
determining area is to measure it from the EPID image. A range of irregular 
shaped fields of known field area were designed using the multi leaf collimators 
(MLC) in the Eclipse 8.6 (Varian Medical Systems, Palo Alto, California, USA) TPS. 
The fields were defined by the MLC leaves while the collimator jaws opening 
remained fixed at 25x25 cm2. The plans were exported to the linac and all 
irradiations were done at 100 MU and dose rate of 400 MU/min. EPID images 
were acquired for these irregular shaped field apertures with 20 cm thicknesses 
of solid water materials to verify the accuracy of calculated equivalent path 
length and hence dose. The images for the computation of irregular fields were 
acquired using the RT chart fields, as described in section 3.2.1. Figures 3-8 (a-f) 
show some of the various aperture shapes used in the study. The shape in figure 
3-8 (a) is commonly encountered whenever there is a need for partial blocking of 
the beam to shield a critical organ. The shape in figure 3-8 (e) was chosen 
because it is clinically similar to the anterior-posterior pelvic radiation fields 
used in the treatment of prostate and cervical cancers. The other shapes were 
chosen to test the abilities of the algorithm and the TPS. For the shape in figure 
3-8 (d), the Eclipse 8.6 TPS has no problem with MLC abutting in open field 
(Varian solved this issue with the introduction of the Distributed Calculation 
Framework (DCF) in Eclipse 8.1). 
A MATLAB code was written to read and detect the radiation field edges from 
the EPID acquired images shown in figures 3-9 (a-f) of the irregular shaped 
apertures. An edge detection algorithm based on searching the entire EPID 
image and computing the approximate gradients of the image intensity function 
was written. An edge is localised at those points where the gradient is a 
maximum. A mask image was derived in which pixels at the edge are 
characterised by ones and all other pixels elsewhere in the image are set to 
zero. 
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Figure 3- 8. Irregular apertures of varying shapes and areas. The dimensions are in cm 
measured at the isocentre. 
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Figure 3- 9. Respective EPID images for the apertures shown in figure 3.7 above 
 
 
By tracing the entire bounded region (irradiated area), edge polygons are formed 
as shown in figures 3-10 (a-f).  
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Figure 3- 10. Respective field edges determined from the EPID images above 
 
The coordinates of the pixels of these polygons are searched and successively 
stored. If the X and Y coordinates of all vertices are known and entered in order 
of successive vertices, then the area of the polygon at the isocentre can be 
calculated (Beyer 1987) using the equation  
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Where,  
• n is the total number of pixels forming the edge polygon,  
• ix and iy  ; i=1, 2, . . ., n are the x and y coordinates of each vertex pixel 
making the bound region;  
• pix is the pixel size (resolution) = 0.784 mm and  
• mag is the magnification.  
The equivalent square areas are approximately obtained from taking the square 
roots of the area in equation (3.18). The area calculation was also tested with 
other images acquired for square, rectangular and wedged fields. The calculated 
areas using the equation above were compared with the expected area and 
percentage differences computed. The automatic calculation of area from the 
image facilitated the calculation of EPL, and hence dose for any irradiated field, 
including conformal shapes of unknown area. The calculated area is used to 
establish an appropriate scatter factor CFs,z(i,j), which is, together with the 
correction coefficients A(i,j), B(i,j) and the image signal obtained without any 
material in the beam Mo(i,j) for open fields, used as described in equations (3.8) 
and (3.12) to predict the EPL. 
 
3.2.5.2 Exit dose from EPID images for irregular fields  
The area calculated above is used to establish an appropriate output factor (OF) 
and the exit dose calculated as described in equation (3.14). The EPL beneath 
the MLC shielded regions is too high (≈ 80 cm) compared to maximum depths for 
TPR table which was measured up to a depth of 40 cm. To facilitate calculation 
of doses in these regions, the TPR table was extrapolated to include values up to 
50 cm. For all calculated EPL greater than 50 cm, the TPR was set to the MLC 
transmission factor. The images for the computation of MLC transmission were 
acquired using fields created in RT chart, as described in section 3.2.1. The MLC 
transmission is defined as the EPID dose (signal) ratio at the central axis of a 
closed MLC measurement to an open beam, for the same field size of 10x10cm2 
(Lorenz et al 2007). The mean pixel values in the 10x10cm2 area were obtained 
for the open field and MLC closed field, that is 
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To verify the accuracy of calculated equivalent path length and hence dose, 
corresponding doses calculated with the TPS were compared with those 
predicted by EPID.  
 
 
3.2.6 Enhanced dynamic wedge fields 
Enhanced dynamic wedge (EDW) dose profiles are computer controlled, 
created by sweeping one of the Y-jaw collimators from starting (open field) to 
closed position (0.5 cm from the opposite fixed Y-jaw), while both the X-jaws 
remain fixed during irradiation (Varian Medical systems 1996, Gibbons 1998, 
Prado et al 2002, Kuperman 2005). Because of the collimator motion, different 
parts of the field are exposed to the primary beam for different lengths of time, 
creating a wedged dose gradient across the field.  The wedged dose distributions 
are generated by means of a single golden segmented treatment table (GSTT) 
for the 60o wedge angle for each beam energy, and the GSTT is used to control 
the position of the moving jaw versus the proportion of the delivered monitor 
units. The dose distributions for the other wedged angles (10o, 15o, 20o, 25o, 30o 
and 45o) used clinically are reproduced by combining the open and 60o wedged 
data beams, (Pasquino et al 2009) and are contained in a unique dose versus jaw 
position table called the Segmented Treatment Table (STT). EDW comprises of 
two parts: the open-field phase and a collimator-sweeping phase, both governed 
by the STT which specifies the moving jaw position in equally spaced steps as a 
function of the cumulative MU. 
 
3.2.6.1 Equivalent path length from EPID images for EDW fields  
The sweeping of the moving jaw across the radiated field modulates the 
radiation intensity passing through the phantom by varying the exposure time of 
any given point, hence the signal reaching the EPID. The images for the 
computation of EDW treatments were acquired using fields created in RT chart, 
as described in section 3.2.1.The edge detection and subsequent calculation of 
irradiated area method, described in section 3.2.5.1, was used for EDW fields. 
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There are two potential approaches for verification of dose for EDW - using 
either the same set of correction coefficients A(i,j), B(i,j) and Mo(i,j) generated 
for open fields or generating another set of coefficients that involve the wedge 
motion in the field. The former approach has some limitations in predicting EPL 
especially for EDW angles above 300,(see section 4.3.3 in results and discussions)  
hence in this study, the latter approach was used. We tested the use of 
correction coefficients A(i,j), B(i,j) and Mo(i,j) on EDW fields but because of the 
limitation described in section 4.3.3, the idea was dropped. 
All the fitting parameter measurements were performed using the Y1-IN 
EDW orientation. The wedged image signal without any material in the beam 
),(0 jiM θ  was calculated for the largest field size of 20x20 cm2 used in this study 
with moving jaw Y1=-10 cm, fixed jaw Y2=10 cm, and fixed length X = 20 cm; 
using the MU fraction calculation methodology with GSTT (Gibbons 1998 and 
Kuperman 2005). For simplicity, the GSTT was represented analytically as an 
exponential function i.e  
 
)exp()( 110 YbaaYGSTT +=   (3. 19) 
    
Where Y is the moving jaw position that ranges from -20 to 10 cm; the fitting 
coefficients a0, a1 and b1 are determined from the Varian published values 
(Varian Medical Systems, 1996). The full-field segmented treatment table 
associated with wedge angle θ  is given by (Kuperman 2005) 
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Where MU is the applied monitor units; GSTT(0) and GSTT(Y=9.5) are the GSTT 
at Y=0 and Y=9.5 respectively (9.5 is due to the fact that the Varian wedge stops 
0.5 cm from the fixed jaw position); K is a geometrical correction factor that 
scales the data from the isocenter to the EPID imager level; 
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The STT is a two-entry table composed of 20 segments (21 instances), which 
gives the positions of the moving jaw versus the proportion of the delivered 
monitor units for each field segment. To simplify data manipulation with the 
EPID, which is comprised of 384x512 pixels;  
• First linear interpolation of the )(YSTT Fθ table was used to create 384 
points (in wedge direction), where all the points outside the desired field 
lengths are reduced to zeros.  
• Secondly this row of 384 pixels is replicated 512 times to constitute 
matrix ),(0 jiM θ . 
• Lastly the generated profiles present a slightly steep effect 
(Papatheodorou et al 1998) towards the end position of the moving jaw. 
Simple averaging of adjacent values was used to smooth the data. 
 
To establish the appropriate coefficients for the wedged fields, an 
additional measurement and subsequent derivation of Aw60(i,j) and Bw60(i,j) for 
the 60o wedge was made. The correction coefficients for any other wedged angle 
θ (Awθ(i,j) and Bwθ(i,j)) were obtained from those of the 60o wedge and the open 
field (Aw0(i,j) and Bw0(i,j)), using weighting factors obtained by the ratio of 
tangents in a way analogous to that applied to the GSTT (Prado et al, 2002). 
That is 
andjiAwjiAwjiA www ),()(),()(),( 0060 += θθ   (3. 22) 
  
),()(),()(),( 0060 jiBwjiBwjiB www += θθ     (3. 23) 
    
With all the necessary factors established, the EPL for the irradiated material 
can be calculated as described in equations (3.8) and (3.12) above. The EPL 
predicted in this way is independent of wedge presence.   
 
                                                
 89 
3.2.6.2 Exit dose from EPID images for EDW fields  
The exit dose can then be calculated as in equation (3.14) and this dose will be 
independent of the wedge effect. The wedge effect in the dose is recovered 
using the STT methodology where Y in this case is truncated to the desired field 
length (in the wedge motion direction) according to the equation  
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In this case GSTT(Ystop) is the GSTT at Y=Ystop, where Ystop = Y2-0.5. As described 
above STTθ(Y) is converted into a 384x512 array to constitute a matrix STTθ(i,j). 
It has been reported that EDW depth dose is almost identical to the open field 
depth dose (Papatheodorou et al 1999, Varian Medical Systems, 1996), hence the 
TPR for open fields can effectively be used in the conversion of EPL to dose.  In 
the presence of an EDW of angle θ, the exit dose in equation (3.15) above is 
modified to  
),,(),(
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Equation 3.25 above was tested by irradiating and subsequently acquiring EPID 
images for 20 cm solid water thickness with 150, 300 and 450 EDW at different 
field sizes. All irradiations were done at 100 MU. Corresponding plans were 
generated with the Eclipse 8.6 TPS for comparison.  
 
  
3.2.7 Dose comparison with treatment planning system 
Cross plane profiles, point dose differences and gamma index methods were 
employed in dose comparisons. The dose distributions obtained for different 
square, irregular and EDW field sizes were used in the evaluation of both the 
exit and entrance doses. All corresponding dose comparisons for TPS and EPID 
were absolute. Plane dose distributions at the exit (z-dmax) and entrance (dmax) 
were calculated in the Eclipse 8.6 (Varian Medical Systems, Palo Alto, California, 
USA) TPS for each of the fields. The calculated plane dose distributions from the 
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TPS were subdivided into a 512 x 384 matrix and imported into the Matlab 
software for comparison with those determined from EPID images. Point dose 
comparisons between the TPS dose (DTPS) and EPID predicted dose (DEPID) were 
calculated at the centres of homogeneous phantoms. For both the TPS and EPID, 
the point doses at the exit were assumed to be the mean of 13x13 pixels (~ 1 
cm) at the central axis. The results were computed using the TPS as the 
reference and percentage differences were calculated as  
 
%100/)( xDDD TPSEPIDTPS −    (3. 26) 
                                                                       
In addition, TPS and EPID dose profiles (1D) were extracted from the centres of 
the irradiated fields and compared. Furthermore, the absolute dose-matrix (2D) 
datasets were evaluated quantitatively by calculating the gamma index, which is 
a measure of the percentage of points passing a selected criterion. The gamma 
index combines both the dose difference (DD) and distance-to-agreement (DTA) 
into a single quantity normalised by the acceptance criteria. With respect to the 
dose distribution in the high-dose gradient region, Low et al (1998) and Chen et 
al (2009) reported that the DTA is equally important to the differences between 
the measured and the calculated doses obtained from the TPS. The DTA is the 
distance between measured data points and the nearest point in the calculated 
dose distribution that exhibits the same dose. 
 
 
3.2.8 Further dose verification with MapCHECK 2 device 
To obtain additional independent verification of EPID calculated exit doses, 
MapCHECK 2 (SUN Nuclear Corporation, Melbourne Florida, USA) was calibrated 
and used to measure directly the exit doses for solid water phantoms. According 
to the manufacturer, MapCHECK 2 is a 2D array of 1527 uniformly spaced diodes, 
active detector resolution area of 0.64 mm2, diode-diode spacing of 7.07mm and 
covering an area of 32x26cm at the isocentre. The device has a build up and 
backscatter to the active detectors region of 2.0 ± 0.1 and 2.75 ± 0.1 g/cm2 
respectively. Figure 3-11 shows a photo of the MapCHECK 2 device. For 
measurements, the device is connected to computer software, which is 
controlled from the operators’ room. During exposure, each diode generates a 
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charge which is proportional to the dose received at that location. The charge is 
integrated, converted from analog to digital form and sent to the computer that 
applies the necessary correction factor and stores the data. The MapCHECK 
device was first calibrated by positioning it on the couch, aligning its detector 
level with the isocenter.  It was then irradiated with a direct anterior (gantry 
angle zero) beam of 100 MU to a 10x10 cm2 field size. The software allows the 
entry of a specified factor (dose corresponding to a given number of MU at 
specific depth and field size) which is used to normalise the data to create a 
calibration file that was used to correct the dose maps for all subsequent 
measurements. 
 
 
 
 
Figure 3- 11: MapCHECK 2 device (SUN Nuclear Corporation, Melbourne Florida, USA) 
 
 
To avoid heavy weight above the MapCHECK device, it was positioned upside-
down; on top of 15 cm thickness of homogeneous solid water (total water 
equivalent material of MapCHECK and solid water is ≈ 20 cm). The gantry was 
rotated to 1800, such that the sensitive side of the MapCHECK device faced the 
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beam direction, as illustrated in figure 3-12. The setup enabled simultaneous 
measurement with MapCHECK and EPID image acquisition. 
 
MapCHECK
EPID
15 cm solid 
water
Collimator with 
posterior beam 
source
 
Figure 3- 12: The setup used for the simultaneous MapCHECK measurement and EPID 
image acquisitions. 
 
 
The MapCHECK and solid water were CT scanned and images exported to the 
TPS. Corresponding plans were generated with the Eclipse 8.6 TPS for exit dose 
comparison. The above setup was used for selected open, conformal (MLC 
shaped) and EDW fields. The plans were exported to the Linac and exposures 
taken, acquiring EPID image and MapCHECK measurements at the same time. To 
compare the dose distributions from the MapCHECK device (sensitive region is 
2.75 cm) with the EPID exit dose (calculated at 1.5 cm), the doses from the 
former were  adjusted. The MapCHECK dose map was resized to the same 
number of 2D data points as those used for the EPID and TPS. The effect of 
resampling the MapCHECK data points was initially investigated to see if it had 
any adverse effect on the 2D dose map. All doses for EPID, MapCHECK and TPS 
are absolute, measured in cGy. 
 
 
 
 
 
 93 
 
 
 
 
4 CHAPTER 4: RESULTS AND DISCUSSION 
4.1 Dosimetric Performance 
4.1.1 Detector reproducibility and response to a reference beam  
Table 4.1 shows that system-II detectors have better short-term reproducibility. 
Repeated exposure of system-II EPIDs showed a standard deviation ranging 
between 0.13% - 0.71% compared to system-I that ranged between 2.74%- 4.93%.  
 
Table 4- 1 Percentage signal short-term reproducibility for the different EPIDs: 
System-I
System-I
System-I
System-I
System-I
System-I
System-II
System-II
System-II
System-II
System-II
System
3.39IDU-II/IAS2H
3.42IDU-II/IAS2F
4.07IDU-II/IAS2E
4.47IDU-II/IAS2C
2.74IDU-II/IAS2B
4.93IDU-II/IAS2A
0.14IDU-20/IAS3 K
0.71IDU-20/IAS3J
0.13IDU-20/IAS3I
0.20IDU-20/IAS3G
0.13IDU-20/IAS3 D
Reproducibility (% ST.DEV)Hardware/softwareEPID
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Figure 4-1 shows the long-term stability of pixel response over a six-month 
period for three system-II EPID detectors. For each detector, the pixel responses 
at the central axis for the first month were compared for the readings in the 
next five subsequent months. The results show that the short-term and long-
term reproducibility for system-II detectors is within ±1.5%, in agreement with 
McCurdy et al (2001).  
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Figure 4- 1. Long term (six months) reproducibility for three system-II detectors  
 
 
Figure 4-2 shows the EPIDs’ responses to a reference beam. System-I EPIDs’ 
showed a significantly wider pixel deviation of 17% compared to 8% for system-II. 
The error bars in figure 4-2 represent a fixed value of 0.22, which is the 
standard error of the mean. 
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Figure 4- 2. Pixel deviation from the mean for each EPID, after exposure to a reference beam 
(50 MU, 400 MU/Min doserate and 10x10cm2 field size).  
 
The signal outputs from the central pixel region (≈ 1.0 cm) for the reference 
beam showed considerable variation from one detector to another, with system-I 
EPID’s having wider pixel deviation of ±9% compared to ±5% for system-II. 
Comparing the responses in figure 4-2 and the period in months each EPID has 
been in clinical use (table 3.1) indicates that individually the EPIDs’ responses to 
the test beam are age independent. Winkler and George (2006) reported 
variations of up to ± 10% on Electa iViewGT EPIDs and observed no relationship 
with age. 
 
4.1.2 Dose-response behaviour / Linearity 
In the integrated mode setup, pixel intensity increased linearly with 
applied monitor units. Figure 4-3 (a) shows typical accelerator output 
measurements using an ionisation chamber. Measurements were done at 140 cm 
source to detector distance. The results indicate that all accelerator outputs 
were stable prior to measurements with EPID’s. The linearity varied with system-
II detectors showing a better fit with measured data compared to system-I. 
Figure 4-3 (b) and (c) shows the signal to monitor units ratio (SMUR) of the 
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detectors normalized to 1000 MU as a function of MU. Ideally the SMUR should be 
unity (100%) regardless of how many MU are used at each exposure. System-II 
detectors showed a response that ranged between 95% - 97% at 5 MU and 
progressively increased with increasing MU. We found that the normalised SMUR 
for system-II EPID deviated from unity by 3-5% for ≤ 10 MU. The linearity was 
within 2% for 20 MU and practically 1% for 50 MU and above. At 1000 MU the 
SMUR is about 1%–1.2 % higher than that at 50 MU for system-II EPID’s. Generally 
the SMUR varied between 3%-5% in the system-II group of EPID’s within the 5-
1000 MU range. System-I detectors show a wider inconsistency in the SMUR 
response. Detectors B,C and F show a gradual increase in SMUR with increasing 
MU. However the SMUR for detectors B and F at 5 MU of 52% and 38% 
respectively are too low compared to the expected values. Similarly their SMUR 
response at 1000 MU is 8% and 7% higher than that at 50 MU. The ionisation 
chamber responses were within 3% in the 5-1000 MU settings for these system-I 
detectors.  
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Figure 4- 3. Figure (a) shows Ionisation chamber response as a function of monitor units for 
different accelerators. Figures (b) and (c) show the signal to monitor units ratio (SMUR) 
variation with monitor units. The readings at various monitor units were normalised to 1000 
MU for the ionisation chambers and EPIDs.  
 
 
Ideally the dosimeter reading ( )M  should be proportional to the incident fluence 
( )Q  and the ratio 




QM  should be constant regardless of MU settings. System-II 
EPID response across the panel became stable (within 0.2%) for MU greater than 
200 MU, in agreement with Greer (2007). The system-II SMUR responses are 
similar to previous studies reported by Greer (2007) and McDermott et al (2006) 
for the Varian a-Si EPIDs and Winkler et al (2005) for Elekta iViewGT. The results 
directly show that there is much more variation for the system-I EPIDs compared 
to system-II.  
Winkler and George (2006) reported an increase in detector sensitivity of 1.7 – 
2.8% for the Elekta iViewGT in the MU range from 30 to 500. At lower MU (< 20), 
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all EPIDs had reduced sensitivity attributable to instability in the accelerator 
doserate and energy during start-up (Winkler et al, 2005). McDermott et al 
(2004) indicated that EPID frames within the first few seconds of irradiation miss 
dose and that the longer the irradiation time, the smaller the deficit. This is 
illustrated in table 4-2, that compares an EPID’s response to a single 20 MU 
exposure to a series of lower-dose exposures with equivalent MU. The results 
indicate variations in the cumulative response for multiple exposures compared 
to a single exposure. The cumulative response for 20 exposures of 1 MU each, is 
3% lower compared to a single 20 MU exposure.  
 
Table 4- 2. Comparison of EPID J (System-II) response to a single 20 MU exposure to a 
series of lower-dose exposures with equivalent MU.  
-0.92%1.62%2.54%2.92%Deficit from single exposure (20 MU)
117179116100115280114200113760Total response (Σ MPV x ANF)
2010521Monitor units per exposure
1241020Number of exposures
 
 
The slow rise in EPIDs signal (McDermott et al 2004), together with doserate 
instability during accelerator start-up, accounts for the under-response at 
shorter irradiation times. 
 
Inconsistencies in the SMUR for system-I were much more significant than 
for system-II. Dead time corrections as indicated by McDermott et al (2006) due 
to frame saturation after every 64 frames could not rectify all the results nor 
could it account for discrepancies at the lower MUs. Chang et al (2003) indicated 
that there is dead time of 0.27 sec every 7.10 sec (the time for acquiring 64 
frames) when accelerator operated at 400 MU/min. The deficit in performance 
in relation to system-II is demonstrated clearly in the pixel reproducibility 
results:  system-I EPIDs averaged 3.8 % compared to 0.3% for system-II as shown 
in table 4-1. The pixel sensitivity reproducibility of the Varian EPID has been 
reported to be within 1% (Menon et al 2004, Greer et al 2003, Greer et al 2007). 
However the image detection-hardware / acquisition-software combinations and 
periods of the EPIDs in clinical use could not be established from these studies.  
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4.1.3 Pixel uniformity-response across the entire detector panel 
Table 4-3 shows the relative pixel response across the EPID detectors, based on 
their locations as illustrated in figure 3-1. There are no significant differences 
between the two acquisition systems in measured pixel uniformity within the 
radiation field. Because of the Dark-field and Flood-field corrections, the beam 
profile is expected to be flat within the irradiated region. All the detectors show 
that the intensity is slightly high at the inner beam (P1–P4) and gradually 
decreasing towards the outer beam of the field (P5–P8), with the exception of 
EPID I whose central response is lower than at the field edges because it had 
been configured for dosimetry and hence the typical horn-shape in its beam 
profile. The trend in all other EPIDs is expected since a large field is used for the 
flood field. The 20x20 cm2 field used in this experiment suffers a reduced 
scatter and therefore rolls off faster than the large field. Variations from the 
centre ROI of 1.0%, 2.2% and 4.5% for square field sizes of 5.0 cm, 7.5 and 10.1 
cm were found. Assessments in the penumbra region (Pavr) show wider variations 
in response between different detectors with system-I having an average 
response of 28.3% compared to 13.5% for system-II.  
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Table 4- 3. Detectors response at different points (figure 3-1) relative to their central position 
P0. Pavr is the average of four points in the beam penumbra region. The subscripts I and II 
indicate whether the detector is a system-I or system-II respectively 
0.2900.9680.9680.9680.9750.9901.0010.9970.996H
-I
0.1920.9650.9690.9650.9620.9920.9970.9980.996F
-I
0.1600.9830.9790.9830.9611.0030.9930.9940.998E
-I
0.4250.9550.9570.9550.9630.9890.9900.9900.999C
-I
0.3620.9710.9740.9710.9730.9941.0010.9960.997B
-I
0.2710.9710.9850.9710.9821.0050.9920.9931.005A
-I
0.1530.9570.9660.9570.9570.9930.9860.9940.994K
-II
0.1450.9590.9700.9590.9550.9970.9780.9970.995J
-II
0.0221.0201.0321.0211.0201.0501.0451.0341.036I
-II
0.1910.9620.9700.9620.9550.9910.9970.9970.996G
-II
0.1640.9570.9670.9570.9590.9970.9870.9940.998D
-II
P
avr
P
8
P
7
P
6
P
5
P
4
P
3
P
2
P
1
Position 
EPID
 
 
The variations in relative pixel uniformity across the EPID detectors were 
less than 5% within the irradiated field. The effect of over response to low 
energy x-rays by the indirect a-Si EPID (Vial et al 2008, McCurdy et al 2001) is 
observed in the penumbra regions of the field, though it is twice as pronounced 
in system-1 than system-II. 
 
4.1.4 Electronic portal imaging device’s relative dosimetry 
Figure 4-4 shows a typical step profile acquired from an EPID image with a step-
wedge compared to the actual transmission measured with the MapCheck 
device. For system-I, the standard deviation in relative signal measured by all 
detectors in the step cross plane profiles beneath the 0.25, 0.50, 0.75, and 1.0 
relative thickness in the Right-Left (Gun-Target) direction were 0.4 (0.9), 0.7 
(1.2), 0.8 (1.4), and 1.0 (1.5) respectively, while for system-II, they were 0.3 
(0.4), 0.5 (0.6), 0.5 (0.9) and 0.6 (1.0) respectively.  Theoretically, the EPID and 
MapCheck results should be the same because they are relative values. The 
agreement between the EPID and MapCheck measurements was within 2% in the 
flat area of each step for both systems. In areas of steep dose gradient, at 
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transitions in the step depth, the maximum distance to agreement of the EPID to 
MapCheck is 2 mm. The residual longitudinal, vertical, lateral and rotational 
misalignment of the wedge with the EPID detector/MapCheck and the primary 
beam direction cannot be ignored. Together, these may account for the 
observed differences. 
 
Step-wedge axis Step-wedge axis
Step-wedge axis
 
Figure 4- 4. Figure (a) shows typical central profiles comparing an EPID acquired image 
(dashed line) and actual MapCheck transmission (straight line) with a four step-wedge. A 
relative signal of 100 indicates an open field transmission; creating a fifth step in the figure.  
The X and Y figures quoted in boxes of figure (b) and (c) are the numerical values on the 
horizontal and vertical axes for each point.      
 
                     
4.1.5 Field size dependence  
A systematic increase in the average pixel intensity was observed when 
increasing the field size from 2x2 cm2 to 20x20 cm2. For system-I, the relative 
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increase in detector responses ranged from 13.6% to 24.4% while system-II 
ranged from 23.0% - 23.4%. This pixel value dependence on field size is also 
reflected by the variation in the EPID scatter factors for the two systems. 
System-II EPID’s had almost identical values of coefficients (equation 3.2) and 
exhibited better data fit to the second order polynomial compared to system-I 
that showed large variability. Table 4-4 shows the polynomial coefficients A0, A1 
and A2, and the 
2R  values for the different EPIDs.  
Table 4- 4. Polynomial coefficients for different EPIDs described in equation 3.2 and the R2 
value for the field size fit. 
0.877130.0370.815System-IH
0.99470.0290.777System-IF
0.89070.0220.830System-IE
0.977100.0360.760System-IC
0.975120.0370.743System-IB
0.93130.0190.836System-IA
0.99960.0270.788System-IIK
0.99960.0270.787System-IIJ
0.99960.0270.789System-III
0.99960.0270.791System-IIG
0.99960.0270.787System-IID
Field size polynomial 
fit (R2 value)
A2x(-10-4)A1A0SystemEPID
 
 
 
Figure 4-5 illustrates the relative signal variation with field size. For small field 
sizes, the EPID readings were slightly lower than the ion chamber readings, and 
when the field sizes is increased, the EPID readings were higher than the ion 
chamber readings, as illustrated in figure 4-5 (a). This effect is due to changes in 
scatter with increased field size. Scatter has a low energy component; its effect 
on the EPID’s phosphor response is enhanced (due to presence of high atomic 
number component in the phosphor material) compared to an ionisation 
chamber (Van Esch et al 2004, Greer et al 2003). The results in figure 4-5 (b) for 
system-I are affected by the poor detector reproducibility of pixel signal. 
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Figure 4- 5. EPID signal variations with field size. The data were normalised to a 10x10cm2 
field size for the two systems. The figure also includes a comparison with an ionisation 
chamber of accelerator B and I for system-I and system-II respectively. 
 
4.1.6 Doserate influence 
The system-II EPIDs show a general decrease in response to increasing doserates 
at both total monitor units values (20 and 100) used in the investigation. Figure 
4-6 (c) shows that the system-II EPID’s sensitivity decreased by between 1.0% - 
1.8% with increasing the doserates in the range 100-600 MU/min.  
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Figure 4- 6. System-II EPIDs response to varying doserates. Figures (a) and (b) show pixel 
values variation with doserate for total doses of 20 MU and 100 MU respectively. The original 
data (points) were fitted to a power potential function in equation 3.3 and the lines show 
the best fit for each EPID. Figure (c) shows data normalised to 400 MU/Min.  
 
 105 
The doubling of the dose rate decreased the EPID’s response by 0.2% to 0.5%. 
After fitting the data to equation 3.3, it was established that the EPIDs’ non-
linearity parameter ∆ were within -0.006±0.002 at both 20 MU and 100 MU for all 
detectors. Figures 4-6 (a) and (b) show typical pixel value variation with 
doserate, obtained for system-II detectors. Using the normalised data (figure 4-
6(c)), the EPIDs sensitivity parameter K were 1.048 and 1.034 for EPIDs I and J 
respectively, independent of monitor unit used. System-I EPIDs did not show any 
consistent doserate response.  
Ideally, the response of any dosimeter 




QM  at two different dose rates 
1





dt
dQ and 
2





dt
dQ should remain constant (Podgorsak 2005). In reality, the 
doserate may influence the dosimeter readings and appropriate corrections may 
be necessary if the detector is to be used for absolute measurements. By 
increasing the doserates from 100 MU/min to 600 MU/min the sensitivity 
decreased by up to 1.8% for the system-II detectors. This is due to the 
synchronisation of the linear accelerator pulses and several preset parameters 
(described in section 3.1) in the IDU-20/IAS3 systems. The EPID response as a 
function of dose rate should be accurately determined especially in dynamic 
treatments. Therefore, the use of a single dose rate calibration curve cannot 
yield completely accurate results. Although it is well known that during IMRT 
delivery the accelerator doserate may vary and the EPID response will vary 
accordingly, in reality, there is very little variation in dose rate at 400 MU/min. 
Beam hold-offs that relate to the mobility of the MLC leaves to keep up with the 
beam should not be seen. Other studies assessing doserate effects on EPID have 
yielded varying results, suggesting that the response is dependent on individual 
vendor, detector and model. The Varian system-II EPIDs studied here show less 
doserate dependency than has been reported for the Elekta iViewGT (Winkler et 
al 2006). They reported changes in detector sensitivity of between 5%-11% in the 
doserate range 50-540 MU/min. The work done by Mohammadi and Bezak (2006) 
on the Varian SLIC EPID indicated that EPID response increased with increasing 
doserates, in the range 50 – 600 MU/min, in contrast to the results described in 
this work for the Varian system-II, that shows a decrease in response with 
increasing doserates. Similar to the Varian system-II detector, the Siemens 
Perkin-Elmer XRD EPID exhibited response variations of ≈ 1% measured between 
50 MU/min and 300 MU/min doserates (Chen et al, 2006). 
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4.1.7 Directional dependence 
Figures 4-7 (a) and (c) show typical pixel responses at different gantry angles 
and collimator angles of 00 and 900 for two system-II EPIDs. Figures 4-7 (b) and 
(d) show their respective data normalised to those at gantry angle zero. The 
relative sensitivity normalised to gantry angle zero ranged between 0.99 – 1.01 
(within 2%). These departures from the values at gantry angle 00 are sufficiently 
small, that they may be considered insignificant. The insignificant variation in 
sensitivity with gantry angle shown in the two cases was exhibited by all system-
II detectors. The work done by Parent et al (2007) and Moore and Seibers (2005) 
reported on how the mechanical parameters relative to the gantry can affect 
the response of the Varian a-Si EPID. The variations were associated with the 
mechanical response of the EPID to changes in the accelerator gantry angle. 
Clarke et al (2008) used a similar approach to measure MLC defined field sizes at 
varying gantry angles using an a-Si EPID. All these studies indicated that the 
deviations from those at 00 were not differentiable from the short term 
variations and may be considered insignificant. 
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Figure 4- 7. Figures (a) and (c) shows pixel responses at different gantry angles for EPIDs G 
and J respectively, while figures (b) and (d) show their data normalised to those at gantry 
angle zero. 
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4.1.8 Further image profile analysis and memory effects 
Figure 4-8 shows typical post irradiation effect on the EPID image profiles 
indicating the memory effect of the EPID, which manifests itself as an increase 
in pixel value for the 20 x 20 cm2 field size in the region of a previous 5 x 5 cm2 
irradiation field. The percentage difference for each EPID was calculated as the 
signal enhancement at the centre (5 x 5 cm2) within the 20 x 20 cm2 field size 
compared to the signal for a 20 x 20 cm2 taken after five minutes. Measurement 
of the EPID detector memory effect for system-I ranged from 1.1% to 1.8% with a 
mean of 1.4% while system-II ranged from 0.3% to 1.4% with a mean of 1.0%.  
 
Figure 4- 8. Central image profiles indicating post irradiation effect on the EPID. The image 
profile (continuous line) was acquired within 12 seconds after 50 MU to a 5x5 cm2 field 
(dashed line) taken earlier. The profile in the inset is the difference between the image 
profiles. The double arrow shows the signal enhancement at the centre (5 x 5 cm2) within 
the 20 x 20 cm2 field size 
 
The EPID memory effect results were independent of the two acquisition 
systems and in agreement with previous studies performed on Varian EPIDs by 
Greer et al (2003) and Van Esch et al (2004). These studies indicated a residual 
increase in the central irradiated region of about 1%. Winkler et al (2005) used 
similar settings (doses, energy, field sizes and time interval) on the Elekta 
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iViewGT to those we used. They indicated a local modification of EPID response 
of up to 6% that may rise up to 16% with increase in photon energy. 
Figure 4-9 shows integrated image profiles for different EPID detectors 
obtained at various monitor units, constant doserate of 400 MU/min and 10x10 
cm2 field size. The images were analysed by obtaining the mean of the two 
central pixel arrays in the Left-Right direction of the detectors.  It should be 
noted that the profiles shown in this figure are related to the mean pixel value 
parameter reported by the EPID system in its un-calibrated state, and are thus 
not directly related to the SMUR data in figure 4-3. The SMUR is dependent on 
both mean pixel value and on the acquired number of frames. All the EPID 
profiles showed varying dependencies on MU accelerator settings. System-I 
images showed wider variations compared to system-II images. These varying 
image responses emphasise the necessity of individualised calibrations for each 
EPID if they are to be used for dosimetry purposes in agreement with previous 
studies (Winkler and George 2006). 
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Figure 4- 9. Typical integrated image profiles for different EPID detectors obtained at 
different MU, constant doserate of 400 MU/min and 10x10 cm2 field size at isocentre. The 
images were analysed in their absolute sense without taking into consideration the averaged 
number of frames at each set MU. 
 
There are some differences in EPID response visible for the low MU fields for 
both systems in figure 4-9. The root cause is the under response at shorter 
irradiation times together with ghosting effects. Other possible causes are the 
nonlinearity of the electronics and sensitivity variations between different EPID 
panels and differences in accelerator outputs. 
 
 
Figure 4-10 illustrates profiles of images acquired by the two systems at 5 and 50 
MU. Figure 4-10(b) shows a 15-25% tilt in the T-G direction cross plane profiles at 
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5MU for system-I which is absent at 50 MU for the same detectors (figure 4-10d) 
or completely absent for system-II, as illustrated in figures 4-10(a) and 4-10(c). 
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Figure 4- 10. Cross profiles images of four EPIDs acquired at 5 and 50 MU in the transverse (L-
R) and radial (G-T) planes of the linear accelerator20x20 cm2 field size at isocentre. System-
1 profiles (b and d) show dose (MU) dependence in the G-T direction 
 
The results indicate limitations of system-I in terms of dose linearity. The 
systems acquire data rows sequentially starting from the gun side scanning 
towards the target direction. At lower MU, the pulsed nature of the radiation 
delivered causes significant fluctuations from one frame to another. 
Accelerators start off at lower doserate and for lower MU; the start side of the 
readout frame (gun side) will read less dose accounting for the gradients in 
figure 4-10. It is possible that the acquisition speed of system-I and the exposure 
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duration at lower MU enhance the effect. Figure 4-10 suggests that the older 
(system-I) EPIDs may not be suitable for step-and-shoot IMRT verification (an 
important application of portal dosimetry) that frequently contains low MU 
segments.  
The inconsistencies in SMUR (figure 4-3) and the imager effect 
demonstrated in figures 4-10 were investigated further by extracting data from 
the “treatment field history” file of the Varis system for about 2.7 million 
treatment records of all our machines since 2001, when the first EPID was 
commissioned. The aim was to find out if there is any correlation between the 
EPID cumulative dose/age and its performance. From the database, the actual 
linear accelerator monitor units delivered for each treatment field when an EPID 
image was acquired were obtained, from which the cumulative dose to the 
imagers could be calculated. Table 4-5 summarises EPID dose related data 
extracted from the “treatment field history” file of the Varis system. As 
expected the Linac and imager doses increase proportionally to the period the 
accelerator has been in clinical use. The percentage of dose delivered with the 
imager out, ranged between 12.2 – 18.7% with mean 14.2%.  
 
Table 4- 5. Different EPIDs, their use period (months) and corresponding approximate dose 
(only corrected for inverse square law) from the Varis system database 
0.171.72.7 16.510K
0.183.14.9 32.817J
0.142.43.8 25.417I
0.124.06.2 44.932G
0.206.710.5 78.834D
0.175.58.6 70.732H
0.154.97.7 56.932F
0.1511.317.6 137.475E
0.1310.917 188.182C
0.2723.536.7 222.386B
0.3025.539.8 212.986A
Imager 
Dose/ 
Month
Imager 
Dose (corr. 
ISL)
Imager 
Dose (KGy)
Linac Dose 
(KGy)
EPID use 
(Months)
EPID 
 
 
 
 113 
System-I EPIDs ageing due to radiation could be another factor causing 
degraded results. Hee et al (2002) reported that radiation damage affects the 
leakage current of photodiodes and the effect showed a linear dependence on 
absorbed dose. This may decrease the whole system performance, although it 
also depends on the aging effects of other components. However the results for 
the imager dose and imager dose per month were inconsistent with the EPID’s 
reproducibility and SMUR and no conclusion could be drawn. 
The overall results indicate the superiority of system-II, due to its lower 
noise readout electronics, higher readout rates and faster data acquisitions 
compared to system-I. The differences in the system synchronisation between 
the two systems may also contribute to the observed differences in the 
dosimetric characteristics and performance, especially for the lower MU. Greer 
(2007) studied the effects of the two Varian acquisition modes at different MU. 
This study indicated that the EPID image profiles were similar at higher monitor 
units and differences were noted in profiles acquired with less than 10 MU. 
 
4.1.9 Electronic portal imaging devices as a dosimeter 
A prerequisite for any clinical dosimetric application is a detailed understanding 
of the detector’s dose-response behaviour. Figure 4-11 shows one of the system-
II EPIDs (J), comparing the pixel value response with ionisation chamber 
measurements at varying monitor units. Results in figure 4-11 (a) are presented 
on linear scale where the abscissa represents the accelerator MU. The left and 
right ordinates represent the EPID pixel and ionisation chamber responses 
respectively. Figure 4-11 (b) shows the same data on a logarithmic scale, 
including the relative response (ratio of Ionisation chamber signal to that of the 
EPID). The EPID and ionisation chamber responses are parallel to each other and 
the relative response is practically constant at all monitor units, which re-
affirms that the EPID image signal, if calibrated correctly, can be matched to 
that of the ionisation chamber. The ionisation chamber is the gold standard 
radiation detector for measurement of absorbed dose. 
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Figure 4- 11. Comparison of EPID response with ion chamber as a function of MU 
 
The intensity of a photon beam is reduced as the absorbing material thickness is 
increased. Figure 4-12 shows the reduction in photon intensity measured with 
the EPID and ion chamber responses when solid water phantom materials of 
various thicknesses were placed between the source and the detectors (EPID and 
ion chamber). At each phantom thickness, both detectors were exposed at same 
radiation conditions. Both the EPID and ion chamber signals were acquired on 
the central axis, and the data for each detector normalised to those when there 
is no absorbing material (thickness = zero). 
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Figure 4- 12 EPID versus ion chamber response with solid water thickness 
 
Increasing the solid water thickness both attenuates and hardens the beam. 
Because the EPID is more sensitive to lower energy photons, its response 
decreases more rapidly than the ion chamber as a function of attenuator 
thickness. Another possible explanation for this effect could be that low-energy 
scatter (secondary photons) is generated in the attenuating material, affecting 
the EPID response. 
 
4.2 Water equivalent path length measured with an EPID 
4.2.1 Variations of the fitting parameters A and B 
Figure 4-13 shows profiles extracted from the fitting parameter matrices A(i,j) 
and B(i,j) along the left-right direction of the EPID. The results in figures 4-13(a) 
and (b) show the symmetrical variations of B(i,j) and A(i,j) with off-axis distance 
for two 6 MV and 16 MV beams respectively. The figures show that the 
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parameters are almost the same (within 1%) for two accelerators at the same 6 
MV beam energy and decrease when the beam energy is increased to 16 MV. The 
B(i,j) parameter, which is theoretically the linear attenuation coefficient, has 
minimum values of 0.052±0.001 cm-1 and 0.024±0.0005 cm-1 for 6 MV and 16 MV 
beams respectively. These minima occur in the centre of the field, with values 
of B(i,j) gradually increasing with increasing distance from the centre up to a 
relative value of 1.2 and 1.3 of their minima for both energies respectively. On 
the other hand, the parameter A(i,j) has its maximum values of -3.0±0.2 x10-4 
cm-2 and -0.2±0.03 x10-4 cm-2 for 6 MV and 16 MV beams respectively in the 
centre of the field, gradually decreasing with increasing distance from the 
centre.  
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Figure 4- 13. Profiles extracted from the fitting parameter matrices A(i,j) and B(i,j) along the 
left-right direction of the EPID. Figures (a) and (b) show the symmetrical variations of B(i,j) 
and A(i,j) with off-axis distance for two 6 MV and 16 MV beams respectively. The X and Y (at 
each point, the Y value is either the A(i,j) or B(i,j) value) quoted in boxes are numerical  
values on the horizontal and vertical axes for each point. Figures (c) and (d) show a 3D 
visualisation of the B(i,j) and A(i,j) fitting parameters respectively. 
 
The parameter B(i,j) is the linear exponent of the expression describing 
the attenuation of the photon beam as it traverses material upstream. It 
increases as the distance from the centre of the EPID orthogonal to the beam 
central axis increases. The trend of parameter B(i,j) is caused by the flattening 
filter being cone shaped. The central part of the beam travels through more 
material and is more filtered than the edges of the beam. Therefore the average 
photon energy through the centre is higher. The results indicates that B(i,j) 
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decreases with increasing beam energy from 6 MV to 16 MV. This is because of 
the attenuation coefficient components due to photoelectric and Compton 
(dominant interaction processes at radiotherapy beam energies) effects being 
inversely proportional to energy (Khan 2003). Monthly repeat of imager 
recalibration over a four-month period indicated that A(i,j) and B(j,j) could be 
reproduced to within 2%, in agreement with Kairn et al (2008). The value of the 
attenuation coefficient, B(i,j) in our case at the centre of the EPID is within ±3% 
compared to other studies (Allen 1999, McDonough et al 1999 and Vanetti de’ 
Palma et al 2005). Backscatter from components of the EPID support arm 
downstream from the detector have been found to influence the signal by up to 
5% (Greer et al 2007, Ko et al 2004). In the derivation of the fitting coefficients 
A(i,j) and B(i,j) (equation 3.4), the EPID signals M(i,j) obtained after imaging 
solid water phantoms are divided by the image signal obtained without any 
material in the beam M0(i,j). Also in equation (3.12), the image signals M1(i,j) 
whose EPL are to be established are divided with M0(i,j) term. This pixel by pixel 
division should theoretically eliminate the support arm effect; Figure 4-13 shows 
that the calibration coefficient profiles in both directions are not distorted due 
to the support arm; hence the support-arm-backscatter correction is not 
required when using the quadratic calibration technique for EPID dosimetry.  
 
 
4.2.2 The phantom scatter and field size correction factors 
As discussed in section 3.2.3 above, scatter and field size corrections are 
required for the EPID to predict thickness at any other field other than the 
reference field.  Figure 4-14 shows the variation of correction factor CF with 
field size and thickness, measured with an EPID for a 6 MV beam. For any field 
other than the reference field size, CF increases with increasing phantom 
thickness. This study is limited to field size of 21.5x21.5 cm2, as the maximum 
that can be imaged with EPID imager positioned 40.0 cm below the isocentre, 
without irradiating the electronic components of the IDU. 
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Figure 4- 14. Correction factor variations as a function of field size for phantom thicknesses 
5cm, 10cm, 15cm, 20cm, and 32 cm for 6 MV beam 
 
 
4.2.3 Monitor unit effects 
Figures 4.15 (a), (c) and (e) show the variation of applied MU with system-II EPID 
response (linearity) for square field sizes of 5, 10 and 20 cm, measured at 400 
MU/min dose rate and thicknesses of 10, 20 and 32 cm respectively. The results 
indicate the generally expected trend, where at any particular thickness the 
response increased with increasing field size, and decreased with increasing 
phantom thicknesses. Figures 4.15 (b), (d) and (f) show SMUR variations 
computed for the same data used in figures 4.15 (a), (c) and (e) respectively 
that exposes significantly reduced values at lower MU.  Figures 4.15 (g) and (h) 
show a repeat of linearity and SMUR but measured at a reduced dose rate of 100 
MU/min for solid water thickness of 20 cm. The linearity response at 100 
MU/min as expected remained unchanged because the total delivered doses are 
independent of doserates, but the SMUR significantly increased for lower MU by 
about 3% and remained practically the same at higher MU.  
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Figure 4- 15. Figures (a), (c) and (e) show system-II linearity for thicknesses 10 cm, 20 cm 
and 32 cm measured at 400 MU/min respectively, while figures (b), (d) and (f) are their 
corresponding SMUR.  Figures (g) and (h) show linearity and SMUR respectively for 
thickness 20 cm measured at 100 MU/min. 
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The accurate determination of EPL is essential in the prediction of dose by EPID. 
For the EPID to predict dose effectively, it is desirable for the EPL to be precise 
and independent of delivered number of monitor units. Ideally the response of 
any radiation detector should be proportional to MU for both open and MLC 
blocked beams (Podgorsak 2005). The concept of linear relationship suggests 
that two quantities are directly proportional to each other for all situations, 
such that the ratios between corresponding entities are practically the same. 
However analysis of the SMUR for the same data used for the linear relationship 
results, revealed lower values at MU below 50, in agreement with McDermott, et 
al (2006). This implies that at lower MUs, the EPID response and MU variations 
are not perfectly proportional. These results can be correlated with that in 
figure 4-9, explained by under response at shorter irradiation times together 
with ghosting effects. The SMUR at a lower dose rate (100 MU/min) was found to 
be more consistent than that at 400 MU/min, indicating that the effect may be 
due to dead time within the imager system. Dead time in frame acquisition can 
result in reasonable loss of signal (Greer et al 2003). The imager has start-delay 
which is fixed and will cause a greater dead-time effect at low exposures. Under 
practical consideration the SMUR measured at 400 MU/min dose rate was only 
dependent on MU but not field size and phantom thickness. Hence a single look-
up table depending on image MU was included in the EPL determination.  
 
4.2.4 Measured and calculated Percentage Exit Thickness Dose 
(PETD) 
Figure 4.16 shows a comparison of the measured and calculated (equation 3.13) 
PETD for square field sizes of 5, 10 and 20 cm and depths of 10, 15, 20 and 32 
cm. As expected PETD decreases with increasing depth and decreasing field 
sizes. The results indicate that the differences between the measured and 
calculated are within 2%. 
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Figure 4- 16. Comparison of measured (meas) and calculated (cal) PETD at selected field 
sizes (FS) and depths.  
 
 
4.2.5 Verification of calculation of the equivalent path length 
4.2.5.1 Equivalent path length for solid water phantoms 
Table 4-6 shows EPL convergence for selected thicknesses and field sizes after 
20 iterations. The first item in each column is the initial solution obtained by 
solving equation 3.8.  The values in the tables are the mean pixel value in a 1.0 
cm2 region of interest at the center of image, stored after each iteration. Using 
equation 3.13, the expected EPL for solid water thicknesses of 10 cm, 20 cm and 
32 cm are 9.9 cm, 19.8 cm and 31.7 cm respectively. The results show that 
convergence to within ± 2mm of the final 20 iteration value was obtained after 
three – four iterations; hence the algorithm was set to repeat itself five times. 
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Previous authors (Fielding et al 2002 and Kairn et al 2008) reported convergence 
in thicknesses after three – five iterations. 
Table 4- 6.  EPL convergence for selected thicknesses (Th) and field sizes (FS) 
 
 
Figure 4-17 shows the EPL profiles calculated from EPID images for selected 
thicknesses of solid water phantoms. The images were acquired at same 100 MU 
at various field sizes. The profiles in figure 4-17 (a-d), extracted in both the X-
direction (solid lines) and Y-direction (doted lines), were acquired with solid 
water of thicknesses 5.0, 10.0, 20.0 and 32.0 cm; and field sizes of 10x10 cm2, 
15x15 cm2, 20x20 cm2 and 15x15 cm2 respectively. From equation 3.13, the EPL 
for these thicknesses would be 4.95, 9.90, 19.80 and 31.68 cm respectively. The 
results in this figure indicate that EPID-measured EPL agrees with that 
calculated using the known physical thickness and electron density (equation 
3.13) to within +/- 2mm. Monthly repeat of imager recalibration and subsequent 
EPL recalculation over a four-month period indicated that for a homogeneous 
solid water phantom, EPL could be reproduced to within +/- 2mm (80% of the 
central field). Towards the field edges, the EPL tends to increase due to the 
beam penumbra. The sharp increase in EPL at the field edges, results in the 
expected decrease in exit dose in these regions.  
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Figure 4- 17. EPL profiles from EPID images for selected solid water phantom thicknesses 
and acquired at different field sizes. The X and Y (at each point, the Y value is the EPL) 
quoted in the boxes are numerical values at the centre on the horizontal and vertical axes 
for each point. 
 
4.2.5.2 Equivalent path length for solid water phantoms with varying monitor 
units 
Figure 4-18 demonstrates the EPL for different thicknesses of solid water 
calculated before and after MU corrections, at different field sizes. The results 
show that at 20 MU, variations in EPL of up to 12 mm can occur between the 
corrected and uncorrected values.  
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Figure 4- 18. Pre-MU (UnCorr) and post-MU (Corr) EPL (calculated before and after MU 
correction respectively) for 10 cm, 20 cm and 32 cm solid water; and field sizes of (a) 5x5 
cm2, (b) 10x10 cm2 and (c) 20x20 cm2.  
 
Comparison of the pre-MU and post-MU EPL (EPL calculated before and after MU 
correction respectively) in figure 4-18, revealed that the latter gave better 
conformity with the expected EPL and were independent of both MU and field 
size. A deviation in EPL of ≈10 mm may result in an uncertainty in PETD of ≈ 3-
5% depending on field size, and hence a discrepancy ≈ 3–5% in the exit dose. 
 
4.2.5.3 Equivalent path length for solid water and non water phantoms  
Figure 4-19 shows profiles from the calculated EPL of various materials of known 
thicknesses and relative electron densities for which EPID images were acquired, 
as described in figures 3-5 (a) and (b), section 3.2.4.1.  
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Figure 4- 19. Profiles extracted from centre of EPL maps for (a) slabs of solid water, bone 
and lung materials positioned in steps, as illustrated in figure 3-5 a. (b) cylindrical lung, solid 
water and cortical bone materials inserted between two 5cm slabs of solid water as 
illustrated in figure 3-5 b. The X and Y (at each point, the Y value is the EPL) quoted in 
boxes are the EPID measured values on the horizontal and vertical axes for each point, while 
P1, P2, P3 and P4 are corresponding calculated values.  
 
Table 4-6 summarises the results from figure 4-19 obtained after the EPID 
calibration in comparison to the calculated EPL using equation 3.17. From these 
results, the calculated and the measured EPL are within ± 3 mm, equivalent to 
2% or less in all cases. 
 
Table 4- 7. Summary of the EPL results from figure 4-19 comparing calculated (equation 
3.13) and those measured from EPID images 
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Calculated and measured EPL are within ± 3 mm for all phantom materials 
and thicknesses. The uncertainty is comparable to Kairn et al’s (2008) Monte 
Carlo simulated results, where they validated radiological thicknesses measured 
with an EPID. The accurate determination of EPL is crucial in the prediction of 
dose by EPID.  An increase or decrease in EPL by ~ 1 cm results in a decrease or 
increase in PETD of ~ 3% and ~5% for field sizes 20cm2 and 5cm2 respectively in 
the thickness-range 10-32 cm. Hence such variations in EPL may result in ~ 3-5% 
discrepancy in the exit dose (Kavuma et al, 2010).  
 
4.3 Dose comparison 
4.3.1  Exit and entrance dose comparison for open fields 
Figure 4-20 shows dose profiles for the homogeneous phantom extracted from 
the centre of the TPS calculated dose and EPID measured dose distributions, 
demonstrating the effect of PETD, envelope and boundary corrections. The 
figure shows a comparison of TPS’s and EPIDs, entrance (figure 4-20 (a)) and exit 
(figure 4-20 (b)) dose profiles for a 20x20 cm2 field, after a 20cm thick solid 
water phantom is irradiated with 200 MU of a 6 MV photon beam. The 
uncorrected EPID profiles indicate that the dose at the centre of the field is 
predicted to within 1%, but remains flat in the entire irradiated region. This is 
expected experimentally because the EPL for the homogeneous phantom is also 
flat, but does not reflect the actual dosimetric situations as shown by the TPS 
profile.  
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(a) (b)
 
Figure 4- 20. Dose profiles at the centre of the EPID images and TPS demonstrating the effect 
of flood field before and after correction for a 20x20 cm2 field, to a 20cm thickness solid 
water material with 200 MU and 6 MV beam. Figure (a) compares TPS and EPID entrance dose 
profiles and figure (b) shows TPS and EPID exit dose profiles. 
 
Figures 4-20 (a) and (b) indicate that the EPID predicts a higher dose outside the 
treatment field compared to the TPS. This is consistent with previous 
investigations, though the effect is more significant for the entrance than for 
the exit doses. Vieira et al (2003) indicated that EPID dose deviations of up to 
10% can occur in penumbra regions. For smaller fields, the EPID doses in the 
penumbra regions were still higher but the differences were within 3%. The 
penumbra dose difference for large field (20x20 cm2) irradiations could have 
been increased because of the field size nearing the reference field size of 
21.5x21.5 cm2. One of the limitation of the method is that it cannot predict dose 
beyond the reference field size, because the fitting parameters A(i,j), B(i,j) and 
the open fields are not modelled in these areas. This possibly explains the 
observed spikes and unexpected discontinuities at the field edges of figure 4-20 
for the EPID predicted dose. Another possibility could be that the a-Si EPID 
detectors are known for their over response to low energy x-rays which are 
common at field edges and penumbra regions (Vial et al 2008, McCurdy et al 
2001). On the other hand, the method we used for the scatter and field size 
correction may also have an influence on the results. The CF correction is 
measured on the central axis and applied everywhere in the EPID.  This would 
miscalculate the dose received by the EPID at the edge of a phantom where 
there is less scatter.  
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Table 4.7 shows a summary of the point dose percentage differences between 
the TPS dose (DTPS) and EPID predicted dose (DEPID) calculated at the centres of 
the homogeneous phantom for a range of field sizes (FS) and thicknesses (T) at 6 
MV. The differences between TPS and EPID, at the exit appear to be increasing 
with field size. For small field size, the EPID predicted a higher dose compared 
to the TPS for all thicknesses while the trend is reversed at large field sizes. This 
is in contrast to the entrance dose differences, which appear to be 
unsystematic, except for the 5x5 cm2.  
 
Table 4- 8. Percentage differences at exit and entrance central points between TPS and EPID 
for different field sizes and solid-water thickness (T) for 6 MV beam 
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The in vivo determination of entrance and exit doses are useful in clinical QA 
programs because the former aim to check the accuracy of MU calculations and 
delivery, while the latter serve in addition to check the influence of the patient 
(presence of inhomogeneities) on the dose calculation. Comparison of central 
axis point doses in table 4-7, at the exit and entrance showed that the TPS and 
EPID predicted values agreed to within 3%. These results show that the EPID 
doses were generally higher and lower than those of TPS at square field sizes of 
5 cm and lower than those of TPS at square field sizes of 20 cm.  This was 
related to a noticeable trend that the EPID’s predicted EPL at 5x5cm2 and 
20x20cm2 were respectively lower and higher than expected values by ~ 1-2mm. 
This could possibly be due to a weakness in a field-size dependent correction in 
our method.  
 
A further comparison of the EPID-calculated and TPS dose distributions was 
carried out using a gamma analysis. Two dimensional measurements in 
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homogeneous phantoms show that the in-vivo dose at the exit and entrance 
could be predicted to within 3% dose difference (DD) and 3 mm distance to 
agreement (DTA) criteria. The results of our in vivo exit dose prediction are 
consistent with previous investigation (Zijtveld et al 2009, McDermott et al 2007, 
Nijsten et al 2007). The failed area (gamma index > 1) for square fields of 5, 10, 
15 and 20 cm was about 3.1 % (average) of all the points in the irradiated regions 
and for all thicknesses. In 90 % of the irradiated field, a gamma map comparison  
between the measured and calculated dose maps showed failed area < 1.5%. The 
proportion of points within tolerance was higher for exit dose than for entrance 
dose. In conventional in vivo dosimetry where direct entrance dose are taken, 
the reverse might be expected, however because the algorithm uses the exit 
doses to predict the entrance doses, then any systematic errors in the 
calculation of the former will manifest in the latter. Hence this supports the 
notion that the use of exit doses is better than using entrance doses. 
 
Figure 4-21 compares the effect of data-points resampling on the results. Figure 
4-21 (a) is the original (53x65) dose map and figure 4-21 (b) shows the same 
central dose map covering an area of 26x26 cm2 resampled to 356x356 data 
points. Figure 4-21 (c) shows cross-plane profiles through both dose maps, 
indicating that the magnitude of the values are insignificantly affected by 
resampling the data.  
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Figure 4- 21: Effect of resampling the MapCHECK data points 
 
 
Figure 4-22 compares the exit dose, as illustrated in section 3.2.8 (figure 3-11), 
between the MapCHECK device measurement and EPID image acquired at the 
same time. The results in this figure shows MapCHECK (a), TPS (b) and EPID 
image (c) dose distributions, acquired with 20x20 cm2 field size and 100 MU. The 
percentage of area in figure (4-22) where the gamma index (3% DD and 3mm 
DTA) failed were 2.5, 3.2 and 2.8 for the TPS vs MapCHECK, EPID vs MapCHECK 
and TPS vs EPID respectively. 
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Figure 4- 22: Figures (a), (b) and (c) compare 2D absolute exit dose (cGy) distributions 
measured with MapCHECK device, calculated with TPS and those from EPID images 
respectively, for a 20x20 cm2 field size and 100 MU. 
 
Figures 4-23 and 4-24 show exit dose comparisons for the step and cylindrical 
phantom cases respectively as described in section 3.2.4.1. Figures 4-23 (a & c) 
and 4-24 (a & c) are TPS predicted dose while figures 4-23 (b & d) and 4-24 (b & 
d) are their respective EPID calculated dose. Figures 4-23 (e) and 4-24 (e) are 
horizontal EPID (dotted lines) and TPS (dashed lines) dose profiles, and EPL (solid 
lines) profiles computed from their respective EPID images. Figures 4-23 (f) and 
4-24 (f) are their respective gamma evaluation between the TPS and EPID 
predicted, calculated at 3% and 3mm DTA tolerance criteria.  
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Figure 4- 23. Exit dose comparison for case in figure 3.5(a) as described in section 3.2.1.1 
Figures (a) and (c) are 2D TPS predicted colour maps and contour distributions, while (b) and 
(d) are their respective EPID calculated doses. Figure (e) shows horizontal EPL and dose 
profiles through the centre of their respective EPID images. Figure (f) is the corresponding 
gamma distributions between the TPS and EPID.    
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Figure 4- 24. Exit dose comparison for the case in figure 3.5(b) as described in section 
3.2.4.1 Figures (a) and (c) are 2D TPS predicted colour maps and contour distributions, while 
(b) and (d) are their respective EPID calculated doses. Figure (e) shows horizontal EPL and 
dose profiles through the centre of their respective EPID images.  Figure (f) is the 
corresponding gamma distributions between the TPS and EPID.    
  
The comparison of dose (right ordinate) and EPL profiles (left ordinate) in figures 
4-23 (e) and 4-24 (e) clearly depicts the inverse relationship between the two. 
Both these figures show discrepancies between the TPS and EPID in regions 
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where there is a steep increase or decrease in dose due to a respectively steep 
decrease or increase in EPL. Gamma index failures are correspondingly seen in 
those areas as indicated in figures 4-23(f) and 4-24(f). 
 
 
Figure 4-25 shows exit dose comparisons for the anthropomorphic lower torso 
phantom as described in figure 3-6. Figure 4-25(f) is the EPID image of this 
phantom obtained with 20x20 cm2 field size and 200 MU.  Figures 4-25 (a) and 
(b) are TPS predicted and EPID calculated dose distributions. Figure 4-25 (c) 
shows horizontal dose profiles from the TPS (dashed lines), EPID (dotted lines) 
and EPL (solid lines) profiles computed from the EPID image. Figure 4-25 (d) 
shows the gamma evaluation between the TPS and EPID predicted, calculated at 
3% and 3mm DTA tolerance criteria. Figure 4-25 (e) shows the dose difference 
(DEPID-DTPS) map. 
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Figure 4- 25. Exit dose comparison for the case in figures 3-6 as described in section 3.2.4.4. 
Figures (a) and (b) are the 2D TPS predicted and EPID calculated dose contours respectively. 
Figure (c) shows horizontal TPS dose (dashed) and EPID dose (dotted line) and EPL profiles 
through the centre of the EPID image. Figure (d) is the corresponding gamma distributions 
between the TPS and EPID. Figure (e) is a 2D dose difference map. Figure (f) is the EPID 
image of the irradiated 20x20 cm2 field area of the phantom. 
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Figure 4-26 shows exit dose comparisons for the same anthropomorphic lower 
torso phantom as described in figure 4-24 above, but for a 10x10 cm2 field size. 
Figures 4-26 (a) and (b) are EPID predicted and TPS calculated dose 
distributions. Figure 4-26 (c) shows the dose difference (DEPID-DTPS) map. Figure 
4-26 (d) is the EPID image of this phantom obtained with 200 MU. 
 
Figure 4- 26. Exit dose comparison for the case in figure 3-6, for 10x10 cm2. Figures (a) and 
(b) are the 2D EPID predicted and TPS calculated dose contours respectively.   Figure (c) is a 
2D dose difference contour distribution. Figure (d) is the EPID image of the irradiated 10x10 
cm2 field area of the phantom. 
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Similar to results in figures 4-20 (a) and (b), figure 4-25 (c) indicates that the 
EPID predicts a higher dose outside the treatment field compared to the TPS. 
The air in the hollow cavity representing sigmoid colon and rectum of the 
anthropomorphic phantom (figures 3-7 and 4-24(f)) results in an increased dose 
along its path and both the TPS (figures 4-25 (a)) and EPID (figures 4-25 (b)) 
demonstrate this effect. The gamma index map in figure 4-25 (d) shows failures 
in the transverse-descending and descending-sigmoid colon junctions. The EPID 
predicted a higher dose than the TPS in the failed areas as demonstrated by the 
dose difference map (figure 4-25 (e)). A similar trend, i.e discrepancies in dose 
distribution is observed in figure 4-26, for a smaller field size. This variation is 
most likely due to increased air spaces in this colon-like structure. As much as 
our EPID dosimetry algorithm takes into account inhomogeneities at the 
conversion to EPL, it does not take into account the effects caused by irregular 
and sharp-edged surfaces on dose. This could be the main cause of discrepancies 
in some areas observed in figures 4-25 and 4-26.  The case scenarios in this study 
may not be identical to those encountered clinically, but they do indicate that in 
some patient anatomies potential dose discrepancies may occur. This is 
supported by the findings of Mcdermott et al (2007) who indicated that gas 
pockets in the rectum may increase the failure percentage when comparing the 
planned and the EPID generated dose of prostate treatments. 
 
4.3.2 Irregular fields 
As mentioned in section 3.2.7 above, the irradiated field area and resulting 
phantom scatter are essential for predicting the EPL from an EPID image and 
hence dose. Table 4-8 shows a summary of the areas calculated from the EPID 
images for the test cases of figure 3-7, compared to their respective expected 
areas. The percentage dose differences were calculated as  
%100
_
__
x
AreaExpected
AreaCalculatedAreaExpected





 −
 
The deviations between EPID predicted and the geometrically expected areas for 
all images used in the study including squares and wedged fields were within 
±1%. 
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Table 4- 9. Comparison of expected and EPID calculated areas for square fields and cases 
described in figure 3.7 
-0.651.851.5Case f
1.0249.5252.0Case e
0.6245.4247.0Case d
-0.5323.6322.0Case c
0.7135.1136.0Case b
-0.1319.2318.8Case a
-0.3433.5432.021.6x20 (60o EDW)
-0.4401.7400.020x20 sq
0.599.5100.010x10 sq
Deference (%)Calculated AreaExpected AreaCase
 
 
The irradiated field areas can be accurately determined from the EPID image to 
within ± 1% uncertainty in all cases.  Scattered radiation in portal images 
depends on beam energy, phantom/ patient thickness and field area (Swindell et 
al 1995, Mayles et al 2007, Kairn et al 2008). Accurate determination of field 
area, which is one of the paramount factors required in the establishment of 
phantom / patient scatter correction and hence EPL and dose, is essential. 
Because there are no simple means to determine the equivalent square for an 
irregularly shaped field, the most commonly used technique to predict the 
scatter / output factor correction is the sector-integration method (Sanz et al 
2001, Podgorsak 2005), where the irregular field is resolved into sectors of 
circular beams originating at the point of interest in the phantom or patient. In 
the proposed method, the EPID image pixel resolution is less than 1.0 mm, hence 
the irradiated areas can be calculated to a high degree of accuracy. However, 
the sector integration method has an additional advantage that it accounts for 
the distances to the point of interest whereas the area calculation method used 
in this study does not. The use of area alone for scatter correction could be 
another source for the discrepancies in our results. 
 
The EPL beneath the MLC shielded regions is too high compared to the maximum 
depths for TPR table which was measured up to a depth of 40 cm. Figure 4-27 
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shows the EPL profile calculated from EPID image of figure 3-8 (d) (MLC aperture 
3-7 (d)). The figure shows that the EPL in the open beam is ≈ 20 cm and rises to 
over 100 cm in the shielded regions. With MLC height (physical thickness) of ≈ 
6.5 cm and electron density of Tungsten ≈ 19.3 g/cc, then according to equation 
3.17, the EPL in the shielded region should be much higher than 100 cm.  This 
indicates that the EPL equation is not accurate at such large values, due to the 
A(i,j) and B(i,j) fitting parameters being optimized for the range 0 – 35 cm. In 
addition, it will be inappropriate to use A(i,j) and B(i,j) due to spectral changes 
and scattering caused by the MLC. Another factor is the difference in pair 
production probability between tungsten and water. 
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Figure 4- 27. EPL profile (along the Y direction) calculated from the EPID image of figure 3.8 
(d) 
 
To facilitate calculation of doses in these regions, the TPR was set to the MLC 
transmission factor. 013.0
___
___
_ ==
SignalEPIDFieldOpen
SignalEPIDClosedMLC
onTransimisiMLC  
The value of the MLC transmission factor measured with the EPID agrees with 
that of Lorentz et al 2007. They indicated that the MLC transmission varies 
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across the irradiated field ranging between 0.016 at the central axis to 0.012 
towards the field edges. 
 
Figure 4-28 shows the EPID and TPS exit dose comparison for the case of figure 
3-7 (a). Figures 4-28 (a) and (b) show the TPS and EPID dose distribution where 
the EPID doses in the shielded regions are calculated as described in previous 
sections. The gamma index (figure 4-28 c) computed from figures 4-28 (a) and 
(b) at 3% DD and 3mm DTA criterion, indicates that 5.8% of the points failed. 
This gamma map shows that most of the discrepancies between the EPID and TPS 
doses are in the shielded regions. Figures 4-28 (d) and (e) and corresponding 
gamma index (f) show the same case, but the doses in the shielded regions have 
been zeroed. This was achieved by: first a matrix is created from the edge 
polygon, (say figure 3-10 (a) for this case) whereby all the enclosed pixels are 
filled with “ones” and “zeros” elsewhere. Secondly, the created matrix is 
multiplied (element by element) with the exit dose matrices. This automatically 
zeroes the doses outside the irradiated fields and the gamma index map (figure 
4-28 f) shows a decrease in number of points failing the criterion.  
 
 
Figure 4- 28. Comparison of TPS (a) and EPID (b) exit doses for case of figure 3-7(a), where 
the doses in shielded areas are compared. Figures (a) and (d) are the same TPS doses but 
the dose data in shielded areas have been zeroed. Similarly, figures (b) and (e) are the same 
EPID doses but the dose data in shielded areas have been zeroed. Figures (c) and (f) are the 
corresponding gamma index maps.  
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Figures 4-29 (a) and (b) show the absolute 2D EPID predicted and TPS exit 
dose distributions respectively, for the cases of figures 3-7 (c). For the MLC-
shaped field in this figure, the difference between the EPID and TPS doses within 
the in-field region was very small. Hence, the percentage of areas in this test 
case where the gamma index (figures 4-29 (c)) evaluated at 3% DD and 3mm DTA 
criterion, was greater than 1.0, was 4.5%. This is well illustrated in a histogram 
figure 4-29(d) showing the actual gamma indices distribution computed from the 
2D gamma index maps of figures 4-29. About 50% of the total points in this figure 
have gamma value less than 0.3, with maximum gamma index of 9.9. The 
observed errors at the edges of the MLC might be partially corrected in the same 
way that the Varian Eclipse 8.6 TPS corrects their MLC delivery, by slight 
adjustment of the field edges when defined by MLC (Vial et al, 2006). This leaf 
offset is about 1.5-2.0 mm (Varian MLC). The effect this leaf offset might cause 
on the field edge dosimetry, need to be investigated.  
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Figure 4- 29: Figures (a) and (b) show EPID and TPS 2D absolute exit dose distributions for 
the irregular shaped apertures in figure 3.7 (c).  Figure (c) demonstrates the gamma index 
map. Figure (d) is a histogram showing the gamma index values, computed from gamma 
map of figure (c). 
 
 
Figure 4-30 compares the absolute 2D dose distributions at the exit for the MLC 
shaped field in figure 3.7 (d) measured by MapCHECK (a), TPS predicted (b) and 
that calculated from EPID image (c). The percentage of areas where the gamma 
index (figures (d), (e) and (f)) evaluated at 3% DD and 3mm DTA criterion, was 
greater than 1.0, were 3.2%, 8.2% and 7.6% for TPS vs MapCHECK, EPID vs 
MapCHECK and TPS vs EPID respectively. 
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Figure 4- 30:Figures (a), (b) and (c) show 2D absolute exit dose (cGy) distributions 
measured with MapCHECK device, calculated with TPS and those from EPID images 
respectively for the irregular shaped field in figure 3.7 (d).  Figures (d), (e) and (f) 
demonstrate the respective 2D gamma maps, evaluated at 3% DD and 3 mm DTA. 
 
In figures 4-30, the dose differences between the EPID, MapCHECK and TPS at 
the centre, where the left and right MLC banks intersect, is much higher, 
resulting in higher gamma values as shown in figure 4-30 (d-f). Most of the 
discrepancies are at the MLC defined edges as illustrated in the 2D dose and 
gamma index distributions of figure 4-30 (d-f). More than 90% the points in the 
test cases for figure 3.7 (c) and (d) passed the gamma index evaluated at 3% DD 
and 3mm DTA criterion.  
 
Figures 4-31 (a) and (b) show the absolute 2D EPID predicted and TPS calculated 
exit dose distributions respectively for the case of figure 3-7 (e). The doses 
under the MLC shielded areas have been zeroed in this figure. Figures 4-31 (c) 
and (d) compare dose profiles extracted from the dose distribution in the X and 
Y directions respectively. The matching between these profiles in the irradiated 
field was within 1%, indicating little or no systematic error. Figure 4-31 (e) 
shows a 2D percentage dose-difference map between the EPID and TPS predicted 
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doses, which demonstrates that most of the discrepancy is towards the field 
edges, also indicated by the gamma index map, figure 4-31 (f). The differences 
between EIPD and TPS towards the radiation field edge are high, ranging from -
30% to 35%.  
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Figure 4- 31: Comparison of EPID and TPS for case of figure 3-7(e) 
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Figure 4- 32. Comparison of EPID and TPS for the cases of figure 3-7 (b) and (f) 
 
Figures 4-32 (a) and (b) compare 2D exit doses in colour-wash predicted from 
EPID images and TPS respectively for the case in figure 3-7 (b).  Figures 4-32 (c) 
and (d) show the same data as dose contours. Figures 4-32 (e) and (f) compare 
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2D exit doses in colour-wash predicted from EPID images and TPS respectively 
for the case in figure 3-7 (f).  Figures 4-32 (g) and (h) show the same data as 
dose contours. Similar to previous cases, the dose matching between the two is 
excellent.  
The doses in the centres of the irradiated fields for all the irregular cases are 
proportional to the areas indicated in table 4-8. In other words, the MLC 
shielding of certain areas within a radiation field not only reduces the dose 
behind the MLC shield, but also reduces the doses in the unshielded areas, in 
agreement with Boesecke et al (1985). Both the EPID and TPS doses convey this 
clearly. 
 
Figure 4-33 shows the exit dose comparison for the anthropomorphic phantom 
case in figure 3-6 as described in section 3.2.4.4, irradiated with an irregular 
field illustrated in figure 3-7 (c), to a dose of 200 MU. Figures 4-33 (a) and (b) 
are the 2D EPID predicted and TPS calculated dose contours respectively. Figure 
(c) shows the corresponding gamma index map and 91.7% of points passed the 3% 
DD and 3mm DTA criteria. Figure (d) is the acquired EPID image from which the 
dose distribution in figure (a) was calculated. The air in the hollow cavity 
representing sigmoid colon and rectum of the anthropomorphic phantom results 
in an increased dose along its path, as demonstrated by both the EPID and TPS 
(figures 4-33 (a) and (b) respectively) dose distributions. 
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Figure 4- 33.  Exit dose comparison for the anthropomorphic phantom case in figure 3-7 as 
described in section 3.2.4.4, irradiated with an irregular field illustrated in figure 3-7 (c). 
Figures (a) and (b) are the 2D EPID predicted and TPS calculated dose contours respectively. 
Figure (c) shows the corresponding gamma index (3% DD and 3mm DTA) map between the 
TPS and EPID. Figure (d) is the acquired EPID image from which the dose distribution in 
figure (a) was calculated.  
 
Within the shielded regions and at the field edges, the percentage 
differences between the calibrated EPID and TPS calculated doses were much 
greater than in the in-field regions. Observed percent differences ranged from 
−15% to as much as 35%. This was partially due to the low EPID signal level in 
these regions compared to TPS. However, the differences in these regions were 
still small in an absolute sense. Similar to the previous example for the square 
field, the air in the hollow cavity representing sigmoid colon and rectum of the 
anthropomorphic phantom results in an increased dose along its path, as 
demonstrated by both the EPID and TPS (figures 4-33 (a) and (b) respectively) 
dose distributions. The error at the edges of the MLC profile might be at least 
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partially corrected the way that the Varian Eclipse planning system corrects 
their MLC delivery for the rounded leaf edge, by a slight adjustment of the field 
edge when defined by the MLC. This leaf offset is usually around 1.5-2.0 mm for 
the Varian MLC. The effect, this leaf offset might cause on field edge dosimetry, 
need to be investigated.  
 
4.3.3 Enhanced dynamic fields  
The edge detection and subsequent calculation of irradiated-area method, 
described in section 3.2.5.1 is similarly effective with EDW fields. Figures 4-34 
(a-f) show 600 EDW EPID images, acquired for 20x20 cm2 (X = 20.0 cm, Y1 = Y2 = 
10.0 cm) field size, total delivered MU of 100. Figure 4-34 (a) was acquired 
without any material and figure 4-34 (d) was acquired with 20 cm of solid water. 
Figures 4-34 (b) and (e) show their corresponding profiles extracted in the wedge 
motion direction, while figures 4-34 (c) and (f) show the field edges deduced 
from their respective EPID images. Figures 4-34 (g), (h) and (i) were acquired 
with same setup as figure 4-34(d), but with a 300 EDW. Despite the variations in 
beam intensities and scattering effect reaching the imager (due to different 
EDWs, with and without solid water phantom), the calculated areas were the 
same. The areas calculated from figures 4-34(c), (f) and (i) were 401.70, 401.89 
and 401.83 respectively, which is within 0.5% uncertainty compared to the 
expected value. 
 
 150 
-15 -10 -5 0 5 10 15
0
10
20
30
40
50
Off-axis distance (cm)
Si
gn
al
(a) (c)(b)
-15 -10 -5 0 5 10 15
0
5
10
15
Off-axis distance (cm)
Si
gn
al
-15 -10 -5 0 5 10 15
0
5
10
15
20
Off-axis distance (cm)
Si
gn
al
(d)
(i)(h)(g)
(f)(e)
Si
gn
al
Si
gn
al
Si
gn
al
 
Figure 4- 34. Figures (a), (d) and (g) show EDW EPIDs acquired with different setups.  
Figures (b), (e) and (h) show their respective profiles, while figures (c), (f) and (i) are the 
corresponding field edges determined from the EPID image. 
 
 
Table 4-9 compares segmented treatment tables calculated with the proposed 
algorithm using equation 3.24 and those printed out after EDW treatment at 100 
MU exposures. The system’s dynalog viewer files were retrieved after delivery, 
where the actual Y1 jaw (moving jaw) position and cumulative monitor units are 
recorded. The two tables on top were obtained using 300 EDW and field size 
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20x20 cm2 (X=20 cm, Y1=10 and Y2=10). The two bottom tables were for 450 
EDW and field size 15x15 cm2 (X=15 cm, Y1=7.5 and Y2=7.5). The exposure to 
the first open field calculated for 300 EDW, with the algorithm is 53.75 MU, 
which is equal to that from the dynalog viewer. For the 450 EDW, the exposure 
to the first open field with the algorithm is 45.89 MU, compared to 45.77 MU 
from the dynalog viewer.  
 
Table 4- 10. Comparison of segmented treatment values calculated with the proposed 
algorithm using equation 3.24 and those printed out after EDW treatment from the linac. 
Dynalog Viewer – 300 EDW
Dynalog Viewer – 450 EDW
Derived using equation 3.24
Derived using equation 3.24
Diff (%)
Diff (%)
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The comparisons of the MU exposures at different Y1 jaw positions for both cases 
are in very good agreement. The last column in the table shows that the 
percentage differences between the derived MU at different jaw positions and 
those from the dynalog file are within ± 0.5%. Results from this table indicate 
that the proposed algorithm can very well replicate the exposure-versus-jaw 
position for the EDW. 
 
The sweeping of the collimator jaw across the irradiated field generates an EPL 
that varies with the EDW angle. Figure 4-35 shows the EPL cross plane profiles 
for EPID images obtained without any material between the source and detector 
at 100 MU and 400MU/min. The EPLs were computed using the set of correction 
coefficients A(i,j), B(i,j) and Mo(i,j) (only for figure 4-35) generated for open 
fields. As indicated in section 3.2.6.1, using parameters for open fields has 
limitations for calculation EPL for EDW fields; hence the main purpose for the 
results in figure 4-35 is to clarify on these drawbacks. For the open field, i.e. 
zero wedge (open in figure 4-35), the EPL measured across the entire field in the 
X and Y direction was 0±0.3 cm. For wedged beams, the EPL profiles in the Y 
(wedge motion) direction are higher at the start of the field and decrease 
gradually as collimator jaw sweeps across the field. For the zero-wedge field the 
entire 100 MU is delivered to the entire field, while the EDW comprises of the 
open-field phase and a collimator-sweeping phase. From the STT calculation 
when a total 100 MU is given, the proportions delivered to the open-field 
segments are 53.8MU, 35.2MU and 15.6 MU for the 300, 450, and 600 EDW 
respectively. For the EDW fields, as the cumulative MU increases, the EPL 
gradually decreases. EDW treatments are optimised such that the intended total 
MU is delivered by the end of treatment field, explaining why the EPL in the Y 
direction are nearly the same. These results clearly depict the inverse 
relationship between EPL and MU (dose).  
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Figure 4- 35. EPL profiles in X and Y directions predicted from images obtained without any 
material between the source and imager for open field (solid lines), 300 (dash-dot lines), 450 
(dot lines) and 600 (dash lines) EDW angles. 
 
 
The EPL computed for EDW using the correction coefficients A(i,j), B(i,j) 
and Mo(i,j) generated for open fields from EPID images is not due to the 
irradiated image alone, but also the influence of the sweeping jaw across the 
field. Cross plane profiles in figure (4-35) illustrate that EPL may rise beyond 20 
cm across field for 450 EDW. The limitation with these open field coefficients is 
that, for EDW angles above 300, the combined EPL contribution from the EDW 
and irradiated material (∼ 20 cm solid water) is high, reaching levels beyond the 
optimised range of calibration values (0-35 cm). Hence EPL in such cases may be 
calculated inappropriately. In addition to that, if the combined EPL goes beyond 
the maximum depths for the TPR table, which was measured up to depths of 40 
cm, then the conversion of EPL to dose may be inaccurate as well. 
 
Figure 4-36 shows measured and derived (equation 3.20) profiles without any 
material in the beam ),(0 jiM θ  in the X and Y directions for 300 (figures (a) and 
(b)) and 450 (figures (c) and (d)) EDW angles. These profiles are compared to the 
measured 600 EDW shown in figures 4-36 (e) and (f). As expected the signal at 
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the start of the moving jaw is much lower for the 600 EDW field and continues to 
increase with decreasing EDW angles. Figures 4-36 (g) and (h) show a 3-D 
visualization of the fitting parameters, for the EDW 300 and 450 angles 
respectively. The main reason why we derived the parameters is analogous to 
the methodology of the Eclipse TPS whereby, during EDW commissioning, only 
the 600 EDW and open field measurements are done. The rest of the EDW angles 
i.e 100, 150, 200, 250, 300 and 450 are generated from the 600 EDW and open field 
measurements (Varian medical Systems, 1996). 
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Figure 4-36. Comparison of measured (solid lines) and derived (dotted lines) profiles 
without any material in the beam ),(0 jiM θ  in the X and Y directions for EDW angles 300 
(figure 4-36 (a) and (b)) and 450 (figure 4-36 (c) and (d)). Figures 4-36 (e) and (f) show the 
profiles for EDW angles 600. Figures 4-36 (g) and (h) show a 3-D visualization of the fitting 
parameter for the EDW 300 and 450 angles respectively. 
 
The results were for a symmetric field size of 20x20 cm2 (X=20 cm, Y1=10 cm 
and Y2=10 cm). The comparison between measured and calculated profiles 
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shows that, in general, a good agreement has been achieved. The deviations 
near the fields’ edges were less than 3%.  
 
Figures 4-37 (a) and (b) show the variations of fitting parameter matrices Bwθ(i,j) 
and Awθ(i,j) along the Y direction of the EPID respectively for open field (θ=0), 
300, 450 and 600 EDW fields. It should be reiterated here that the Bwθ(i,j) and 
Awθ(i,j) parameter for 60
0 EDW (W60-meas in figure 4-37) were only 
experimentally determined; they were used to determine Bwθ(i,j) and Awθ(i,j) 
parameter for other EDW angles (i.e 450, 300 and 150). The results were for a 
symmetric field size of 20x20 cm2 (X=20 cm, Y1=10 cm and Y2=10 cm).The 
results also compare the measured and derived data profiles (equations 3.22 and 
3.23) of Bwθ(i,j) and Awθ(i,j) for the EDW angles 30
0 and 450. As illustrated in the 
results, there are significant variations in Bwθ(i,j) and Awθ(i,j) for open field and 
EDW fields. Unlike the open field data, which are symmetric about the central 
axis, the wedged parameters tend to reflect the slope of the wedge. This is a 
direct consequence of applying equations 3.22 and 3.23 to recalculate the 
parameters for wedged fields. 
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Figure 4- 37. Figures (a) and (b) show the variations of fitting parameter matrices Bwθ(i,j) 
and Awθ(i,j) along the Y direction of the EPID respectively for open field (θ=0), 300, 450 and 
600 EDW fields. The results also compare the measured and derived profiles for the 300 and 
450. Figures 4-37 (c) and (d) show a 3-D visualizations of the fitting parameters for 300 EDW 
field. 
 
 
The derived data using equations (3.19) – (3.24) were used for the exit dose 
(equation 3.25) calculations of EDW fields. Figures 4-38 (a) and (b) are 2D exit 
dose distributions for EPD and TPS respectively for a 150 EDW with 20x20 cm2 
(X=20cm, Y1=10 cm, Y2=10cm) field size. Figure 4-38 (c) shows the gamma index 
map, calculated at 3% dose difference and 3 mm distance to agreement criteria. 
The percentage area (points) that failed gamma criteria was 4.2%. Figure 4-38 
(d) shows a 2D pixel-by-pixel percentage dose difference between the EPID and 
TPS exit dose distributions. The percentage dose differences were calculated as 
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%100)( x
D
DD
TPS
EPIDTPS − . Figures 4-38 (e) and (f) are their corresponding exit dose 
cross plane profiles in the X and Y direction respectively.  
 
Figure 4- 38. Figures (a) and (b) are 2D exit dose distributions for EPD and TPS respectively 
for a 150 EDW with 20x20 cm2. Figures (c) and (d) show their corresponding exit dose cross 
plane profiles in the X and Y direction respectively. Figures (e) and (f) show the percentage 
dose difference map and gamma index (3% DD and 3mm DTA) respectively.  
 
The truncation of the GSTT profile to reduce it to a desired field size results in 
the automatic zeroing of EPID doses outside the irradiated region; hence for 
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comparison purposes the TPS doses are similarly zeroed outside the irradiation 
field.  
 
Figures 4-39 (a) and (b) illustrate colourwash 2D exit dose distributions for EPID 
and TPS respectively for a 300 EDW with 15x15 cm2 (X=15cm, Y1=7.5 cm, 
Y2=7.5cm) field size. Figures 4-39 (c) and (d) are their corresponding exit dose 
cross plane profiles in the X and Y direction respectively. Figure 4-39 (e) shows a 
2D pixel-by-pixel percentage dose difference between the EPID and TPS exit 
dose distributions. Figure 4-39 (f) shows the gamma index map, calculated at 3% 
dose difference and 3 mm distance to agreement criteria. The percentage area 
(points) that failed gamma criteria was 5.5 %. 
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Figure 4- 39. Figures (a) and (b) are 2D colourwash exit dose distributions for EPD and TPS 
respectively for a 300 EDW with 15x15 cm2. Figures (c) and (d) show their corresponding exit 
dose cross plane profiles in the X and Y direction respectively. Figures (e) and (f) show the 
percentage dose difference map and gamma index (3% DD and 3mm DTA) respectively.  
 
Figures 4-40 (a) and (b) show EPID and TPS dose distributions respectively, for 
images obtained for the same setup as in figure 4-39 above, but images acquired 
at 200 MU. The calibration fitting parameters were all obtained for images at 
100 MU. The purpose of this figure is to reaffirm that the same parameters can 
be used to predict EPL for EDW and hence dose, for any other non-reference MU. 
Figures 4-40 (c) and (d) also show the profiles dose difference. Discrepancies are 
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noted at the field edges where there are highest dose gradients, with largest 
differences at the level where the Y1 jaw stops.  
(d)(c)
(b)(a)
 
Figure 4- 40. Figures (a) and (b) are 2D exit dose distributions for EPD and TPS respectively 
for a 300 EDW with 15x15 cm2 and 200 MU. Figures (c) and (d) show their corresponding exit 
dose cross plane profiles and dose differences (dashed lines) in the X and Y direction 
respectively. 
 
Figures 4-41 (a) and (b) illustrate 2D exit dose distributions for EPD and TPS 
respectively for a 450 EDW with 10x10 cm2 (X = 10.0 cm, Y1 = 5.0 cm, Y2 = 5 cm) 
field size. Figures 4-41 (c) and (d) are their corresponding exit dose cross plane 
profiles in the X and Y direction respectively. Figure 4-41 (e) shows a 2D pixel-
by-pixel percentage dose difference between the EPID and TPS exit dose 
distributions while figure 4-41 (f) shows the gamma index map, calculated at 3% 
dose difference and 3 mm distance to agreement criteria. The percentage area 
(points) that failed gamma criteria was 7.6%.  
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Figure 4- 41. Figures (a) and (b) are 2D exit dose distributions for EPD and TPS respectively 
for a 450 EDW with 10x10 cm2. Figures (c) and (d) show their corresponding exit dose cross 
plane profiles in the X and Y direction respectively. Figures (e) and (f) show the percentage 
dose difference map and gamma index (3% DD and 3mm DTA) respectively. 
 
Figures 4-42 (a) and (b) illustrate 2D exit dose distributions for EPD and TPS 
respectively for a 600 EDW with 20x20 cm2 (X = 20.0 cm, Y1 = 10.0 cm, Y2 = 10 
cm) field size. Figures 4-42 (c) and (d) are their corresponding exit dose cross 
plane profiles in the X and Y direction respectively. Figure 4-42 (e) shows a 2D 
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pixel-by-pixel percentage dose difference between the EPID and TPS exit dose 
distributions.  
 
Figure 4- 42. Figures (a) and (b) are 2D exit dose distributions for EPD and TPS respectively 
for a 600 EDW with 20x20 cm2. Figures (c) and (d) show their corresponding exit dose cross 
plane profiles in the X and Y direction respectively. Figure (e) shows the percentage dose 
difference map. 
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The profiles for all the test cases described in figures 4-38 to 4-42 are practically 
superimposed within 70% of the irradiated field. The largest deviations are 
towards the field edges (regions of steep dose gradients). Results in figures 
comparing exit doses in cross plane and 2D dose distribution for EDW show a 
good matching between the EPID and TPS for different EDW angles and field 
sizes. The cross plane dose comparisons for EDW indicate that the EPID had 
slightly lower doses of 1-2% at the field edges compared to TPS. This could be 
linked to the ),(),(),,( jiAandjiBjiM wwo θθθ  data matrices in figures 4-36, 4-37 
(a) and 4-37 (b) respectively, which compare cross plane profiles of derived and 
measured coefficients. Towards the edges, both the derived 
),(),( jiBandjiM wo θθ  are lower than the measured, while ),( jiAwθ is higher. 
An interplay between these factors results in an increase in EPL and hence a 
decrease in dose towards the field edges. Another possible reason for the failure 
at the edges is the utility of the GSTT described in equation 3.20. It tends to 
break down for large fields and deviations of 2-4% between measurement and 
calculated values have been reported (Gibbons 1998, Prado et al 2002 and 
Kuperman 2005). The variations in dose-rates during EDW dose delivery could be 
another factor that can affect EPID dose distribution, causing discrepancies. The 
readout of the a-Si array are synchronized with the beam pulses, hence EPIDs 
are calibrated at each accelerator dose-rate. The dark and flood field images 
are different at each doserate due to variation in image acquisition timing. 
Doserate variations that occur during EDW treatments could potentially affect 
the EPID signal, where the system is calibrated at a fixed accelerator dose-rate. 
Lastly, the disagreements are at the field edges (regions of steep dose gradients) 
where dose predictions may be inaccurate (Vieira et al 2003). 
 
Figures 4-43 (a) and (c) compare typical profiles from EPID images 
acquired for the YI-IN and Y2-OUT for 30o and 45o EDW respectively. Figures 4-43 
(b) and (d) show the same data superimposed onto each other by flipping the Y1-
IN data. The images were acquired for 20x20 cm2 with moving jaw Y1=10 cm, 
fixed jaw Y2=10 cm and X=20 cm at same SDD and 200 MU. The profiles were 
extracted from the centres of the images in the EDW motion direction. The 
results show that EPID pixel value responses for Y1-IN and Y2-OUT are practically 
symmetrical, implying that data for Y2-OUT jaw orientation can be created from 
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that of Y1-IN jaw orientation by data mirroring, saving valuable re-measurement 
time. 
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Figure 4- 43. Figures (a) and (c) compare EPID image profiles for Y1-IN (solid lines) and Y2-
OUT (dash lines) for 30o and 45o EDW respectively. Figures (b) and (d) show the same data 
superimposed onto each other by flipping the Y1-IN data. 
 
All the EDW coefficients data and test cases in this study were acquired 
with Y1-IN jaw orientations. Results from figure 4-43 which is also in agreement 
with Greer et al (2007), indicate that EPID pixel value response for Y1-IN and Y2-
OUT for the same radiation field settings are practically symmetrical. Hence the 
data fitting coefficients for Y2-OUT can be created from the Y1-IN by data 
mirroring, saving valuable time of re-measurements.  
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Figure 4-44 compares EDW dose distributions for 15x15 cm2 symmetric 
field size, Y2-OUT jaw motion and 100 MU. The EPID data used for dose 
calculation were obtained by data mirroring as described above. The difference 
between the TPS and EPID dose was calculated for each point within the 2D data 
matrix. The cross plane dose differences in figure 4-44 (c) (displayed as a dashed 
line) illustrates that most of the discrepancies are at the edges, similar to the 
Y1-IN jaw orientation. Figure 4-44 (d) shows the gamma index map, where the 
percentage of area (3% DD and 3mm DTA) failed was 6.9. 
 
 
Figure 4- 44. Figures (a) and (b) are 2D exit dose distributions for EPD and TPS respectively 
for a 300, Y2- OUT, EDW with 15x15 cm2. Figure (c) shows their corresponding exit dose 
cross plane profiles and dose differences (dashed lines) in the Y direction. Figure (d) is the 
gamma map (3% DD and 3mm DTA) computed from figures (a) and (b). 
 
 
Figure 4-45 shows another case were the Y1-IN data were used to calculate the 
exit dose for an EPID acquired image. The results in this figure compare 
MapCHECK (a), TPS (b) and EPID image (c) dose distributions, acquired with 450 
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EDW, 15x15 cm2 symmetric field size, Y2-OUT jaw motion, collimator angle 900 
and 200 MU. The EPID data used for exit dose calculation was obtained by 
mirroring the Y1-IN data as described above. We used a rotated collimator angle 
in this example to show that the fitting data coefficients can be used at various 
beam orientation. The percentage of area in figure 4-45 where the gamma index 
(3% DD and 3mm DTA) failed were 5.5, 7.2 and 7.8 for the TPS vs MapCHECK, 
EPID vs MapCHECK and TPS vs EPID respectively. Reasonably large differences 
are at the field edges as illustrated by the EPID vs MapCHECK dose-difference 
profile in figure 4-45 (d). However this is not due to using the Y1-IN data to 
compute dose for Y2-OUT, as results in figures 4-38 and 4-42 also show a similar 
effect at the edges. 
 
 168 
(b) (a) 
(c) 
(e) γ - TPS vs MAPCHK (f) γ - EPID vs MAPCHK (g) γ - TPS vs EPID
(d) 
 
Figure 4- 45. Figures (a), (b) and (c) show 2D absolute exit dose (cGy) distributions 
measured with the MapCHECK device, calculated with TPS and those from EPID images 
respectively, for a 450, Y2- OUT, EDW with 15x15 cm2. The image was acquired with 200 MU 
at collimator angle 900. Figure (d) shows the corresponding exit dose cross plane profiles 
and dose differences between EPID and MapCHECK profiles (dot-dashed line) in the X 
direction. Figures (e), (f) and (g) demonstrate the respective 2D gamma maps, evaluated at 
3% DD and 3 mm DTA.Figure (d) is the gamma map (3% DD and 3mm DTA) computed from 
figures (a) and (b). 
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Figures 4-46 and 4-47 show exit dose comparisons for the anthropomorphic 
phantom case in figure 3-7(c) as described in section 3.2.6, irradiated with 300 
(Y1- IN, collimator angle 00) and 450 (Y2- OUT, collimator angle 900) EDW fields 
respectively.  The EPID images were acquired and TPS calculations were done 
with 100 MU and with 15x15 cm2 symmetric field. Figures 4-46/4-47(a) and (b) 
compare 2D TPS and EPID dose contours respectively. Figures 4-46/4-47(c) and 
(d) compare TPS and EPID cross plane profiles in the X and Y directions 
respectively. Figures 4-46(e) and 4-47(e) are the respective percentage dose 
difference maps between the TPS and EPID. Figures 4-46(f) and 4-47(f) show the 
acquired EPID images from which the dose distributions in figures 4-46(b) and 4-
47(b) respectively, were calculated. The EPID and TPS dose distributions 
illustrated in the two examples above, compare favourably well in low dose 
regions, but significant deviations are noticed in high dose areas (towards the 
end position of the moving jaw).  
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Figure 4- 46. Exit dose comparison for the anthropomorphic phantom case in figure 3-7 as 
described in section 3.2.4.4, irradiated with 100 MU, 300 EDW, Y1- IN, collimator angle 00, 
with 15x15 cm2 symmetric field. Figures (a) and (b) compare 2D TPS and EPID dose contours 
respectively. Figures (c) and (d) compare cross plane profiles in the X and Y respectively. 
Figure (e) shows the percentage dose difference map between the TPS and EPID doses. 
Figure (f) is the acquired EPID image from which the dose distribution in figure (b) was 
calculated. 
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Figure 4- 47. Exit dose comparison for the anthropomorphic phantom case in figure 3-7 as 
described in section 3.2.4.4, irradiated with 100 MU, 450 EDW, Y2- OUT, collimator angle 
900, with 15x15 cm2 symmetric field. Figures (a) and (b) compare 2D TPS and EPID dose 
contours respectively. Figures (c) and (d) compare cross plane profiles in the X and Y 
respectively. Figure (e) shows the percentage dose difference map between the TPS and 
EPID doses. Figure (f) is the acquired EPID image from which the dose distribution in figure 
(b) was calculated. 
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4.3.4 Comparison of exit dose results with other literature 
The present exit dose results for open and MLC shield fields can be 
compared to the work done by Parsaeia and El-Khatib (1998), Pasma et al (2002) 
and Chen et al (2006). Parsaeia and El-Khatib (1998) investigated the dosimetric 
characteristics of a scanning liquid-filled ionization chamber (SLIC) EPID. To 
assess the system’s response in relation to incident radiation beam intensity, a 
series of characteristic curves were obtained for various field sizes and nominal 
energies of 6 and 10 MV photons. This study indicated that the response of the 
imaging system was dependent on incident radiation intensity and could be 
described to within 1% accuracy on central axis using a square root function. 
They used attenuating homogeneous phantom materials with thicknesses ranging 
from 0 – 22.5 cm and field sizes 5x5 cm2 and 10x10 cm2. This study compared 
relative transmission dosimetry with ionisation chamber measurements. Portal 
dose measurements at the plane of the detector, on central axis of the beam 
showed that the imaging system was capable of measuring the portal 
transmission dose to within 3% of the ionisation chamber results for 
homogeneous material. For 2D dosimetry applications, the system was calibrated 
with a 10 cm Perspex block used as beam flattening material on the detector 
cassette to correct for variations in individual ion chamber sensitivity and the 
effect of non-uniform beam profiles produced by the flattening filter. Open and 
wedged dose profiles measured agreed with ion chamber measured profiles to 
within 3.5% accuracy. The main limitation of this study was the requirement of 
additional material (10 cm Perspex block) to be placed on top of detector, which 
can be an obstacle in lateral fields. The profile agreements are comparable with 
results from our study. 
Pasma et al (2002) used a fluoroscopic CCD camera based EPID for 
evaluating portal dosimetry of static wedged fields, an extension of the method 
they had published for open fields Pasma et al (1998). Their methods are based 
on calculation of 2D functions, describing the transmission of a photon beam 
through a patient for both open and wedged fields. The transmission functions 
are used for the prediction of portal dose images (dose distribution behind the 
patient) in a plane normal to the beam axis, which are compared with PDIs 
measured with an EPID. The calculations are based on the planning CT scan of 
the patient and on the irradiation geometry as determined in the treatment 
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planning process. Similar to work by Parsaeia and El-Khatib (1998), these studies 
were evaluated by computing percentage transmissions (main distinction 
between these studies and our study were we compare dose directly), measured 
with an ionisation chamber. The results indicated that for low and high energy 
photon beams of 6 and 23 MV, good agreement of approximately 1.2% (excluding 
points at steep dose gradient) were found between calculated and measured 
transmissions for homogeneous Perspex slabs (thicknesses of 10-30 cm) and a 
thorax phantom. The agreement in profiles for both open and wedged fields, 
shows noticeable large deviations at field edges, comparable to our results. 
The Chen et al (2006) group slightly modified a convolution calibration 
method that has previously been used to calibrate liquid-filled ion and camera-
based EPIDs, to calibrate a Siemens Perkin-Elmer EPID detector for exit 
dosimetry. The modified model utilised two convolution kernels: one to describe 
the flat panel detector and one to describe the water dose. They also 
represented the effects of the EPID energy response and the variations in the 
beam energy spectrum using a tabulated conversion function. The study limited 
itself to solid water phantoms less than 11 cm in thickness and the 
anthropomorphic (head) phantom. This is in contrast with the present study, 
where exit doses for thicknesses in the range of 5 to 32 cm and a pelvis 
anthropomorphic phantom have been calculated. For the centred fields 
excluding the smallest, the Chen et al (2006) EPID profiles fell within 3.1% of the 
ionisation chamber measured dose. This is very much in agreement with the our 
results where, within the irradiated regions, the average dose differences 
(computed for all cases and for 80% of the irradiated field) between the EPID 
and TPS is within 3%. The Chen et al (2006) study also indicated that, out of the 
field, the percent difference between the calibrated EPID and ion chamber 
measured signals was much greater due to the low signal level in this region. 
They observed percent differences ranging from −10% to as much as 65%; which 
is not much different from what we measured in the MLC shielded regions. The 
Chen et al (2006) exit dose verification study did not include wedged or EDW 
fields. The main limitation in the Chen et al (2006) study was the frame 
acquisition / calibration capabilities of their EPID detector, which restricted 
their analysis to single frame images of 2–4 MUs. The study concluded that to 
acquire clinical exit-beam measurements, suitable multi-frame acquisition mode 
would need to be implemented. 
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In all the studies discussed above, the authors used static wedged fields, rather 
than EDW used in our study. There is scanty information in literature about 
portal dosimetry of EDW using EPID. The work done by Greer and Barnes (2007) 
only assessed the dosimetric performance of an a-Si EPID for measurement and 
quality assurance of enhanced dynamic wedge profile and wedge factor. Similar 
work was done by Al Kattar (2009), and also addressed only quality assurance of 
enhanced dynamic wedge using the a-Si500 EPID. This work therefore, provides a 
novel assessment of the use of EPID to predict EPL and exit dose in routine 
clinical treatments, including EDW fields. 
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5 CHAPTER 5: CONCLUSIONS AND FUTURE 
WORK 
5.1 Conclusions 
The dosimetric properties of eleven accelerators in clinical use were 
examined.  The EPID age and image acquisition system showed influence on the 
results with the system-II giving better data reproducibility and linearity fit than 
system-I. Uniformity was within 95% and independent of detector. Dose-rates 
and EPID field size factors have similar curves, thus can be described by 
analytical functions. Memory effects are system and age independent. System-II 
performance data are in agreement with other Varian a-Si500 EPID reports. 
Deviations are seen with the system-I which are attributed to detector age and 
acquisition software. Generally the results confirm the suitability of all the EPIDs 
for quantitative dosimetry, though there is a significant improvement in 
uniformity of response in those devices using software/hardware versions 
IAS3/IDU-20 over the older IAS2/IDU-II.  
 
The objective of radiotherapy is to deliver an absolute dose to a reference 
point with an uncertainty of ± 3%. The results obtained in this work show that 
detectors with software/hardware versions IAS3/IDU-20 have a degree of 
accuracy well in excess of that required to allow their use in routine verification 
of delivered dose within this tolerance. However limitations in reproducibility 
and linearity mean that detectors with software/hardware versions IAS2/IDU-II 
are less suitable for routine quantitative IMRT dosimetric verification. 
 
Various authors have approached portal dosimetry by radiological 
thickness / EPL calculations to verify treatment delivery when correcting EPID-
image-derived dose data. This work has proposed a simple means to convert EPL 
to estimated dose, using an analytical method for the accurate prediction of in 
vivo dose using an EPID. The PETD data, boundary and envelope profiles have 
been used to convert the EPL into dose information at the exit. The developed 
tool is capable of converting EPID images into 2D dose maps, thus giving a real-
time measure of the actual patient dose delivered during each treatment 
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fraction.   Following some simple commissioning measurements, the tool may be 
implemented on almost any radiotherapy unit with an EPID. This will allow in 
vivo dosimetry to become a routine part of radiotherapy quality assurance, thus 
improving patient safety in radiotherapy centres. The method takes into account 
inhomogeneities at each pixel in the process of establishing the EPL. The 
determined EPL by the QCM method for homogeneous water and non-water 
equivalent materials are within ± 3mm. Furthermore, the evaluation of the 
method at two different beam energies provides a significant extension to 
previous work.  
It has been shown that the QCM, applied to EPID images of homogeneous 
solid water phantoms, can be used to accurately predict 2D exit doses for 
conformal and EDW fields. The inclusion of MU correction improved the EPL 
determination and hence exit dose for various field sizes and thicknesses. The 
irradiated field areas can be accurately determined from EPID images to within ± 
1% uncertainty. Good agreement between the EPID predicted, MapCHECK 
measured and TPS calculated dose distributions were obtained for conformal and 
EDW test cases, with more than 90% of pixels within the irradiated field meeting 
a gamma index criteria of 3% DD and 3mm DTA. But it should be emphasised 
that, for practical in vivo dosimetry, these areas of reduced accuracy at the 
field edges are less important. 
The method requires the acquired EPID image, the delivered number of 
monitor units and angle of EDW (if used) as clinical input parameters to predict 
the equivalent path length (EPL) and exit dose. It is the author’s belief that the 
algorithm developed here provides a clinically effective high resolution 2D in 
vivo dosimetry system for radiotherapy. It is concluded that the EPID QCM is an 
accurate and convenient method for online in vivo dosimetry and may therefore 
replace existing techniques.  
The pixel sensitivity reproducibility of the Varian EPID has been reported to 
be within 1% (Greer et al 2003, Menon et al 2004, Kavuma et al 2008). It was 
established that the fitting coefficients were reproducible to within 2% (section 
4.2.1) and also the EPL is reproducible to within ± 2mm (section 4.2.5.1). This 
consistency in response gives a high level of confidence in the sensitivity of the 
system for its intended in vivo dosimetry use. Grattan et al (2010) investigated 
the positional stability of the Varian EPID R-arm and Exact-arm support systems 
and concluded that the latter, which also is used in this study, provided more 
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reproducible positions than the former.  This study indicated that the mean 
misalignment error for the Exact-arm was approximately 2.0 mm, which may not 
cause adverse dosimetric effects. 
It is indicated in the materials and methods (section 3.2.1) that test plans 
with desired field settings were created using the Varian RT chart software and 
that these  were scheduled in the time planner, exported to the accelerator and 
treatments executed in the clinical mode, acquiring single integrated images at 
the end of each treatment. The acquired images were then opened using the 
Varian portal dosimetry software and exported as ASCII files for analysis in 
Matlab. This means that our transit dosimetry algorithm should require only 
minimal work to be integrated into the existing commercial Varian portal dose 
image prediction (PDIP) and other operating / clinical software. 
In the current study, we used the Varian a-Si 500 with IAS3 (pixel format 
384x512 and pixel pitch in each dimension of 0.784 mm x 0.784 mm). The 
developed method can easily be adapted to the Varian’s imager system (a-Si 
1000 with pixel format 768x1024 and pixel pitch in each dimension of 0.392 mm 
x 0.392 mm) that comes with TrueBeam (Varian’s new brand of linear 
accelerators). It will require image acquisitions on linac with these new imagers 
to determine the correction coefficient matrices A(i,j), B(i,j) and the open field 
matrix M0(i,j). The rest of the algorithm will remain unchanged. A change in 
beam characteristics has a significant effect on fitting coefficients and as 
indicated in section 4.2.1, the flattening filter has a significant influence on the 
shape of the fitting matrices. For TrueBeam that has the option of producing 
flattened and unflattened beams, two sets of data will be required for dose 
verification. Alternatively, the effect of the flattening filter on matrices A(i,j), 
B(i,j) and M0(i,j) can be characterised, but this needs further investigation. 
 
 
5.2 Possible future direction 
Despite the promising Gamma-Dose analysis, there is still work that needs to be 
done on developing the procedure. Often it is not straightforward to interpret 
the compared 2D dose deviations in terms of clinical implications for the 
patient. Therefore a method to derive 3D patient dose, based on EPL measured 
with an EPID needs to be established, that is the 2D EPID dose must be 
translated to a patient dose. Several authors have investigated the translation of 
EPID dose to patient dose at points along the central axis (Chang et al, 2000); 
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the patient dose at the midplane (Boellaard et al, 1998) and the full 3D patient 
dose distribution (Patridge et al, 2002 and Louwe et al, 2003). For an accurate 
dose determination in the target area, tissue density data of the patient during 
the actual treatment fraction is essential. These data can be obtained by 
performing an additional cone-beam CT scan just before the fraction in which 
the dose measurement is performed. By extending the current procedure to 
incorporate Cone- Beam CT (CBCT) images of the patient, taken before 
treatment, the calculated exit dose from EPID can be back projected into the CT 
data, and this will permit volumetric (3D) verification. Since the current 
algorithm has been verified extensively, particularly for the EDW, it would be 
expected that the 3D result will be more generally applicable to a wider range 
of clinical situations, comparable to the work done by: 
1) McDermott et al (2008), who use CBCT images to reconstruct a phantom 
for in-vivo calculation. They use the EPID for transit dosimetry and then 
assumed that the CBCT-based phantom is homogeneous and water-like.  
2) Chen et al (2006), whereby in their procedure they reconstructed the 
dose delivered to the patient based on treatment-time portal images and 
pre-treatment MV CBCT images of the patient. They calibrated the MV 
CBCT in terms of electron density and used this information together with 
dosimetric calibration of the portal imager for dose calculation. 
Predicting the transmitted dose based on cone-Beam CT data acquired at 
treatment should ideally be performed in the future and this would improve the 
effectiveness and reliability of transit in vivo dosimetry techniques.  
Further work needs to be done to assess the algorithm in situations not 
involving normal beam incidence on the phantom / patient. More investigation is 
needed to extend the scope of the algorithm to model doses in asymmetric EDW 
fields. Gibbons (1998) and Prado et al (2002) indicated that although simple in 
approach, the MU fraction model’s prediction of EDW factors accurately, is 
limited in large or asymmetric fields. They suggested various means of modifying 
the MU fraction model to generalise it for both symmetric and asymmetric 
beams, based on beam-segmentation superposition. These beam summation 
methods are however, difficult to implement in routine clinical MU calculation 
schemes. Critical parameters and factors that may result in discrepancies 
between predicted and measured doses during clinical application may include 
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SDD variations, patient target volume variations, etc. These need to be well 
characterised.  
Once the 3D verification is complete, the QCM will then be applicable for 
all static, conformal and EDW delivery techniques. Further development of the 
procedure will be necessary to extend verification to techniques that involve 
dynamic motion of MLCs during treatment, e.g. IMRT and Rapidarc. To use the 
QCM for dynamic treatment verification will require further testing. First, the 
linearity of the EPID panel response with respect to irradiation time, as 
determined by the moving MLCs, should be investigated. The fitting coefficients 
(A(i,j), B(i,j), Mo(i,j)) which are the pillars in the conversion of the EPID signal to 
EPL, need to be re-examined for the case of dynamic MLCs. 
It may be possible to increase the EPID signal strength by changing the 
time between reset frames and imaging frames, and by decreasing the number 
of frames per sync pulse. Although the EPID dosimetric response will be raised, it 
may introduce more noise into the image. Hence this was not investigated as we 
attempted to keep the image acquisition set-up conditions as close as possible to 
the clinical imaging conditions.  
Investigation in clinical situations is the subject of our continued work in 
order to demonstrate the usefulness, strengths and limitations of the current 
algorithm on actual patients. 
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Appendix A: Solving Quadratic Equations 
The solutions of the quadratic equation 
ax2+ bx + c = 0                                                  A1 
where a, b and c are real fixed numbers, are given in exact form by the well 
known quadratic formula given by  
                                 
a
acbb
x
2
)4( 2 −±−
=                                              A2 
However if a, b and c are optimised values as in the case for the derivation of 
A(i,j) and B(i,j) in section 3.2, giving rise to unreasonable roots, then continued 
fractionation (iteration) is used to approximate the solution. The idea is that a 
function is found that, given an approximation of the solution as input (xold), 
outputs a more precise approximation (xnew). If this function is used iteratively 
by recycling the values produced on each iteration, better and better solutions 
will be reached. This process can be continued until the required level of 
precision is reached. 
The iterative scheme given in section 3.2 comes from rearrangement of equation 
(1) obtained as follows.  
Starting with:                                                       ax2+ bx + c = 0   
Taking c to the right side of the equation gives:     ax2+ bx  = - c                     A3 
Adding ax2 to both sides gives:                               2ax2+ bx  = ax2 – c              A4 
Take out a common factor:                                    x(2ax + b) = ax2 – c            A5 
Divide through  
    
bax
cax
x
+
−
=
2
2
                                                          A6 
Set up the iterative scheme as  
     
bax
cax
x
n
n
n +
−
=+ 2
2
1                                                        A7 
where xn is the old solution (xold) and xn+1 is the new solution (xnew), which is the 
second order iterative method scheme and converges quickly to the roots of the 
quadratic. 
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MATLAB ALGORITHM FOR DETERMINING THE EPL 
%Using Matlab we read EPID image and Open image data (EPID_data and OPEN) 
TRANS = -log(EPID_data./OPEN); 
 
% From equation 3.8 
Xn = (-B + sqrt(B.^2+4*A.*TRANS))./(2*B); % Xn is the initial solution 
Xn_c = mean(mean(Th_un(186:198,250:262))); %Xn_c is initial mean pixel value 
% in a 1cm ROI (first No in each coloum of Table 4-6) 
 
% Effect of MU correction 
MUs = [20 50 100 200 500]; 
MU_factor = [0.970 0.990 1.000 1.004 1.009]; 
SMUR = interp1(MUs,MU_factor,MU); % 1D Interpolation to get MU factor which  
%the image was acquired 
 
Thickness = [0 5 10 15 20 26 32 50]; 
FieldSize = [4.9 10 15 20 21.5]; 
          
% Table of correction factor  
CF = [1.216    1.281    1.368    1.447    1.523    1.640    1.739    1.840     
      1.097    1.152    1.218    1.268    1.325    1.393    1.445    1.550 
      1.046    1.076    1.116    1.138    1.178    1.206    1.249    1.350 
      1.009    1.016    1.033    1.037    1.043    1.048    1.060    1.070  
      1.000    1.000    1.000    1.000    1.000    1.000    1.000    1.000]; 
 
for i = 1:n % n is total number of times we want to iterate 
   corr = interp2(Thickness, FieldSize,CF, Xn, FieldArea*ones(384,512))/SMUR;  
   % 2D interpolation to find scatter correction (corr) due to thickness Xn, 
   % and field size (FieldArea). FieldArea is determined from EPID image 
   % using equation 3.18 
   Xn+1 = (A.*Xn.^2 -log(corr.*data./OPEN))./(2*A.*Xn + B); % equation 3.12 
   Xn+1(find(isnan(Xn+1))) = 0.0; % Any value in data which is not a number 
%(NAN) is replaced by 0 
EPL_c = mean(mean(Xn+1(186:198,250:262)));%EPL_c is mean pixel value in  
%1cm ROI  
   
end 
   
Note1: A, B and C are fixed, but the correction (corr) keep on changing, 
meaning that the coefficient of C keeps on changing, which enable the Xn+1 
values to change at each iteration. 
Note 2: corr is also a 384x512 matrix (i.e correction is applied for each pixel 
depending on the previously calculated value or EPL). corr is evaluated at the 
same area (FieldArea) of the irradiated EPID image. 
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Proof of the Convergence of the iteration 
 
According to Newton’s Method, a function xn+1 = g(xn), converges quadratically to 
r if g’(r)=0, where r is a fixed point of g, (that is g(r)=r). 
 
If we let f(x) = ax2+ bx + c = 0 ,                                                                    A8 
Then the first derivative of f(x) is given by  baxxf += 2)('                             A9 
 
From equation A7, let  g(x)  = 
b2ax
cax
x
n
2
n
1n +
−
=+                                                A10 
  
The derivative of g, 2
2
'
)2(
)2(2)(2)(
bax
baxaxcaxa
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n
nnn
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++−−
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                                             2
2
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APPENDIX B: Relation between TPR and PETD 
 
Consider the diagram below that relates the TPR and PETD for the same field 
area and phantom depth z. 
P1 Po dmax
d
SAD
f1
SourceSource
P2
z/2
f2
Source
dmax
TPR setup PETD setup
z
Po dmax
f0
Source
dmax
dmaxP’o
f0
 
 
 
The TPR at a point P1 located at an effective depth, maxdzd −= , is related to 
doses D(P1) and D(Po) at P1 and at dmax respectively by `                        
( ) ( )( )oPD
PD
PTPR 11 =                                                                                    B1 
The PETD for a depth d measured at point P2 is given by     
( ) ( )( )'22 oPD
PD
PPETD =  B2 
Where D(P2) and D(P
’
o) are doses at P2 and at dmax respectively. The dose D(P1) is 
given by 
2
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11
1 )(100
),()( 





+
=
df
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and dose 
2
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2 )(100
),()( 


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

+
=
df
f
PD
fPPDD
PD oo   B4 
neglecting the effect of appropriate back scatter at P’o and at P2.  
Combining equations B1-  B4,                     
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Where f1, fo and f2 are respective SSDs as shown in the figure above.  
Using the Mayneord factor that relates PDDs measured at different SSDs, then 
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Thus 
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Equation B8 implies that PETD is TPR, corrected for inverse square law, i.e 
taking into account the shift in the calculation point away from the isocenter. 
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